Publications, Presentations, Leadership, Service, and Awards

1. Macoska JA (2023). The use of beta-sitosterol for the treatment of prostate cancer and benign prostatic hyperplasia. Am J Clin Exp Urol. 2023 Dec 15;11(6):467-480. PMID: 38148931; PMCID: PMC10749388.

2. D’Arcy Q, Sarna-McCarthy M, Bowen D, Soto FO, Zarringhalam K, Macoska JA (2023). Beta-Sitosterol Alters Collagen Distribution in Prostate Fibroblasts. J Diet Suppl. 2023 Nov 7:1-14. doi: 10.1080/19390211.2023.2276943. Epub ahead of print. PMID: 37933457.

3. Liu TT, Pascal LE, Bauer SR, Miles HN, Panksepp JB, Lloyd GL, Li L, DeFranco DB, Ricke WA (2023). Age-Dependent Effects of Voluntary Wheel Running Exercise on Voiding Behavior and Potential Age-Related Molecular Mechanisms in Mice. J Gerontol A Biol Sci Med Sci. 2024 Jan 10:glae007. DOI: 10.1093/gerona/glae007. Epub ahead of print. PMID: 38198648.
4. Adrian AE, Liu TT, Pascal LE, Bauer SR, DeFranco DB, Ricke WA (2023). Aging-Related Mitochondrial Dysfunction is a Driver of Fibrosis in Benign Prostatic Hyperplasia. J Gerontol A Bio Sci Med Sci. 20 September 2023. DOI:10.1093/gerona/glad222
5. Popovics P, Skalitzky KO, Schroeder E, Jain A, Silver SV, Van Fritz F, Uchtmann KS, Vezina CM, Ricke WA (2022). Steroid Hormone Imbalance Drives Macrophage Infiltration and Spp1/Osteopontin+ Foam Cell Differentiation in the Prostate. J Pathol. PMID: 36825524; PMCID: PMC10231633; DOI: 10.1002/path.6074
6. Spiegelhoff A, Wang K, Ridlon M, Lavery T, Kennedy CL, George S, Stietz KPK (2023). Polychlorinated Biphenyls (PCBs) Impact Prostatic Collagen Density and Bladder Volume in Young Adult Mice Exposed during in Utero and Lactational Development. Toxics. 2023 July 13; 11(7):609; PMID 34337439; PMC8317607.
7. Ruetten H, Sandhu SK, Fox O, Zhu J, Sandhu JK, Vezina CM (2022). The Impact of Short Term, Long Term and Intermittent E.coli Infection on Male C57BL/6J Mouse Prostate Histology and Urinary Physiology. Amer J Clin Exp Urol. 2023 Feb 25;11(1):59-68; PMID 36923725; PMC10009312.
8. Thomas S, Ricke WA, Li L (2023). Toxicoproteomics of Mono(2-ethylhexyl) Phthalate and Perfluorooctanesulfonic Acid in Models of Prostatic Diseases. Chem Res Toxicol. 2023 Feb 7; Online ahead of print. PMID 36749316. DOI: 1021/acs.chemrestox.2c00328.
9. Nicholson TM, Best SL, Ricke EA, Timms BG, Ricke WA (2022). White’s Operation: The History of 19^th Century Attempts to Treat Prostate Disease with Castration. Am J Clin Exp Urol. 2022 Dec 25;10(6):462-466. eCollection 2022. PMID 36636690; PMC9831916.
10. Delafield DG, Miles HN, Ricke WA, Li L (2022). Higher Temperature Porous Graphitic Carbon Separations Differentially Impact Distinct Glycopeptide Classes. J Am Soc Mass Spectrom. 2023 Jan 4;34(1):64-74. PMID 36450095; PMC9812930; DOI: 1021/jasms.2c00249.
11. D’Arcy Q, Gharaee-Kermani M, Zhilin-Roth A, Macoska JA (2022). The IL-4/IL-13 Signaling Axis Promotes Prostatic Fibrosis. PLoS One. 2022 Oct 6;17(10): e0275064. PMID 36201508; PMC9536598; DOI: 1371/journal.pone.027506.
12. Jia L, Strand DW, Goueli RS, Gahan JC, Roehrborn CG, Mauck RJ (2022). PSA Density is Associated with BPH Cellular Composition. Prostate. 2022 Jun 2 [Online ahead of print]. PMID 35652549; DOI: 1002/pros.24367.
13. Hudson CN, He K, Pascal LE, Liu TT, Myklebust LK, Dhir R, Srivastava P, Yoshimura N, Wang Z, Ricke WA, DeFranco DB (2022). Increased COX-1 Expression in Benign Prostate Epithelial Cells is Triggered by Mitochondrial Dysfunction. Am J Clin Exp Urol. 2022 Aug 15;10(4):234-245. eCollection 2022. PMID 36051613; PMC9428567.
14. Kennedy CL, Spiegelhoff A, Lavery T, Wang K, Manuel RJ, Wang Z, Wildermuth H, Keil Stietz K (2022). Developmental Polychlorinated Biphenyl (PCB) Exposure Alters Voiding Physiology in Young Adult Male and Female Mice. Am J Clin Exp Urol. 2022 Apr 15;10(2):82-97. eCollection 2022. PMID 35528463; PMC9077147.
15. Peterson NT, Vezina CM (2022). Male Lower Urinary Tract Dysfunction: An Overlooked Endpoint in Toxicology Research. 2022 Feb 16;10(2). DOI: 10.3390/toxics10020089.
16. Delafield DG, Miles HN, Liu Y, Ricke WA, Li L (2021). Complementary Proteome and Glycoproteome Access Revealed Through Comparative Analysis of Reversed Phase and Porous Graphitic Carbon Chromatography. Anal Bioanal Chem. 2022 Feb 9. PMID 35137243. DOI: 1007/s00216-022-03934-7.
17. Ruetten HM, Wehber M, Murphy M, Cole C, Sandhu S, Oakes R, Bjorling DE, Waller K, Viviano K, Vezina CM (2021). A Retrospective Review of Canine Benign Prostatic Hyperplasia with and without Prostatitis. Clin Theroigenol. 2021 Dec;13(4):360-366. PMID 35070484; PMC8782267; NIHMS 1768784.
18. Nguyen JL, Ricke EA, Liu TT, Gerona R, MacGillivray L, Wang Z, Timms BG, Bjorling DE, vom Saal FS, Ricke WA (2021). Bisphenol-A Analogs Induce Lower Urinary Tract Dysfunction in Male Mice. Biochem Pharmacol. 2021 Dec 31;114889. PMID 34979091; PMC9436030; DOI: 10.1016/j.bcp.2021.114889.
19. Popovics P, Jain A, Skalitzky KO, Schroeder E, Ruetten H, Cadena M, Uchtmann KS, Vezina CM, Ricke WA (2021). Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation. Int J Mol Sci. 2021 Nov 18;22(22):122461. PMID 34830342; PMC8617904; DOI: 10.3390/ijms222212461.
20. Bauer SR, Walter LC, Ensrud KE, Suskind AM, Newman JC, Ricke WA, Liu TT, McVary KT, Covinsky K (2021). Assessment of Frailty and Association with Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy. JAMA Netw Open. 2021 Nov 1;4(11):e2134427. PMID 34817584; PMC8613596; DOI: 1001/jamanetworkopen.2021.34427.
21. Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan JC, Hutchinson RC, Mohler JL, Roehrborn CG, Strand DW (2021). 5-alpha Reductase Inhibitors Induce a Prostate Luminal to Club Cell Transition in Human Benign Prostatic Hyperplasia. Pathol. 2021 Dec 20. PMID 34928497; PMC8930464 [available 2023-04-04]; NIHMS1765937; DOI: 10.1002/path.5857.
22. Tannenbaum AP, Grimes MD, Brace CL, Johnson CJ, Koebe SD, Anzia LE, Mao L, Ricke WA, Hernando D, Roldán-Alzate A, Wells SA (2021). Effects of Metabolic Syndrome on Anatomy and Function of the Lower Urinary Tract Assessed on MRI. 2021 Sep 24;S0090-4295(21)00892-X; PMID 34571092; PMC8760147 [available on 2023-01-01]; DOI: 10.1016/j.urology.2021.09.006.
23. Ruetten HM, Henry GH, Liu TT, Spratt HM, Ricke WA, Strand DW, Vezina CM. A NEW Approach for Characterizing Mouse Urinary Pathophysiologies. Physiol Rep. 2021 Aug;9(15):e14964; PMID: 34337899; PMC8326900; DOI: 14814/phy2.14964.
24. Jin R, Strand DW, Forbes CM, Case T, Cates JMM, liu Q, Ramirez-Solano M, Milne GL, Sanchez S, Wang ZY, Bjorling DE, Miller NL, Matusik RJ (2021). The Prostaglandin Pathway is Activated in Patients Who Fail Medical Therapy for Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms. The Prostate. 20 July 2021 [online ahead of print]; PMID: 34288015; PMC8750893; DOI: 10.1002/pros.24190.
25. Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan JC, Hutchinson RC, Venkat SM, Roehrborn CG, Vezina CM, Strand DW (2021). Single Cell Analysis of Mouse and Human Prostate Reveals Novel Fibroblasts with Specialized Distribution and Microenvironment Interactions. J Pathol. 2021 Jun 26 [online ahead of print]; PMID: 34173975; PMC8429220 [available 2022-10-01]; NIHMS1717909; DOI: 1002/path.5751.
26. Abler LL, O’Driscoll CA, Colopy SA, Keil Stietz KP, Wang P, Wang Z, Hartmann F, Crader-Smith SM, Ouellette JN, Mehta V, Oakes S, Grimes MD, Mitchell GS, Baan M, Gallagher SJ, Davis DB, Kimple ME, Bjorling DE, Watters JJ, Vezina CM (2021). Influence of Intermittent Hypoxia, Obesity and Diabetes on Male Genitourinary Anatomy and Voiding Physiology. Amer J Physiol Renal Physiol. 2021 June 14 [online ahead of print]; PMID: 34121451; PMC8807064; DOI: 1152/ajprenal.00112.2021.
27. Turco AE, Oakes SR, Keil Stietz KP, Dunham CL, Joseph DB, Chathurvedula TS, Girardi NM, Schneider AJ, Gawdzik J, Sheftel CM, Wang P, Wang Z, Bjorling DE, Ricke WA, Tang W, Hernandez LL, Keast JR, Bonev AD, Grimes MD, Strand DW, Tykocki NR, Tanguay RL, Peterson RE, Vezina CM (2021). A Neuroanatomical Mechanism Linking Perinatal TCDD Exposure to Lower Urinary Tract Dysfunction in Adulthood. Dis Models Mech. 2021 Jun 24;dmm.049068; PMID: 34164643; PMC8326766; DOI: 1242/dmm.049068.
28. Joseph DB, Turco AE, Vezina CM, Strand DW (2020). Progenitors in Prostate Development and Disease. Dev Biol. 2021 May;473:50-58. PMID: 33529704; PMC7987809 [available on 2022-05-01]; DOI: 1016/j.ydbio.2020.11.012.
29. Wegner KA, Ruetten H, Girardi NM, O’Driscoll CA, Sandhu JK, Turco AE, Abler LL, Wang P, Wang Z, Bjorling DE, Malinowski R, Peterson RE, Strand DW, Marker PC, Vezina CM (2021). Genetic Background but Not Prostatic Epithelial Beta-catenin Influences Susceptibility of Male Mice to Testosterone and Estradiol-induced Urinary Dysfunction. Am J Clin Exp Urol. 2021 Feb 28; 9(1):121-131. PMID: 33816700; PMC8012832.
30. Thomas S, Dunn CD, Campbell LJ, Strand DW, Vezina CM, Bjorling DE, Penniston KL, Li L, Ricke WA, Goldberg TL (2021). A Multi-omic Investigation of Male Lower Urinary Tract Symptoms: Potential Role for JC Virus. PloS One. 2021 Feb 25; 16(2):e0246266. PMID: 33630889; PMC7906371; DOI: 1371/journal.pone.0246266.
31. Keil Steitz KP, Kennedy CL, Sethi S, Valenzuela, Nunez A, Wang K, Wang Z, Wang P, Spiegelhoff, Puschner B, Bjorling DE, Lein PJ (2021). In Utero and Lactational PCB Exposure Drives Anatomic Changes in the Juvenile Mouse Bladder. Current Research in Toxicology. 12 January 2021; 2(1-18); DOI: 10.1016/j.crtox.2021.01.002.
32. Vellky JE, McSweeney ST, Ricke EA, Ricke WA (2020). RNA-binding Protein DDX3 Mediates Posttranscriptional Regulation of Androgen Receptor: A Mechanism of Castration Resistance. PNAS. 2020 Nov 10;117(45):28092-28101. [e-pub 2020 Oct 26]. PMID: 33106406; PMC7668093 [available on 2021-04-26]; DOI: 1073/pnas.2008479117.
33. Ruetten H, Sanhu J, Mueller B, Wang P, Zhang HL, Wegner KA, Cadena M, Sandhu S, Abler LL, Zhu J, O’Driscoll CA, Chelgren B, Wang Z, Shen T, Barash J, Bjorling DE, Vezina CM (2020). A Uropathogenic coli UTI189 Model of Prostatic Inflammation and Collagen Accumulation for Use in Studying Aberrant Collagen Production in the Prostate. AJP-Renal. 2020 Nov 2; PMID: 33135480; PMC7847049 [available on 2022-01-01]; DOI: 10.1152/ajprenal.00431.2020.

• Vellky JE, Ricke WA (2020). Development and Prevalence of Castration-resistant Prostate Cancer Subtypes. Neoplasia. 2020 Nov;22(11):566-575. PMID: 32980775; PMC7522286; DOI: 1016/j.neo.2020.09.002.

28. Launer BM, McVary KT, Ricke WA, Lloyd GL (2020). The Rising Worldwide Impact of Benign Prostatic Hyperplasia. BJUI International. 2020 Oct 30. PMID: 33124118; DOI: 1111/bju.15286.
29. Anzia LE, Johnson CJ, Mao L, Hernando D, Bushman WA, Wells SA, Roldán-Alzate A (2020). Comprehensive Non-invasive Analysis of Lower Urinary Tract Anatomy using MRI. Abdom Radiol. 2020 Oct 11. PMID: 33040167; DOI: 1007/s00261-020-02808-9.
30. Vellky JE, Ricke EA, Huang W, Ricke WA (2020). Expression, Localization, and Function of the Nucleolar Protein BOP1 in Prostate Cancer Progression. Am J Pathol. 2020 Oct 8;S0002-9440(20)30454-5. PMID: 33039351; PMC7768348 [available on 2022-01-01]; DOI: 1016/j.ajpath.2020.09.010.
31. Bauer SR, Scherzer R, Suskind AM, Cawthon P, Ensrud KE, Ricke WA, Covinsky K, Marshall LM (2020). Co-Occurrence of Lower Urinary Tract Symptoms and Frailty Among Community-Dwelling Older Men. J Am Geriatr Soc. 2020 Aug 21; PMID: 32822081; PMC7744321 (available on 2021-12-01); DOI: 1111/jgs.16766.
32. Wei P, Hao L, Thomas S, Buchberger AR, Steinke L, Marker PC, Ricke WA, Li L (2020). Urinary Amine Metabolomics Characterization with Custom 12-plex Isobaric DiLeu Labeling. J Am Soc Mass Spectrom. 2020 Jul 17; PMID: 32678615; PMC7484200; DOI: 1021/jasms.0c00110.
33. Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Vezina CM, Matusik RJ, Ricke WA, Grabowska MM (2020). Prostatic Osteopontin Expression is Associated with Symptomatic Benign Prostatic Hyperplasia. Prostate. 2020 July [Epub 2020 May 1]; PMID: 32356572; PMC7485377 [available on 2021-07-01]; NIHMS1600763; DOI: 1002/pros.23986.
34. Ruetten H, Cole C, Wehber M, Wegner K, Girardi N, Peterson N, Scharpf B, Romero MF, Wood M, Colopy S, Bjorling DE, Vezina CM (2020). An Immunohistochemical Prostate Cell Identification Key Indicates that Aging Shifts Procollagen 1A1 Production from Myofibroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction. PloS One. 2020 Jul 29; 15(7): e0232561; DOI: 1371/journal.pone.0232564.
35. Bartolone SN, Ward EP, Wang Z, Zwaans BMM, Chancellor MB, Bjorling DE, Lamb LE (2020). Micturation Defects and Altered Bladder Function in the Klotho Mutant Mouse Model of Aging. Am J Clin Exp Urol. 2020 Jun 25; PMID: 32699807; PMC7364365.
36. Fraser MO, Smith PP, Sullivan MP, Bjorling DE, Campeau L, Andersson KE, Yoshiyama M (2020). Best Practices for Cystometric Evaluation of Lower Urinary Tract Function in Muriform Rodents. Neurourol Urodynam. 2020 Jun 8; PMID: 32511810; PMC7641986 [available on 202108-01]; NIHMS1603287; DOI: 1002/nau.24415.
37. Joseph DB, Henry GH, Malewska A, Iqbal NS, Ruetten HM, Turco AE, Abler LL, Sandhu SK, Cadena MT, Malladi VS, Reese JC, Mauck RJ, Gahan JC, Hutchinson RC, Roehrborn CG, Baker LA, Vezina CM, Strand DW. (2020) Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. Prostate Aug;80(11):872-884. PMID: 32497356; DOI: 1002/pros.24020.
38. Taylor JA, Jones MB, Besch-Williford CL, Berendzen AF, Ricke WA, vom Saal FS (2020). Interactive Effects of Perinatal BPA or DES and Adult Testosterone and Estradiol Exposure on Adult Urethral Obstruction and Bladder, Kidney, and Prostate Pathology in Male Mice. Int J Mol Sci. 2020 May 30; PMID 32486162, PMC7313472; DOI: 3390/ijms211113902.
39. Dietz C, Rueden CT, Helfrich S, Dobson ETA, Horn M, Eglinger J, Evans III EL, McLean DT, Novitskaya T, Ricke WA, Sherer NM, Zijlstra A, Berthold MR, Eliceiri KW (2020). Integration of the ImageJ Ecosystem in KNIME Analytics Platform. Front Comput Sci. 2020 Mar 17 [Epub ahead of print]; PMID: 32905440; PMC7469687; DOI: 3389/FCOMP.2020.00008.
40. Zwaans BMM, Wegner KA, Bartolone SN, Vezina CM, Chancellor MB, Lamb LE (2020). Radiation Cystitis Modeling: A Comparative Study of Bladder Fibrosis Radio-sensitivity in C57BL/6, C3H, and BALB/c Mice. Physiol Rep. 2020 Feb;8(4):e14377. PMID: 32109348; PMC7048381; DOI: 14814/phy2.14377.
41. Thomas S, Hao L, DeLaney K, McLean DT, Steinke L, Marker PC, Vezina CM, Li L, Ricke WA (2020). Spatiotemporal Proteomics Reveals the Molecular Consequences of Hormone Treatment in a Mouse Model of Lower Urinary Tract Dysfunction. J Proteome Res. 2020 Feb 28 [Epub ahead of print]; PMID: 32108482; PMC733919, DOI: 1021/acs.jproteome.9b00451.
42. Turco AE, Thomas S, Crawford LK, Tang W, Peterson RE, Li L, Ricke WA, Vezina CM (2020). In Utero and Lactational 2,3,7,8-tetrachlorodibenzo-p­-dioxin (TCDD) Exposure Exacerbates Urinary Dysfunction in Hormone-treated C57BL/6J Mice Through a Non-Malignant Mechanism Involving Proteomic Changes in the Prostate that Differ from Those Elicited by Testosterone and Estradiol. Am J Clin Exp Urol. 2020 Feb 25;8(1):59-72 [eCollection 2020]. PMID: 32211455; PMC7076297.
43. Maguire M, Larsen MC, Vezina CM, Quadro L, Kim Y-K, Tanumihardjo SA, Jefcoate CR (2020). Cyp1b1 Directs Srebp-mediated Cholesterol and Retinoid Synthesis in Perinatal Liver; Association with Retinoic Acid Activity During Fetal Development. PloS One. 2020 Feb 6;15(2):e0228436. PMID: 32027669; PMC7004353; DOI: 1371/journal.pone.0228436.
44. Wegner KA, Mueller BR, Unterberger CJ, Avila EJ, Ruetten H, Turco AE, Oakes SR, Girardi NM, Halberg RB, Swanson SM, Marker PC, Vezina CM (2020).Prostate Epithelial-specific Expression of Activated PI3K Drives Stromal Collagen Production and Accumulation. J Pathol. 2020 Feb; 250(2):231-242 [Epub 2019 Nov 28]. PMID: 31674011; PMC7071816; DOI: 1002/path.5363.
45. Wu H, Liu B, Yang K, Winston-McPherson GN, Leisten ED, Vezina CM, Ricke WA, Peterson RE, Tang W (2020). Synthesis and Biological Evaluation of FICZ Analogues as Agonists of Aryl Hydrocarbon Receptor. Bioorg Med Chem. 2020 Jan 7 [Epub ahead of print]. PMID: 31952965; PMC7077633; DOI: 1016/j.bmcl.2020.126959.
46. Ruetten H, Wegner KA, Kennedy CL, Turco AE, Zhang HL, Wang P, Sandhu JK, Sandhu SK, Morkrid J, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2020). Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Urethral Histology. Am J Physiol-Renal Physiol. 2020 Jan 6 [Epub ahead of print]. PMID: 31904290; PMC7099510; DOI: 1152/ajprenal.00540.2019.
47. Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu JK, Sandhu SK, Mueller BR, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2020). Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Functional Assessment. Am J Physiol-Renal Physiol. 2020 Jan 6 [Epub ahead of print]. PMID: 31904290; PMC6843040; DOI: 1152/ajprenal.00540.2019.
48. Farahmand S, O’Connor C, Macoska JA, Zarringhalam K (2019). Causal Inference Engine A Platform for Directional Gene Set Enrichment Analysis and Inference of Active Transcriptional Regulator. Nucleic Acids Res. 2019 Dec 16;47(22):11563-11573. PMID: 31701125; DOI: 1093/nar/gkz1046.
49. Uchtmann KS, Taylor JA, Timms BG, Stahlhut RW, Ricke EA, Ellersieck MR, vom Saal FS, Ricke WA (2019). Fetal Bisphenol A and Ethinylestradiol Exposure Alters Male Rat Urogenital Tract Morphology at Birth: Confirmation of Prior Low-dose Findings in CLARITY-BPA. Reprod Toxicol. 2020 Jan; 91:131-141 [Epub 2019 Nov 19]. PMID: 31756437; PMC7339120; DOI: 1016/j.reprotox.2019.11.007.
50. Vellky JE, Bauman TM, Ricke EA, Huang W, Ricke WA (2019). Incidence of Androgen Receptor and Androgen Receptor Variant 7 Coexpression in Prostate Cancer. 2019 Dec; 79(16)):1811-1822 [Epub 2019 Sep 10]. PMID: 31503366; PMC7339117; DOI: 10.1002/pros.23906.
51. Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu J, Sandhu S, Morkrid J, Mueller BR, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2019). Insight and Resources from a Study of the “Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology”. Toxicol Pathol. 2019 Dec; 47(8):1038-1042 [Epub 2019 Oct 29]. PMID: 31662055; PMC6910975; DOI: 1177/0192623319877867.
52. Macoska JA, Uchtmann KS, Leverson GE, McVary KT, Ricke WA (2019). Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the Medical Therapy of Prostatic Symptoms (MTOPS) Study. J Urol. 2019 Dec; 202(6):1240-1247 [Epub 2019 Jun 12]. PMID: 31188728; PMC7339116; DOI: 1097/JU.0000000000000385.
53. Cunha GR, Sinclair A, Ricke WA, Robboy SJ, Cao M, Baskin LS (2019). Reproductive Tract Biology: Of Mice and Men. Differentiation. 2019 Nov-Dec; 110:49-63 [Epub 2019 Sep 6]. PMID: 31622789; PMC7339118; DOI: 1016/j.diff.2019.07.004.
54. Bhandari RK, Taylor JA, Sommerfeld-Sager J, Tillitt DE, Ricke WA, Vom Saal FS (2019). Estrogen Receptor 1 Expression and Methylation of Esr1 Promoter in Mouse Fetal Prostate Mesenchymal Cells Induced by Gestational Exposure to Bisphenol A. Environ Epigenet. 2019 Aug 22; 5(3):dvz012 [eCollection 2019 Jul]. PMID: 31463084; PMC6705189; DOI: 1093/eep/dvz012.
55. Liu TT, Rodgers A, Nicholson TN, Macoska JA, Marker PC, Vezina CM, Bjorling DE, Roldán-Alzate A, Hernando D, Lloyd GL, Hacker T, Ricke WA (2019). Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing. J Vis Exp. 2019 Aug 14; (150), e59802; PMID: 31475976; PMC7328372; DOI: 3791/59802.
56. Lloyd GL, Marks JM, Ricke WA (2019). Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What is the Role and Significance of Inflammation? Curr Urol Rep. 2019 Aug 3; 20(9):54. PMID: 31377881; PMC7339114; DOI: 1007/s11934-019-0917-1.
57. Dalghi MG, Clayton DR, Ruiz WG, Al-Bataineh MM, Satlin L, Kleyman T, Ricke WA, Carattino M, Apodaca G (2019). Expression and Distribution of PIEZO1 in the Mouse Urinary Tract. Am J Physiol-Renal Physiol. 2019 Aug 1; 317(2):F303-321 [Epub 2019 Jun 5]. PMID: 31166705; PMC6732449; DOI: 1152/ajprenal.00214.2019.
58. Liu TT, Ewald JA, Ricke EA, Bell R, Collins C, Ricke WA (2019). Modeling Human Prostate Cancer Progression in Vitro. 2019 Jul 20; 40(7):893-902. PMID: 30590461; PMC6642366; DOI: 10.1093/carcin/bgy185.
59. Sehgal PD, Bauman TM, Nicholson TM, Vellky JE, Ricke EA, Tang W, Xu W, Huang W, Ricke WA (2019). Tissue-specific Quantification and Localization of Androgen and Estrogen Receptors in Prostate Cancer. Hum Pathol. 2019 Jul; 89:99-108 [Epub 2019 May 3]. PMID: 31054895; PMC6642018; DOI: 1016/j.humpath.2019.04.009.
60. Turco AE, Cadena MT, Zhang HL, Sandhu JK, Oakes SR, Chathurvedula T, Peterson RE, Keast JR, Vezina CM (2019). A Temporal and Spatial Map of Axons in the Developing Mouse Prostate. Histochem Cell Biol. 2019 Jul; 152(1):35-45 [Epub 2019 Apr 11]. PMID: 30976911; PMC6685201; DOI: 1007/s00418-019-01784-6.
61. McLean D, Rutkowski DR, Liu TT, Hernando D, Ricke WA, Roldán-Alzate A (2019). MRI-based Method for Lower Urinary Tract Dysfunction in Mice. Am J Clin Exp Urol. 2019 Jun 15; 7(3):153-158 [eCollection 2019]. PMID: 31317054; PMC6627546.
62. Wang Z, Guzman EC, Nimunkar A, Keil KP, Vezina CM, Ricke WA, Macoska J, Bjorling DE (2019). Void Sorcerer: An Open Source, Open Access Framework for Mouse Uroflowmetry. Am J Clin Exp Urol. 2019 Jun 15; 7(3):170-177 [eCollection 2019]. PMID: 31317056; PMC6627548.
63. Hao L, Thomas S, Greer T, Vezina CM, Bajpai S, Ashok A, De Marzo AM, Bieberich CJ, Li L, Ricke WA (2019). Quantitative Proteomic Analysis of a Genetically Induced Prostate Inflammation Mouse Model via Custom 4-plex DiLeu Isobaric Labeling. Am J Physiol-Renal Physiol. 2019 Jun 1; 316(6):F1236-F1243 [Epub 2019 Apr 17]. PMID: 30864837; PMC6620594; DOI: 1152/ajprenal.00387.2018.
64. Ricke WA, Bruskewitz RC, Liu TT (2019). Targeting a Fibrotic Bottleneck May Provide an Opening in the Treatment of LUTS. Am J Physiol-Renal Physiol. 2019 Jun 1; 316(6):F1091-1093 [Epub 2019 Mar 13]. PMID: 30864837; PMC6620586; DOI:1152/ajprenal.00102.2019.
65. Vellky JE, Ricke EA, Huang W, Ricke WA (2019). Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis. Am J Pathol. 2019 Jun; 189(6):1256-1267 [Epub 2019 Mar 27]. PMID: 30926334; PMC6547056; DOI: 1016/j.ajpath.2019.02.011.
66. Affas S, Schäfer FM, Algarrahi K, Cristofaro V, Sullivan MP, Yang X, Costa K, Sack B, Gharaee-Kermani M, Macoska JA, Gundogdu G, Seager C, Estrada CR Jr, Mauney JR (2019). Augmentation Cystoplasty of Diseased Porcine Bladders with Bi-Layer Silk Fibroin Grafts. Tissue Eng Part A. 2019 Jun; 25(11-12):855-866 [Epub 2018 Oct 26]. PMID: 30191762; PMC6589503; DOI: 1089/ten.TEA.2018.0113.
67. Liu TT, Thomas S, McLean DT, Roldán-Alzate A, Hernando D, Ricke EA, Ricke WA (2019). Prostate Enlargement and Altered Urinary Function Are Part of the Aging Process. 2019 May 13; 11(9):2653-2699. PMID: 31085797; PMC6535061; DOI: 10.18632/aging.101938.
68. Almanza D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, Colaneri C, Riley T, Macoska JA (2019). Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. Dig Dis Sci. 2019 May; 64(5):1257-1269 [Epub 2018 Dec 5]. PMID: 30519850; PMC6512804; DOI: 1007/s10620-018-5398-4.
69. Macoska JA, Wang ZY, Virta J, Zacharias N, Bjorling DE (2019). Inhibition of the CXCL12/CXCR4 Axis Prevents Periurethral Collagen Accumulation and Lower Urinary Tract Dysfunction In Vivo. 2019 May; 79(7):757-767 [Epub 2019 Feb 27]. PMID: 30811623; PMC7269149; DOI: 10.1002/pros.23781; NIHMS: 101632.
70. Lloyd GL, Ricke WA, McVary KT (2019). Inflammation, Voiding and BPH Progression. J Urol. 2019 May; 201(5):868-870 [Epub 2019 Jan 25]. PMID: 30694937; PMC7339115; DOI: 1097/JU.0000000000000049.
71. Wegner KA, Mehta V, Johansson JA, Mueller BR, Keil KP, Abler LL, Marker PC, Taketa MM, Headon DJ, Vezina CM (2019). Edar is a Downstream Target of Beta-catenin and Drives Collagen Accumulation in the Mouse Prostate. Biol Open. 2019 Mar 18; 8(3), pii:bio037945. PMID: 30745437; PMC6451354; DOI: 1242/bio.037945.

• Joseph DB, Chandrashekar AS, Abler LL, Chu L-F, Thomson JA, Vezina CM (2019). Epithelial DNA Methyltransferase-1 Regulates Cell Survival, Growth and Differentiation in Developing Prostate Buds. Dev Biol. 2019 Mar 15; 447(2):157-169 [Epub 2019 Jan 16]. PMID: 30659795; PMC6469356; DOI: 1016/j.ydbio.2019.01.011; NIHMS1519785.

73. Joseph DB, Chandrashekar AS, Chu L-F, Thomson JA, Vezina CM (2019). A Folic Acid-Enriched Diet Attenuates Prostate Involution in Response to Androgen Deprivation. 2019 Feb; 79(2):183-194 [Epub 2018 Oct 8]. PMID: 30298636; PMC6420320; DOI: 10.1002/pros.23723.
74. Joseph DB, Strand DW, Vezina CM (2018). DNA Methylation in Development and Disease: An Overview for Prostate Researchers. Amer J Clin Exp Urol. 2018 Dec 20; 6(6):197-218 [eCollection 2018]. PMID: 30697577; PMC6334199.
75. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra. Cell Reports. 2018 Dec 18; 25(12):3530-3542.e5. PMID: 30566875; PMC6411034; DOI: 1016/j.celrep.2019.11.086; NIHMS1517612.
76. Hill WG, Zeidel ML, Bjorling DE, Vezina CM (2018). The Void Spot Assay: Recommendations on the Use of a Simple Micturition Assay for Mice. Amer J Physiol-Renal Physiol. 2018 Nov 1; 315(5):F1422-1429 [Epub 2018 Aug 29]. PMID: 30156116; PMC6293303; DOI: 1152/ajprenal.00350.2018.
77. Nicholson TM, Nguyen JL, Leverson GE, Taylor JA, Vom Saal FS, Wood RW, Ricke WA (2018). The Endocrine Disruptor Bisphenol-A is Implicated in Urinary Voiding Dysfunction in Male Mice. Am J Physiol-Renal Physiol. 2018 Nov 1; 315(5):F1208-F1216 [Epub 2018 Jul 18]. PMID: 30019933; PMC6293302; DOI: 1152/ajprenal.00582.2017.
78. Hao L, Shi Y, Thomas S, Vezina C, Bajpai S, Ashok A, Bieberich CJ, Ricke WA, Li L (2018). Comprehensive Urinary Metabolomic Characterization of a Genetically induced Mouse Model of Prostatic Inflammation. Int J Mass Spectrom. 2018 Nov; 434:185-192 [Epub 2018 Sep 22]. PMC6414212; DOI: 1016/j.ijms.2018.09.017; NIHMS 1013142.
79. Wegner KA, Abler LL, Oakes SR, Mehta GS, Ritter E, Hill WG, Zwaans BMM, Lamb LE, Wang Z, Bjorling DE, Ricke WA, Macoska J, Marker PC, Southard-Smith EM, Eliceiri KW, Vezina CM (2018). Void Spot Assay Procedural Optimization and Software for Rapid and Objective Quantification of Rodent Voiding Function, Including Overlapping Urine Spots. Amer J Physiol-Renal Physiol. 2018 Oct 1; 315(4):F1067-1080 [Epub 2018 Jul 4]. PMID: 29972322; PMC6230749; DOI: 1152/ajprenal.00245.2018.
80. Shea MP, O’Leary KA, Wegner KA, Vezina CM, Schuler LA (2018). High Collagen Density Augments mTOR-dependent Cancer Stem Cells in ERα+ Mammary Carcinomas, and Increases mTOR-independent Lung Metastases. Cancer Lett. 2018 Oct 1; 433:1-9 [Epub 2018 Jun 20]. PMID: 29935374; PMC6064659; DOI: 1016/j.canlet.2018.06.025.
81. Abler LL, Vezina CM (2018). Links Between Lower Urinary Tract Symptoms, Intermittent Hypoxia, and Diabetes: Causes or Cures? Respir Physiol Neurobiol. 2018 Oct; 256:87-96 [Epub 2017 Sep 18]. PMID: 28923778; PMC5857412; DOI: 1016/j.resp.2017.09.009.
82. Cunha GR, Vezina CM, Isaacson D, Ricke WA, Timms BG, Cao M, Franco O, Baskin LS (2018). Development of the Human Prostate. 2018 Sep-Oct; 103:24-45 [Epub 2018 Sep 4]. PMID: 30224091; PMC6234090; DOI: 10.1016/j.diff.2018.08.005. Review.
83. Joseph DB, Chandrashekar AS, Abler LL, Chu LF, Thomson JA, Mendelsohn C, Vezina CM (2018). In Vivo Replacement of Damaged Bladder Urothelium by Wolffian Duct Epithelial Cells. Proc Natl Acad Sci USA. 2018 Aug 14; 115(33):8394-8399 [Epub 2018 Jul 30]. PMID: 30061411; PMC6099915; DOI: 1073/pnas.1802966115.
84. Ruetten H, Wegner KA, Romero MF, Wood MW, Marker PC, Strand DW, Colopy SA, Vezina CM (2018). Prostatic Collagen Architecture in Neutered and Intact Canines. 2018 Aug; 78(11):839-848 [Epub 201 May 8]. PMID: 29740846; PMC6356104; DOI: 10.1002/pros.23641; ISSN 1097-0045; NIHMS1003000.
85. Hao L, Wang J, Page D, Asthana S, Zetterberg H, Carlsson C, Okonkwo OC, Li L (2018). Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease. Sci Rep. 2018 Jun 18; 8(1):9291. PMID: 29915347; PMC6006240; DOI: 1038.s41598-018-27031-x.
86. Coriano CG, Liu F, Sievers CK, Liang M, Wang Y, Lim Y, Yu M, Xu W (2018). A Computational-Based Approach to Identify Estrogen Receptor Alpha/Beta Heterodimer Selective Ligands. Mol Pharmacol. 2018 Mar; 93(3):197-207 [Epub 2018 Jan 4]. PMID: 29295894; PMC5801554; DOI: 1124/mol.117.108696.
87. Patalano-Salsman S, Rodriguez-Nieves J, Colaneri C, Cotellessa J, Almanza D, Zhilin-Roth A, Riley T, Macoska J (2018). CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled to Cullin-RING Ubiqutin Ligase Activation. Sci Rep. 2018 Feb 22; 8(1):3499 [Epub 2018 Feb 22]. PMID: 29472636; PMC5823879; DOI: 1038/s41598-018-21506-7.
88. Ritter KE, Wang Z, Vezina CM, Bjorling DE, Southard-Smith EM (2017). Serotonin Receptor 5-HT3A Affects Development of Bladder Innervation and Urinary Bladder Function. Front Neurosci. 2017 Dec 12; 11:690 [Epub 2017 Dec 12]. PMID: 29311772; PMC5732969; DOI: 3389/fnins.2017.00690.
89. Wegner KA, Cadena MT, Trevena R, Turco AE, Gottschalk A, Halberg RB, Guo J, McMahon JA, McMahon AP, Vezina CM (2017). An Immunohistochemical Identification Key for Cell Types in Adult Mouse Prostatic and Urethral Tissue Sections. PLoS One. 2017 Nov 16; 12(11):e0188413 [Epub 2017 Nov 16]. PMID: 29145476; PMC5690684; DOI: 1371/journal.pone.0188413.
90. Liu F, Ma F, Wang Y, Hao L, Zeng H, Jia C, Wang Y, Liu P, Ong IM, Li B, Chen G, Jiang J, Gong S, Li L, Xu W (2017). PKM2 Methylation by CARM1 Activates Aerobic Glycolysis to Promote Tumorigenesis. Nat Cell Biol. 2017 Nov; 19(11):1358-70 [Epub 2017 Oct 24]. PMID: 29058718; PMC5683091; DOI: 1038/ncb3630.
91. McLean DT, Strand DW, Ricke WA (2017). Prostate Cancer Xenografts and Hormone Induced Prostate Carcinogenesis. 2017 Sep-Oct; 97:23-32 [Epub 2017 Sep 8]. PMID: 28923776; PMC6413512; ISSN 1432-0436; DOI: 10.1016/j.diff.2017.08.005.
92. Keikhosravi A, Liu Y, Drifka C, Woo KM, Verma A, Oldenbourg R, Eliceiri KW (2017). Quantification of Collagen Organization in Histopathology Samples Using Liquid Crystal Based Polarization Microscopy. Biomed Opt Express. 2017 Aug 29; 8(9):4243-56 [Epub 2017 Oct 3]. PMID: 28966862; PMC5611938; DOI: 1364/BOE.8.004243.
93. Liu Y, Keikhosravi A, Mehta GS, Drifka CR, Eliceiri KW (2017). Methods for Quantifying Fibrillar Collagen Alignment. Methods Mol Biol. 2017; 1627:429-51 [Epub 2017 Aug 24]. PMID: 28836218; PMC6343484; DOI: 1007/978-1-4939-7113-8_28.
94. McAuley E, Mustafi D, Simons B, Valek R, Zamora M, Markiewicz E, Lamperis S, Williams A, Roman B, Vezina CM, Karczmar G, Oto A, Vander Griend D (2017). Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction. Amer J Pathol. 2017 Aug 18; 187:2378-2387. PMID: 28823870; PMC5762949; DOI: 1016/j.ajpath.2017.07.014.
95. Wegner KA, Keikhosravi A, Eliceiri KW, Vezina CM (2017). Fluorescence of Picrosirius Red Multiplexed With Immunohistochemistry for the Quantitative Assessment of Collagen in Tissue Sections. J Histochem Cytochem. 2017 Aug; 65(8):479-90 [Epub 2017 Jul 12]. PMID: 28692327; PMC5533271; DOI: 1369/0022155417718541.
96. Strand DW, Costa DN, Francis F, Ricke WA, Roehrborn CG (2017). Targeting Phenotypic Heterogeneity in Benign Prostatic Hyperplasia. 2017 Jul-Aug; 96:49-61 [Epub 2017 Aug 4]. PMID: 28800482; PMC566834; DOI: 10.1016/j.diff.2017.07.005. Review.
97. Shishkova E, Zeng H, Liu F, Kwiecien NW, Hebert AS, Coon JJ, Xu W (2017). Global Mapping of CARM1 Substrates Defines Enzyme Specificity and Substrate Recognition. Nat Commun. 2017 May 24; 8:15571 [Epub 2017 May 26]. PMID: 28537268; PMC5458078; DOI: 1038/ncomms15571.
98. Le B, Powers GL, Tam YT, Schumacher N, Malinowski RL, Steinke L, Kwon G, Marker PC (2017). Multi-drug Loaded Micelles Delivering Chemotherapy and Targeted Therapies Directed Against HSP90 and the PI3K/AKT/mTOR Pathway in Prostate Cancer. PLoS One. 2017 Mar 28; 12(3):e0174658 [Epub 2017 Mar 28]. PMID: 28350865; PMC5370140; DOI: 1371/journal/pone.0174658.
99. Mulligan WA, Wegner KA, Keil KP, Mehta V, Taketo M, Vezina CM (2017). Beta-Catenin and Estrogen Signaling Collaborate to Drive Cyclin D1 Expression in Developing Mouse Prostate. 2017 Jan-Feb; 93:66-71 [Epub 2016 Dec 2]. PMID: 27918915; PMC5285411; DOI: 10.1016/j.diff.2016.11.002.
100. Drifka CR, Leoffler AG, Mathewson K, Mehta G, Keikhosravi A, Liu Y, Lemanik S, Ricke WA, Weber SM, Kao WJ, Eliceiri KW (2016). Comparison of Picrosirius Red Staining with Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples. J Histochem Cytochem. 2016 Sep; 64(9):519-29 [Epub 2016 Jul 22]. PMID: 27449741; PMC5006137; DOI: 1369/0022155416659249.
101. Hao L, Greer T, Page D, Shi Y, Vezina CM, Macoska JA, Marker PC, Bjorling DE, Bushman W, Ricke WA, Li L (2016). In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. Sci Rep. 2016 Aug 9; (6):30869. PMID: 27502322; PMC4977550; DOI: 1038/srep30869.
102. Rodriguez-Nieves JA, Patalano SC, Almanza D, Gharaee-Kermani M, Macoska JA (2016). CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion Through Non-Canonical EGFR/MEK/ERK Signaling. PLoS One. 2016 Jul 19; 11(7):e0159490 [eCollection 2016]. PMID: 27434301; PMC4951124; DOI: 1371/journal/pone.0159490.
103. Liu TT, Grubisha MJ, Frahm KA, Wendell SG, Liu J, Ricke WA, Auchus RJ, DeFranco DB (2016). Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor Beta (Erbeta) Response to 5alpha-reductase Inhibition in Prostate Epithelial Cells. J Biol Chem. 2016 Jul 8; 291(28):14747-60 [Epub 2016 May 13]. PMID: 27226548; PMC4938192; DOI: 1074/jbc.M115.711515.
104. Gharaee-Kermani M, Moore BB, Macoska JA (2016). Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion. PLoS One. 2016 Jul 1; 11(7):e0158357 [eCollection 2016]. PMID: 27367854; PMC4930165; DOI: 1371/journal.pone.0158357.
105. Jeong CH, Gao L, Dettro T, Wagner ED, Ricke WA, Plewa JM, Flaws JA (2016). Monohaloacetic Acid Drinking Water Disinfection By-Products Inhibit Follicle Growth and Steroidogenesis in Mouse Ovarian Antral Follicles In Vitro. Reprod Toxicol. 2016 Jul; 62:71-6 [Epub 2016 May 2]. PMID: 27151372; PMC4905796; DOI: 1016/j.reprotox.2016.04.028.
106. Bauman TM, Vezina CM, Ricke EA, Halberg RB, Huang W, Peterson RE, Ricke WA (2016). Expression and Colocalization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression. Hum Pathol. 2016 May; 51:124-33 [Epub 2016 Jan 19]. PMID: 2706770; PMC4830919; DOI: 1016/j.humpath.2015.12.024.
107. Bauman TM, Ricke EA, Drew SA, Huang W, Ricke WA (2016). Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging. J Vis Exp. 2016 Apr 8; (110):53837. PMID: 27167094; PMC4913774; DOI: 3791/53837.
108. Ricke WA, Lee CW, Clapper TR, Schneider AJ, Moore RW, Keil KP, Abler LL, Wynder JL, López Alvarado A, Beaubrun I, Vo J, Bauman TM, Ricke EA, Peterson RE, and Vezina CM (2016). In utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood. Toxicol Sci. 2016 Apr; 150(2):429-40 [Epub 2016 Feb 9]. PMID: 26865671; PMC4900134; DOI: 1093/toxsci/kfw009.
109. Thomas S, Hao L, Ricke WA, Li L (2016). Biomarker Discovery in Mass Spectrometry-Based Urinary Proteomics. Proteomics Clin Appl. 2016 Apr; 10(4):358-70 [Epub 2016 Feb 11]. PMID: 26703953; PMC4888976; DOI: 1002/prca.201500102. Review.
110. Keil KP, Abler LL, Altmann HM, Bushman W, Marker PC, Li L, Ricke WA, Bjorling DE, Vezina CM (2016). Influence of Animal Husbandry Practices on Void Spot Assay Outcomes in C57BL/6J Male Mice. Neurourol Urodyn. 2016 Feb; 35(2):192-8 [Epub 2014 Nov 12]. PMID: 25394276; PMC4428995; DOI: 1002/nau.22692.
111. Bauman TM, Becka AJ, Sehgal PD, Huang W, Ricke WA (2015). SIGIRR/TIR8, an Important Regulator of TLR4 and IL-1R-mediated NF-kB Activation, Predicts Biochemical Recurrence after Prostatectomy in Low-Grade Prostate Carcinomas. Hum Pathol. 2015 Nov; 46(11):1744-51 [Epub 2015 Jul 29]. PMID: 26344417; PMC4661098; DOI: 1016/j.humpath.2015.07.015.
112. Gamat M, Malinowski RL, Parkhurst LJ, Steinke LM, Marker PC (2015). Ornithine Decarboxylase Activity is Required for Prostatic Budding in the Developing Mouse. PLoS One. 2015 Oct 1; 10(10):e0139522 [eCollection 2015]. PMID: 26426536; PMC4534462; DOI: 1371/journal.pone.0139522.
113. Wynder JL, Nicholson TM, DeFranco DB, Ricke WA (2015). Estrogens and Male Lower Urinary Tract Dysfunction. Curr Urol Rep. 2015 Sep; 16(9):61. PMID: 26156791; PMC4732275; DOI: 1007/s11934-015-0534-6; NIHMS753980. Review.
114. Greer T, Hao L, Nechyporenko A, Lee S, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS). PLoS One. 2015 Aug 12; 10(8):e0135415 [eCollection 2015]. PMID: 26267142; PMC4534462; DOI: 1371/journal.pone.0135415.

• Begley LA, Kasina S, Shah RB, Macoska JA (2015). Signaling Mechanisms Coupled to CXCL12/CXCR4-mediated cellular Proliferation are PTEN-dependent. Am J Clin Exp Urol. 2015 Aug 8; 3(2):91-9 [eCollection 2015]. PMID: 26309898; PMC4539110.

116. Bauman TM, Ewald JA, Huang W, Ricke WA (2015). CD147 Expression Predicts Biochemical Recurrence after Prostatectomy Independent of Histological and Pathologic Features. BMC Cancer. 2015 Jul 25; 15:549. PMID: 26209327; PMC4514016; DOI: 1186/s12885-015-1559-4.

• Bjorling DE, Wang Z, Vezina CM, Ricke WA, Keil KP, Yu W, Guo L, Zeidel ML, Hill WG (2015). Evaluation of Voiding Assays in Mice: Impact of Genetic Strains and Sex. Amer J Physiol-Renal Physiol. 2015 Jun 15; 308(12):F1369-78 [Epub 2015 Apr 22]. PMID: 25904700; PMC4469884; DOI: 1152/ajprenal.00072.2015.

118. Keil KP, Abler LL, Altmann HM, Wang ZY, Wang P, Ricke WA, Bjorling DE, Vezina CM (2015). Impact of a Folic Acid-Enriched Diet on Prostate and Urinary Function in Mice Treated with Testosterone and Estradiol. Amer J Physiol-Renal Physiol. 2015 Jun 15; 308(12):F1431-43 [Epub 2015 Apr 8]. PMID: 25855514; PMC4469891; DOI 1152/ajprenal.00674.2014.
119. Theberge AB, Yu J, Young EW, Ricke WA, Bushman W, Beebe DJ (2015). Microfluidic Multiculture Assay to Analyze Biomolecular Signaling in Angiogenesis. Anal Chem. 2015 Mar 17; 87(6):3239-46 [Epub 2015 Feb 26]. PMID: 25719435; PMC4405103; DOI: 1021/ac503700f.
120. Moses MA, Henry EC, Ricke WA, Gasiewicz TA (2015). The Heat Shock Protein 90 Inhibitor, (-)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model. Cancer Prev Res (Phila). 2015 Mar; 8(3):249-57 [Epub 2015 Jan 20]. PMID: 25604133; PMC4355219; DOI: 1158/1940-6207.CAPR-14-0224.
121. Nicholson TM, Moses MA, Uchtmann KS, Keil KP, Bjorling DE, Vezina CM, Wood RW, Ricke WA (2015). Estrogen Receptor-α is a Key Mediator and Therapeutic Target for Bladder Complications of Benign Prostatic Hyperplasia. J Urol. 2015 Feb; 193(2):722-729 [Epub 2014 Aug 25]. PMID: 25167991; PMC4305478; DOI: 1016/j.juro.2014.08.093.
122. Powers GL, Hammer KDP, Domenech M, Frantskevich K, Malinowski RL, Bushman W, Beebe DJ, Marker PC (2015). Phosphodiesterase 4D Inhibitors Limit Prostate Cancer Growth Potential. Mol Cancer Res. 2015 Jan; 13(1):149-60 [Epub 2014 Aug 22]. PMID: 25149359; PMC4312503; DOI: 1158/1541-7786.MCR-14-0110.
123. Bauman TM, Vezina CM, Huang W, Marker PC, Peterson RE, Ricke WA (2014). Beta-Catenin is Elevated in Human Benign Prostatic Hyperplasia Specimens Compared to Histologically Normal Prostate Tissue. Am J Clin Exp Urol. 2014 Dec 25; 2(4):313-22 [eCollection 2014]. PMID: 25606577; PMC4297327
124. Bauman TM, Nicholson TM, Abler LL, Eliceiri KW, Huang W, Vezina CM, Ricke WA (2014). Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules. PLoS One. 2014 Oct 2; 9(10):e109102 [eCollection 2014]. PMID: 25275645. PMC4183548; DOI: 1371/journal.pone.0109102.

1. Caesar, R., Sarna-McCarthy M, Macoska, J. Urinary Collagen Levels are Diagnostic for Men with Severe Lower Urinary Tract Symptoms (LUTS). American Urological Association Annual Meeting, San Antonio, May 3-6, 2024.
2. Rezania, M. Javid, W.A. Ricke. Integrating Algorithmic Development to Research Recruitment: Building a New System. The International Association for Dental Research, March 13-16, New Orleans, LA
3. Ridlon M, Kennedy CL, Wang K, Spiegelhoff A, Stietz KK. Developmental exposure to polychlorinated biphenyls alters bladder contractility in mice with sex- and dose-dependence. Nov 29, 2023. Kansas City, MO. 2023 Annual CAIRIBU Meeting.
4. Kennedy CL, Ridlon M, Spiegelhoff A, Jenny Jia, Wang K, Stietz KK. Developmental exposure to polychlorinated biphenyls alters voiding function in adult mice in part via a CCR2 mediated mechanism. Nov 29, 2023. Kansas City, MO. 2023 Annual CAIRIBU Meeting.
5. Ambrogi M, Ridlon M, Stietz K, Hernandez L, Vezina C. Role of Peripheral 5-HT in the urethral tonus and voiding: Preliminary Results.International Continence Society Annual Meeting. September 27-29, 2023. Toronto, Canada.
6. Morrison J, Farhat W, Keil Stietz KP. Examination of Gene Markers of Urethral Development in Sonic Hedgehog Signaling Deficient Mice.KUH Summer Undergraduate Research Symposium. University of Wisconsin-Madison. Aug. 1-3, 2023.
7. Wang K, Ridlon M, Kennedy CL, Jia Z, Keil Stietz KP. Polychlorinated Biphenyls Do Not Affect Mouse Prostate Development. KUH Summer Undergraduate Research Symposium. University of Wisconsin-Madison. Aug. 1-3, 2023.
8. Ridlon M, Kennedy CL, Spiegelhoff A, Keil Stietz KP. Developmental Exposure to the Environmental Toxicant Polychlorinated Biphenyls (PCBs) Alters Voiding Physiology and TRPV1-mediated Voiding in Mice. UW Madison SVM Research Day, April 12th 2023.
9. Kennedy CL, Ridlon M, Spiegelhoff A, Wang K, Jia Z, Pyles K, Keil Stietz KP. Developmental exposure to polychlorinated biphenyls in combination with a high fat diet alters voiding function in adult mice potentially via inflammatory mechanisms. UW Madison SVM Research Day, April 12th 2023.
10. Lafin J, Malewska A, Zimmern P, Carmel M, Lemack G, Strand DW, Goueli R (2023). “A Cellular Atlas of the Normal Adult Human Female Urethra”. American Urological Association 2023 Annual Meeting, Chicago, IL, April 28-May 1, 2023.
11. Nuno M, Lafin J, Scarpini C, Savelyeva A, Wang Z, Gahan J, Jia L, Lewis C, Murray S, Cheng Y, Margulis V, Woldu S, Strand DW, Coleman N, Amatruda J, Frazier L, Murrary M, Bagrodia A (2023). “Comparison of Serum miR-371a-3p Assay Performance by Digital Droplet PCR and Reverse Transcriptase Quantitative PCR in Malignant Germ Cell Tumor Patients”. American Urological Association 2023 Annual Meeting, Chicago, IL, April 28-May 1, 2023.
12. Farhat W, Yadav P, Ambrogi M, Spiegelhoff A, Vezina CM, Keil Stietz KP (2023). “Role of Shh Pathway in Urinary Continence and its Impact on Cellular Fate in Mouse Urethra”. American Urological Association 2023 Annual Meeting, Chicago, IL, April 28-May 1, 2023.
13. Grimes MD, Sokovich C, Richmond E, Huang W, Vezina CM (2023). “Epithelial Differentiation is Altered in Urethral Lichen Sclerosus”. American Urological Association 2023 Annual Meeting, Chicago, IL, April 28-May 1, 2023.
14. Kennedy CL, Ridlon M, Spiegelhoff A, Wang K, Keil Stietz KP (2023). “Developmental Exposure to Polychlorinated Biphenyls in Combination with High Fat Diet Alters Voiding Parameters in Adult Mice Potentially via Inflammatory Mechanisms”. Society of Toxicology Annual Meeting, Nashville, TN, March 20-23, 2023.
15. Ridlon M, Kennedy CL, Spiegelhoff A, Keil Stietz KP (2023). “Developmental Exposure to the Environmental Toxicant, Polychlorinated Biphenyls, Alters Voiding Physiology, Bladder Innervation, and TRPV1-mediated Voiding in Mice”. Society of Toxicology Annual Meeting, Nashville, TN, March 20-23, 2023.
16. Ricke EA, Liu TT, Ricke WA (2023). “Effects of Pirfenidone on Lower Urinary Tract Dysfunction”. Keystone Symposium – “Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies”, Banff Springs, Alberta, Canada, March 19-23, 2023.
17. Liu TT, Hernando D, Ricke EA, Ricke WA (2023). “Halofuginone Decreases Fibrosis and Improves Urinary Function in Aged Mice”. Keystone Symposium – “Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies”, Banff Springs, Alberta, Canada, March 19-23, 2023.
18. Manuel RSJ, Scharpf B, Chandrashekar S, Kennedy C, Ridlon M, Fox O, Vezina CM (2022). “Testing Aryl Hydrocarbon Receptor (AhR) Modulation via 2-(1H-Indol-3-ylcarbonyl)-4-Thiazolecarbosylic Acid Methyl Ester (ITE) as a Treatment for Antigen-induced Experimental Autoimmune Prostatitis in Mice”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
19. Ambrogi M, Bandera P, Sandhu S, Holmes HL, Mishra J, Hernandez L, Kumar S, Romero MF, Vezina CM (2022). “The Role of Urethral Neuroendocrine Cells in Urinary Tract Infection”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
20. Sandhu S, Ambrogi M, Wehner L, Romero MF, Vezina CM (2022). “The Response of Prostatic and Urethral Neuroendocrine Cells to Prostatic Inflammation”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
21. Sandhu J, Chandrashekar S, Ruetten H, Scharpf B, Fox O, Vezina CM (2022). “Identification of Collagen Producing Cell Lineages in the Inflamed Mouse Prostate”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
22. Peterson NT, Ambrogi M, Graf P, Manuel RSJ, Peterson RE, Vezina CM (2022). “SlincR: A New Modulator for Inflammation in the Reproductive Tract”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
23. D’Arcy Q, Bowen D, Macoska JA (2022). “Alteration of Intracellular Collagen 1 Distribution in Prostate Fibroblasts by Beta-sitosterol, the Major Component of Prostate Health Supplements”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
24. Ridlon M, Kennedy CL, Spiegelhoff A, Wang K, Keil Stietz K (2022). “Developmental Exposure to the Environmental Toxicant, Polychlorinated Biphenyls, Alters Voiding Physiology, Bladder Volume, Nerve Density, and TRPV1 Agonism in Mice”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
25. Liu TT, Hackner L, DeFranco DB, Ricke WA (2022). “Alterations in Estrogen Metabolism Alleviates the Development of Steroid Hormone Induced Lower Urinary Tract Dysfunction”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
26. Gonzalez-Pereira JP, Johnson C, Shahid L, Bushman W, Roldán-Alzate A (2022). “Investigation of Lower Urinary Tract Biomechanics Using Dynamic MRI and Computational Fluid Dynamics”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
27. Richmond E, Sokovich C, Huang W, Vezina CM, Grimes MD (2022). “Urethral Lichen Sclerosus Tissue Displays a Loss of Basal Epithelial Markers”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
28. Silver SV, Skalitzky KO, Vezina CM, Ricke WA, Popovics P (2022). “Macrophage Differentiation in the Prostate in a Mouse Model of Steroid Hormone Imbalance”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
29. Miles HN, Tomlin DM, Adrian AE, Ricke WA, Li L (2022). “On-tissue Imaging of Steroid Hormones in Mouse Prostate Using MALDI Post-ionization”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
30. Agnew LP, Adrian AE, Miles HN, Liu TT, Li L, Ricke WA (2022). “Spatiotemporal Proteomic Analysis as a Compliment to Immunohistochemistry”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
31. Scharpf BR, Sandhu J, Chandrashekar S, Strand DW, Vezina CM (2022). “Identification and Mechanism of the Collagen Producing Cell in the Development of Lower Urinary Tract Dysfunction”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
32. Liu TT, Hackner L, DeFranco DB, Ricke WA (2022). “Alterations in Estrogen Metabolism Alleviates the Development of Steroid Hormone Induced Urinary Tract Dysfunction”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
33. Adrian AE, Qin Y, Pascal L, Liu TT, Watkins C, Shiva S, Denu J, DeFranco DB, Ricke WA (2022). “Characterizing Oxidative Phosphorylation Defects Associated with Aging and Benign Prostatic Hyperplasia (BPH)”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
34. Zhang H, Abdelmoemen MFE, Liu TT, Ricke WA (2022). “The Expression of Prostatic Androgen Receptor Shows Lobe-specific Changes During Aging in Mouse”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
35. Miles HN, Adrian AE, Ricke WA, Li L (2022). “On-tissue Imaging of Steroid Hormones in Mouse Prostate Using MALDI-2”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
36. Agnew LP, Adrian AE, Miles HN, Liu TT, Li L, Ricke WA (2022). “Spatiotemporal Proteomic Analysis as a Compliment to Immunohistochemistry”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Bethesda, MD, November 30-December 2, 2022.
37. Skalitzky K, Adrian AE, Liu TT, Ricke WA, DeFranco D, Pascal L (2022). “Human Prostate Stromal Cell Responses to Metabolic Stress”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
38. Hackner LG, Liu TT, Adrian AE, DeFranco DB, Ricke WA (2022). “Examining the Role of NDUFS3 in Benign Prostatic Hyperplasia”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
39. Stangis MM, Ricke WA (2022). “Loss of FGF-5 in an In Vitro Model of CRPC Leads to Morphologic Changes, Impedes Clonogenicity”. Society for Basic Urologic Research (SBUR) Annual Meeting, Orlando, FL, November 10-13, 2022.
40. Adrian AE, Miles HN, Liu TT, Ricke EA, DeFranco DB, Li L, Ricke WA (2022). “Mitochondrial Dysfunction is a Potential Driver of Fibrosis in Benign Prostatic Hyperplasia (BPH) as a Result of Aging.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
41. Ambrogi M, Bandera P, Sandhu S, Holmes HL, Mishra J, Hernandez L, Kumar S, Romero MF, Vezina CM (2022). “The Role of Urethral Neuroendocrine Cells in Urinary Tract Infection.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
42. Broman M, Lanman N, Vickman R, Cresswell G, Paez JS, Henry G, Strand DW, Hayward SW, Ratliff TL (2022). “Immune Cell Single-cell RNA Sequencing Analysis Suggest a Role for Age-associated T Cell Subset in Symptomatic Benign Prostatic Hyperplasia. UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
43. Chandrashekar S, Sandhu J, Ruetten H, Scharpf B, Vezina CM (2022). “Identification of Cell Types that Contribute to Fibrotic Disease in the Prostate.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
44. Gonzalez-Pereira JP, Johnson CJ, Wells S, Bushman W, Roldán-Alzate A (2022). “Assessment of Bladder Biomechanics Using MRI.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
45. Hackner LG, Liu TT, Ricke WA (2022). “Impact of CYP7B1 Disruption in Mouse Models of Urinary Dysfunction.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
46. Johnson C, Kounga M, Gonzalez-Periera JP, Wells S, Bushman W, Roldán-Alzate A (2022). “The Analysis of Urethra Biomechanics During Voiding Using MRI.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
47. Kennedy CL, Spiegelhoff, Lavery TC, Wang K, Keil Stietz KP (2022). “Developmental Exposure to Environmental Contaminants, Polychlorinated Biphenyls, Impact Voiding Parameters in Young Adult Mice.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
48. Lavery TCM, Spiegelhoff A, Kennedy CL, Ridlon M, Keil Stietz KP (2022). “PCB Exposure Causes Changes in Axonal Growth at Specific Timepoints in Cultured Dorsal Root Ganglia.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
49. Miles HN, Adrian AE, Li L, Ricke WA (2022). “Optimizing a MALDI-MSI Workflow for Detection of Proteins in Mouse Prostate Tissues.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
50. Peterson NT, Rivera-Gonzalez KS, Lipinski RJ, Peterson RE, Vezina CM (2022). “A Role for a Long Non-coding RNA, SlincR, in Mouse Development.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
51. Rice J, Kim C, Johnson C, Bushman W, Roldán-Alzate, A (2022). “In Vitro Validation of a Real-time 3D MRI Urodynamics Protocol.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
52. Ridlon M, Kennedy CL, Spiegelhoff A, Keil Stietz K (2022). “Developmental Exposure to the Environmental Toxicant, Polychlorinated Bisphenyls, Leads to Increases in Mouse Bladder Volume, Nerve Density, and Mast Cells.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
53. Ruetten HM, Henry GH, Liu TT, Spratt HM, Ricke WA, Strand DW, Vezina CM (2022). “A NEW Approach for Characterizing Mouse Urinary Pathophysiologies.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
54. Shahid L, Gonzalez-Periera JP, Johnson C, Li Y, Rowinski D, Roldán-Alzate A (2022). “Simulating Bladder Voiding Using Real-time MRI-based Computational Fluid Dynamics: A Pilot Study.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
55. Skalitzky KO, Popovics P, Ricke WA (2022). “The Role of Osteopontin in Steroid Hormone-induced Immune Cell Infiltration of the Prostate.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
56. Speigelhoff A, Lavery TC, Kennedy CL, Wang K, Keil Stietz KP (2022). “Polychlorinated Biphenyls Affect Proliferating Prostate Cells in Adult Exposed Male Mice.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
57. Stanczak EF, Fuller T, Xia H, Heredero Bermejo I, Strand DW, Arrizabalaga G, Jerde TJ (2022). “Toxoplasma gondii Infection Induces Lower Urinary Tract Symptoms (LUTS) in Mice and Correlates to BPH-LUTS Incidence and Epithelial Nodule Formation in Men.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
58. Stangis MS, Miles HN, Hackner L, Liu TT, Li L, Ricke WA (2022). “Development and Utilization of CRISPR-cas9 Mediated Protein Knockout Cell Lines as a Resource for Translational Prostate Research.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
59. Stangis MM, Liu TT, Ricke WA (2022). “An Evaluation of Short-term Treatment with Raloxifene as an Interventional Therapy for BPH/LUTS.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
60. Zhang H, Abdelmoemen MFE, Liu T, Ricke WA (2022). “The Expression of Prostatic Androgen Receptor Shows Lobe-specific Changes During Aging in Mouse.” UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI, June 29-30, 2022.
61. Ridlon M, Kennedy CL, Spiegelhoff A, Keil Stietz KP (2022). “Developmental Exposure to the Environmental Toxicant, Polychlorinated Biphenyls, Leads to Increases in Mouse Bladder Volume, Nerve Density, and Mast Cell.” Graduate Women In Science Annual Meeting, Madison, WI, June 23-25, 2022.
62. Adrian AE, Miles HN, Liu TT, Ricke EA, DeFranco DB, Li L, Ricke WA (2022). “Mitochondrial Dysfunction is a Potential Driver of Fibrosis in Benign Prostatic Hyperplasia (BPH) as a Result of Aging.” Graduate Women In Science Annual Meeting, Madison, WI, June 23-25, 2022.
63. Stangis MM, Miles HN, Hackner L, Liu TT, Li L, Ricke WA (2022). “Development and Utilization of CRISPR-cas9 Mediated Protein Knockout Cell Lines in Translational Prostate Cancer Research.” Graduate Women In Science Annual Meeting, Madison, WI, June 23-25, 2022.
64. Miles HN, Liu TT, Ricke WA, Li L (2022). “Pharmacological DDX Inhibition in a Cellular Model of Castration Resistant Prostate Cancer Induces a Senescent-like Phenotype”. American Society for Mass Spectrometry (ASMS) Annual Meeting, Minneapolis, MN, June 5-9, 2022.
65. Adrian AE, Miles HN, Ricke WA, Li L (2022). “Understanding the Molecular Mechanisms Driving Benign Prostatic Hyperplasia Through Spatiotemporal Proteomic Analysis.” American Society for Mass Spectrometry (ASMS) Annual Meeting, Minneapolis, MN, June 5-9, 2022.
66. Adrian AE, Miles HN, Liu TT, Li L, Ricke WA (2022). “Characterizing Mitochondrial Dysfunction of the Aging Prostate via Mass Spectrometry Methods.” American Aging Association Annual Meeting, Madison, WI, May 17-20, 2022.
67. Ghasemzadeh A, Walczak B, Vezina CM, Bushman W, Huang W, Grimes M (2022). “CD44 Expression is Reduced in Lichen Schlerosus.” 2022 Annual Meeting of the American Urological Association, New Orleans, LA, May 13-16, 2022.
68. Esdaille AR, Lawrence EM, Kyriakopoulos C, Johnson BP, Roldán-Alzate, A, Huang W, Beebe DJ, Emamekhoo H, Wells S, Lang JM, Cho SY, Jarrard DF (2022). “¹⁸F-DCFPyL PSMA PET Imaging Improves Detection of Nodal Metastases in Comparision to Conventional Imaging in Patients with Locally Advanced or Oligometastatic Prostate Cancer.” 2022 Annual Meeting of the American Urological Association (AUA), New Orleans, LA, May 13-16, 2022.
69. Popovics P, Skalitzky KO, Schroeder E, Jain A, Vezina CM, Ricke WA (2022). “Loss of Osteopontin Improves Urinary Function and Alters the Prostatic Immune Environment.” 2022 Annual Meeting of the American Urological Association (AUA), New Orleans, LA, May 13-16, 2022.
70. Jia L, Strand DW, Roehrborn CG, Mauck RJ (2022). “PSA Density is Correlated with BPH Cellular Composition.” 2022 Annual Meeting of the American Urological Association (AUA), New Orleans, LA, May 13-16, 2022.
71. Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan J, Hutchinson RC, Mohler JL, Roehrborn CG, Strand DW (2022). “5 Alpha Reductase Inhibitors Induce a Prostate Luminal to Club Cell Transition in Human BPH.” 2022 Annual Meeting of the American Urological Association (AUA), New Orleans, LA, May 13-16, 2022.
72. Forbes C, Miller NL, Case T, Strand DW, Liu Q, Ramirez-Solano M, Cates JM, Porter NA, Kim H-YH, Wages P, Mohler JL, Matusik RJ, Jin RJ (2022). “5-Alpha Reductase Inhibitors Suppress Dihydrotestosterone in Benign Prostate Hyperplasia Requiring Surery and Cause Steroidogenesis via 5ARI Induced Pathway.” 2022 Annual Meeting of the American Urological Association (AUA), New Orleans, LA, May 13-16, 2022.
73. Skalitzky K, Popovics P, Ricke WA (2022). “The Role of Osteopontin in Steroid Hormone-induced Immune Cell Infiltration of the Prostate”. UW-Madison Undergraduate Research Symposium, Madison, WI, April 28-29, 2022.
74. Schroeder E, Popovics P, Ricke WA (2022). “Steroid Hormone Imbalance Stimulates Osteopontin Expression and Inflammation in the Mouse Prostate”. UW-Madison Undergraduate Research Symposium, Madison, WI, April 28-29, 2022.
75. Skalitzky K, Popovics P, Ricke WA (2022). “The Role of Osteopontin in Steroid Hormone-induced Immune Cell Infiltration of the Prostate”. UW-Madison School of Pharmacy Spring Symposium, Madison, WI, April 19, 2022.
76. Kennedy CL, Spiegelhoff A, Lavery TC, Wang K, Keil Stietz KP. (2022). “Developmental Exposure to Environmental Contaminants, Polychlorinated Biphenyls, Impact Voiding Parameters in Young Adult Mice”. UW-Madison School of Veterinary Medicine Phi Zeta Research Day, Madison. April 6, 2022.
77. Miles HN, Liu TT, Ricke WA, Li L (2022). “Pharmacological DDX3 Inhibition in a Cellular Model of Castration Resistant Prostate Cancer Induces a Senescent-like Phenotype.” 2022 UW Carbone Cancer Center Research Retreat, Madison, WI, March 2, 2022.
78. Stangis MM, McLean DT, Liu TT, Ricke WA (2022). “FGF-5 Stimulates Metastasis and Anchorage-independence in Prostate Cancer.” 2022 UW Carbone Cancer Center Research Retreat, Madison, WI, March 2, 2022.
79. Stangis MM, Miles HN, Liu TT, Li L, Ricke WA (2022). “Development of CRISPR-CAS9 Mediated Protein Knockout Cells as a Tool and Resource for Prostate Cancer Research.” 2022 UW Carbone Cancer Center Research Retreat, Madison, WI, March 2, 2022.
80. Zhang H, Liu TT, Liu P, Ong I, Ricke WA (2022). “The RNA-binding protein DDX3 Regulates Androgen Receptor Expression in the Castration-resistant Prostate Cancer.” 2022 UW Carbone Cancer Center Research Retreat, Madison, WI, March 2, 2022.
81. Miles HN, Liu TT, Ricke WA, Li L (2022). “Pharmacological DDX3 Inhibition in a Cellular Model of Castration Resistant Prostate Cancer Induces a Senescent-like Phenotype.” 2022 UW Carbone Cancer Center Research Retreat, Madison, WI, March 2, 2022.
82. Gravrok R, Kihshen H, Grimes MD, Tannenbaum AP, Johnson CJ, Mao L, Brace CL, Hernando D, Roldán-Alzate A, Ricke WA, Wells SA (2021). “Effect of Metabolic Syndrome on the Lower Urinary Tract of Men Assessed on MRI.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
83. Miles HN, Adrian AE, Liu TT, Li L, Ricke WA (2021). “Understanding the Molecular Mechanisms Driving Benign Prostatic Hyperplasia Through Spatiotemporal Proteomic Analysis.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
84. Zhang H, Liu TT, Ricke WA (2021). “Prostatic Androgen Receptor Expression Decreases with Age and May be Regulated by DDX3X in Mice.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
85. Stangis MM, Miles HN, Liu TT, Ricke WA (2021). “Development of CRISPR-CAS9 Mediated Protein Knockout Cells as a Tool and Resource for Prostatic Research.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
86. Stangis MM, Ricke EA, McLean DT, Ricke WA (2021). “Characterization of FGF-5 Expression in Prostatic Tissue.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
87. Schroeder E, Skalitzky KO, Vezina CM, Ricke WA, Popovics P (2021). “Steroid Hormone Imbalance Stimulates Osteopontin Expression and Inflammation in the Mouse Prostate.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
88. Townsend J, Liu TT, Strand DW, Dhir R, Ricke WA (2021). “Racial Disparity in Men with Benign Prostatic Hyperplasia.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
89. Adrian AE, Liu TT, Ricke EA, DeFranco DB, Ricke WA (2021). “Mitochondrial Dysfunction Contributes to Fibrosis in Aging-associated Benign Prostatic Hyperplasia (BPH).” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
90. Chathurvedula T, Popovics PP, Garvey DR, Uchtmann KS, Ricke EA, Peterson RE, Vezina CM, Ricke WA (2021). “Dissecting the Role of Epithelial vs. Stromal Estrogen Receptor α in Lower Urinary Tract Dysfunction.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
91. Liu TT, Adrian AE, Pascal LE, Bauer SR, Panksepp JB, DeFranco DB, Ricke WA (2021). “Frailty is Increased in Aging Mice with Lower Urinary Tract Dysfunction.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
92. Skalitzky KO, Schroeder E, Vezina CM, Ricke WA, Popovics P (2021). “Loss of Osteopontin Function Attenuates Immune Cell Infiltration and Collagen Accumulation in a Steroid Hormone-Induced Lower Urinary Tract Dysfunction Model.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
93. Ambrogi M, Bandera P, Sheftel CM, Holmes HL, Mishra J, Hernandez LL, Kumar S, Romero MF, Vezina CM (2021). “The Role of Urethral Neuroendocrine Cells in Urinary Tract Infection.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
94. Grimes MD, Walczak B, Vezina CM, Bushman W, Huang W (2021). “CD44 Expression is Decreased in Lichen Sclerosus.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
95. Mora EM, Vezina CM, Huang W, Grimes MD (2021). “Collagen Content and Fiber Count is Increased in Human Lichen Sclerosus.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
96. Joseph DB, Henry GH, Malewska A, Reece JC, Mauck RJ, Gahan J, Hutchinson RC, Mohler JL, Roehrborn CG, Strand DW (2021). “Spatial Transcriptomics Reveals a Transition from a Prostate Luminal to Club-like Cell State in 5-alpha Reductase Inhibitor Treated BPH Patients.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
97. Sandhu J, Ruetten H, Scarpf B, Chandrashekar S, Vezina CM (2021). “Identification of Collagen Producing Cell Lineages in the Inflamed Mouse Prostate.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
98. Peterson NT, Turco AE, Scharpf BR, Peterson RE, Vezina CM (2021). “A New Mechanism Linking In Utero Environmental Chemical Exposure to Prostatic Innervation and Urinary Voiding Dysfunction.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
99. Sarna-McCarthy M, Macoska JA (2021). “Interleukin-4 Represses Extrinsic Pathway-Mediated Apoptosis in Human Prostate Fibroblasts.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
100. D’Arcy Q, Macoska JA (2021). “Interleukin-4 Promotes Human Prostate Fibroblast Extracellular Matrix Protein Deposition.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2021, Virtual, December 2-3, 2021.
101. Gravrok R, Kihshen H, Grimes MD, Tannenbaum AP, Johnson CJ, Mao L, Brace CL, Hernando D, Roldán-Alzate A, Ricke WA, Wells SA (2021). “Effect of Metabolic Syndrome on the Lower Urinary Tract of Men Assessed on MRI.” 20^th Annual Medical Student Research Forum, University of Wisconsin-Madison, Madison, WI, November 22, 2021.
102. Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan J, Hutchinson RC, Mohler JL, Roehrborn CG, Strand DW (2021). “Spatial Transcriptomics Reveals a Transition from a Prostate Luminal to Club-like Cell State in 5-alpha Reductase Inhibitor Treated BPH Patients.” Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
103. Zhang H, Liu TT, Ricke WA (2021). “Prostatic Androgen Receptor Expression Decreases with Age and May be Regulated by DDX3X in Mice.” Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
104. Stangis MM, McLean DT, Liu TT, Ricke WA (2021). “FGF-5 Stimulates Metastasis and Ancorage-indepencence in Prostate Cancer”. Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
105. Adrian AE, Liu TT, Ricke EA, DeFranco DB, Ricke WA (2021). “Mitochondrial Dysfunction Contributes to Fibrosis in Aging-associated Benign Prostatic Hyperplasia (BPH)”. Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
106. Miles HN, Ricke WA, Li L (2021). “The Impact of Pharmacological DDX3 Inhibition on Metastatic CRPC Cell Model Through Integrated Omics Analysis”. Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
107. Popovics P, Jain A, Skalitzky KO, Schroeder E, Vezina CM, Ricke WA (2021). “Osteopontin Deficiency Improves Urinary Function in a Steroid Hormone-induced Lower Urinary Tract Dysfunction Model”. Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
108. Sarna-McCarthy M, Macoska JA (2021). “Interleukin-4 Represses Extrinsic Pathway-Mediated Apoptosis in Human Prostate Fibroblasts”. Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
109. D’Arcy A, Macoska JA (2021). “Interleukin-4 Promotes Human Prostate Fibroblast Extracellular Matrix Protein Deposition”. Society for Basic Urologic Research (SBUR) Fall Symposium, Virtual, November 4-7, 2021.
110. Miles HN, Ricke WA, Li L (2021). “The Impact of Pharmacological DDX3 Inhibition on a Model of Prostate Cancer Progression through Integrated Omics Analyses”. American Society for Mass Spectrometry (ASMS) Meeting 2021, Philadelphia, PA, October 31-November 4, 2021.
111. Joseph DB, Henry GH, Malewska A, Strand DW (2021). “Spatial Transcriptomics Approach to Pinpoint Cellular Heterogeneity in 5-alpha Reductase Treatment Resistance.” 2021 Annual Meeting of the American Urological Association, Virtual, September 10-13, 2021.
112. Dai J, Morgan T, Goueli R, Parrott D, Strand DW, Costa D, Roehrborn C, Gahan J (2021). “Magnetic Resonance Imaging Features Associated with Histology of Benign Prostatic Hyperplasia Nodules: A Predictive Model.” 2021 Annual Meeting of the American Urological Association, Virtual, September 10-13, 2021.
113. Wang Z, Hou J, Bjorling DE (2021). “MicroRNA-29a Regulates TGF-β1-Induced Expression of Collagen 1a1 in Human Urothelial Cells.” 2021 Annual Meeting of the American Urological Association, Virtual, September 10-13, 2021.
114. Popovics P, Jain A, Skalitzky K, Schroeder E, Ruetten H, Cadena M, Vezina CM, Ricke WA (2021). “Loss of Osteopontin Leads to the Resolution of E.coli-induced Prostatic Inflammation and Fibrosis.” 2021 Annual Meeting of the American Urological Association, Virtual, September 10-13, 2021.
115. 2021 July 20, American Aging Association (AGE) Annual Conference, Madison, WI. “Mitochondrial Dysfunction Contributes to Fibrosis in Aging-associated Benign Prostatic Hyperplasia (BPH)”, Alexis Adrian.
116. Johnson C, Tannenbaum A,  Koebe S,  Anzia L,   Mao L,  Grimes M,  Hernando D, Roldán-Alzate A, Wells S. “Effect of Metabolic Syndrome on Anatomy and Function of the Lower Urinary Tract.” International Society for Magnetic Resonance in Medicine Annual Meeting- Virtual. May 15-20, 2021.
117. Joseph DB, Henry GH, Malewska A, Strand DW (2021). “Spatial Transcriptomics Approach to Pinpoint Cellular Heterogeneity in 5-alpha Reductase Treatment Resistance.” Duke Multidisciplinary Benign Urology Research Symposium, Virtual Meeting, April 29-30, 2021.
118. Sandhu JK, Ruetten H, Scharpf B, Vezina CM (2021). “Identification of Collagen Producing Cell Lineages in the Inflamed Prostate.” Duke Multidisciplinary Benign Urology Research Symposium, Virtual Meeting, April 29-30, 2021.
119. Scharpf BR, Ruetten HM, Fox OR, Strand DW, Vezina CM (2021). “The Role of CTGF in the Development of Lower Urinary Tract Dysfunction (LUTD).” Duke Multidisciplinary Benign Urology Research Symposium, Virtual Meeting, April 29-30, 2021.
120. Popovics P, Jain A, Skalitzky K, Schroeder E, Ruetten H, Cadena M, Vezina CM, Ricke WA (2021). “Loss of Osteopontin Leads to the Resolution of E.coli-induced Prostatic Inflammation and Fibrosis.” Duke Multidisciplinary Benign Urology Research Symposium, Virtual Meeting, April 29-30, 2021.
121. Han W, Liu M, Han D, Li M, Toure AA, Patalano-Salsman SC, Macoska JA, Gao S, Cai C (2021). “RB1-loss in Castration-resistant Prostate Cancer Reprograms Androgen Receptor Signaling and Confers Vulnerability to LSD1 Inhibition.” AACR Annual Meeting 2021, Philadelphia, PA, April 10-15, 2021 and May 17-21, 2021.
122. Pewowaruk RJ, Hernando D, Wells SA, Bushman WA, Roldán-Alzate A (2020). “Urinary Flow Dynamics – MRI-based Computational Modeling.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
123. Adrian A, Yilmaz G, Goksu Y, Vuckovic I, Macura S, Chebib F, Harris PC, Eirin A, Lerman A, Lerman LO, Torres VE, Irazabal MV (2020). “Betaine-dependent Re-methylation Abnormalities Contribute to Homocysteine-mediated Endothelial Dysfunction in Polycystic Kidney Disease.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
124. Reese KJ, Cogal AG, Lieske JC, Harris PC (2020). “Identifying Causative Variants in Patients with Monogenic Stone Disease.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
125. Popovics PP, Jain A, Van F, Ruetten H, Cadena M, Uchtmann KS, Vezina CM, Ricke WA (2020). “Loss of Osteopontin Function Prevents the Development of Urinary Dysfunction in coli-induced Prostatic Inflammation.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
126. Miles HN, Ricke EA, Li L, Ricke WA (2020). “Profiling Differences in Secreted and Intracellular Proteomic Expression in a Cellular Model of Benign Prostatic Hyperplasia.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
127. Liu TT, Ricke EA, DeFranco DD, Ricke WA (2020). “Mitochondrial Dysfunction and Cellular Senescence due to Aging Contributes to Prostatic Fibrosis.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
128. DeFranco DB, He K, Liu TT, Ricke WA, Pascal LE, Wang Z, Di Maio R, Greenamyre JT. “Mitochondrial Dysfunction in Benign Prostatic Hyperplasia.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
129. Myklebust L, Hudson C, Liu TT, Pascal L, He K, DeFranco D, Ricke WA (2020). “The Co-localization of COX-1 and COX-2 in Aged Mouse Prostate and Human Prostate.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
130. Medenwald R, Liu TT, Ricke WA (2020). “The Effectiveness of Pirfenidone and Halofuginone in the Reversal of Prostatic Fibrosis and BPH in Mice.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
131. Jain A, Popovics P, Ortiz Hernandez C, Liu TT, Ricke WA (2020). “Immunohistochemical Analysis of Epithelial Cell Composition in the Mouse Prostatic Urethra.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
132. Lu GB, Liu TT, Bauman T, Uchtmann KS, vom Saal F, Ricke WA (2020). “Impact of Bisphenol-A on Urogenital Tract Morphology in Developing Mice.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
133. Bauer S, Ensrud K, Walter L, Suskind A, Ricke WA, Liu TT, McVary K, Covinsky K (2020). “Association of Frailty with Clinical Benign Prostatic Hyperplasia Progression and Serious Adverse Drug Events: the MTOPS Study”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
134. Grimes MD, Vezina CM, Huang W (2020). “Decreased CD44 Expression is Associated with Increased Hyaluronic Acid Abundance in Human Lichen Schlerosus”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
135. Joseph DB, Henry GH, Malewska A, Reese JC, Hutchinson RC, Roehrborn CG, Strand DW (2020). “Decoding Stromal Heterogeneity across BPH Phenotypes”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
136. Ruetten H, Henry G, Strand DW, Vezina CM (2020). “A Phenome-Based Approach for Characterizing Mouse Urinary Pathophysiologies”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
137. Turco AE, Oakes SR, Popovics P, Rogers A, Sheftel C, Cadena M, Peterson RE, Hernandez L, Hacker T, Bjorling DE, Bonev A, Tykocki N, Vezina CM (2020). “Testosterone and Estradiol Mediate Male Voiding Dysfunction by Reducing Prostatic Smooth Muscle Ppp112b Abundance and Impairing Muscle.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
138. Garvey DR, Uchtmann KS, Peterson RE, Vezina CM, Ricke WA (2020). “Epithelial Estrogen Receptor-alpha is Involved in the Development of Lower Urinary Tract Dysfunction”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3-4, 2020.
139. Joseph DB, Henry GH, Malewska A, Wegner KA, Macuk R, Gahan J, Hutchinson R, Roehrborn C, Vezina CM, Strand DW (2020). “Decoding Stromal Heterogeneity Across BPH Phenotypes.” Society for Basic Urologic Research (SBUR) Annual Meeting, Virtual Meeting, November 11-14, 2020.
140. Turco AE, Oakes SR, Keil-Stietz K, Chathurvedula T, Girardi N, Schneider AJ, Gawdzik J, Sheftel C, Wang P, Wang Z, Bjorling DE, Ricke WA, Tang W, Hernandez L, Keast JR, Bonev A, Tykocki N, Tanguay RL, Peterson RE, Vezina CM (2020). “A Neuroanatomical Mechanism Linking Perinatal Chemical Exposure to Prostate Smooth Muscle Hyperactivity and Altered Voiding Function.” Society for Basic Urologic Research (SBUR) Annual Meeting, Virtual Meeting, November 11-14, 2020.
141. Cotellessa JF, Patalano S, Riley T, Macoska JA (2020). “Development of Urinary RNA Biomarkers for Renal Cell Carcinoma Prognosis”. Society for Basic Urologic Research (SBUR) Annual Meeting, Virtual Meeting, November 11-14, 2020.
142. Garvey DR, Uchtmann KS, Peterson RE, Vezina CM, Ricke WA (2020). “Stromal Estrogen Receptor-alpha is Involved in the Development of Lower Urinary Tract Dysfunction”. Society for Basic Urologic Research (SBUR) Annual Meeting, Virtual Meeting, November 11-14, 2020.
143. Liu TT, Myklebust L, Ricke EA, DeFranco DB, Ricke WA (2020). “Mitochondrial Dysfunction due to Aging Contributes to Prostatic Fibrosis.” Society for Basic Urologic Research (SBUR) Annual Meeting, Virtual Meeting, November 11-14, 2020.
144. Liu TT, Ricke EA, DeFranco DB, Ricke WA (2020). “Mitochondrial Dysfunction due to Aging Contributes to Prostatic Fibrosis.” Gerontological Society of America (GSA) 2020 Annual Scientific Meeting, Virtual Meeting, November 4-7, 2020.
145. Anaam D, Holmes HL, Gregory AV, Thao K, Stiller A, Romero PZ, Vezina CM, Harris PC, Kline TL, Romero MF (2020). “Pathobiology of Cyst Progression in Nbce1A and Pkd1(RC/RC) Mouse Models”. American Society of Nephrology Annual Meeting, Virtual Meeting, October 22-25, 2020.
146. Anzia L, Johnson C, Hernando D, Bushman W, Wells SA, Roldán-Alzate A (2020). “Segmentation and 3D Anatomical Renderings of Pelvic MRI Allow Quantitative Analysis of Lower Urinary Tract Anatomy”. International Society for Magnetic Resonance in Medicine Annual Meeting, Virtual Meeting, August 10-14, 2020.
147. Ruetten HM, Cole C, Wehber M, Wegner K, Girardi N, Peterson NT, Scharpf B, Romero M, Wood M, Colopy S, Bjorling DE, Vezina CM (2020). “An Immunohistochemical Prostate Cell Identification Key Indicates that Aging Shifts Procollagen 1A1 Production from Myofibroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction” (Poster Presentation). UW-Madison Veterinary Summer Scholars Symposium, Virtual Meeting, August 2020.
148. Launer BM, McVary KT, Ricke WA, Lloyd GL (2020). “1990 to Now: Critical Global Trends in LUTS/BPH.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
149. Joseph DB, Henry GH, Malewska A, Wegner KA, Macuk R, Gahan J, Reese JC, Hutchinson R, Roehrborn C, Vezina CM, Strand DW (2020). “Identification of Cognate Proximal Cell Types of the Mouse and Human Prostate and their Enrichment in Human Benign Prostatic Hyperplasia.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
150. Kenigsber A, Mauck RJ, Diaz de Leon A, Roehrborn C, Strand DW, Costa D (2020). “A Multiparametric Magnetic Resonance Imaging (MPMRI) Pilot Study of Prostatic Peri-urethral Fibrosis (PUF), A Possible Alternative Source of LUTS.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
151. Gheinani AH, Sack BS, Piper M, Atta H, Cotellessa JF, Lambrinos G, Costa K, Doyle C, Patalano S, Cristofaro V, Sullivan M, Macoska JA, Adam R (2020). “Multiomics-based Characterization of Bladder Remodeling After Spinal Cord Injury.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
152. Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM (2020). “Increased Expression of Osteopontin in the Prostate is Associated with the Clinical Progression of BPH.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
153. Wang Z-Y, Hou J, Bjorling DE (2020). “TGF-β1 Regulates Expression of Collagen 1A1 in Mouse Urothelial Cells.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
154. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2020). “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
155. Ortiz Hernandez CJ, Ricke WA (2020). “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells.” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
156. Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Vezina CM, Matusik RJ, Ricke WA, Grabowska MM (2019). “Prostatic Osteopontin Expression is Associated with Symptomatic Benign Prostatic Hyperplasia” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
157. Garvey DR, Uchtmann KS, Peterson RE, Vezina CM, Ricke WA (2020). “Stromal Estrogen Receptor-alpha is Involved in the Development of Lower Urinary Tract Dysfunction.” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
158. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2020). “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
159. Ruetten HM, Cole C, Wehber M, Wegner K, Girardi N, Peterson NT, Scharpf B, Romero M, Wood M, Colopy S, Bjorling DE, Vezina CM (2020). “An Immunohistochemical Prostate Cell Identification Key Indicates That Aging Shifts Procollagen 1A1 Production from Myofibroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction” (1-min Flash Talk). Duke KURe University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
160. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2020). “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” Endocrine Society (ENDO) Annual Meeting, San Francisco, CA, March 28-31, 2020.
161. Turco AE, Oakes SR, Chathurevelda T, Keil KP, Girardi N, Hernandez HH, Peterson RE, Bonev A, Tykocki N, Vezina CM (2020). “IUL TCDD Increases Noradrenergic Axon Density and Nerve-Evoked Smooth Muscle Contraction in Mouse Prostate.” The 59^th Annual Meeting of the Society of Toxicology, Anaheim, CA, March 15-19, 2020 (cancelled).
162. Popovics P, Awadallah WN, Kohrt S, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM (2019). “Increased Expression of Osteopontin in the Prostate is Associated with the Clinical Progression of BPH.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
163. Myklebust LM, Liu TT, Ricke WA (2019). “Aging Exacerbates Lower Urinary Tract Dysfunction and Causes Epigenetic Modifications Altering the Sex Steroid Hormone Environment in Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
164. Ruetten HM, Wehber M, Cole C, Cadena MT, Wegner KA, Romero MF, Wood MW, Colopy SA, Bjorling DE, Vezina CM (2019). “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
165. Anzia L, Johnson C, Wells S, Bushman W, Hernando D, Roldán-Alzate A (2019). “Segmentation and 3D Anatomical Renderings from Pelvic MRI Provide a Novel Method to Quantify Clinically Relevant Features of the Bladder and Prostate.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
166. Broman MM, Lanman NA, Vickman RE, Franco OE, Hayward SW, Henry GH, Strand DW, Ratliff TL (2019). “Immune Cell Interactions in Benign Prostatic Hyperplasia.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
167. Bonnemaison ML, Gharaee-Kermani M, Macoska JA (2019). “Prostate Fibrosis is Coupled to a Mesenchymal IL-4/IL-3 Autocrine Loop.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
168. Ortiz Hernandez CJ, Ricke WA (2019). “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
169. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2019). “Estrogen Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
170. Liu TT, Ricke WA (2019). “Aging Alters Steroid Hormone Metabolism and Exacerbates Lower Urinary Tract Dysfunction in Mice.” The Gerontological Society of America (GSA) Annual Meeting, Austin, TX, November 13-17, 2019.
171. Ortiz Hernandez CJ, Ricke WA (2019). “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
172. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2019). “Estrogen Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
173. Popovics P, Awadallah WN, Kohrt S, Case TC, Miller NL, Ricke EA, Ramirez-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM (2019). “Osteopontin Exacerbates the Inflammatory Environment in the Prostate.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
174. Bonnemaison ML, Gharaee-Kermani M, Macoska JA (2019). “Prostatic Fibrosis is Coupled to a Mesenchymal IL4/IL3 Autocrine Loop.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
175. Gao S, Chen S, Han D, Wang Z, Li M, Han W, Besschetnova A, Zhou F, Barrett D, Luong MP, Owiredu J, Liang Y, Ahmed M, Petricca J, Macoska JA, Corey E, Chen S, Balk SP, Housheng HH, Cai C (2019). “LSD1-mediated Demethylation of FOXA1 Regulates AR Cistrome in Prostate Cancer.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
176. Han W, Toure AA, Han D, Gao S, Cai C (2019). “A Preclinical Study of the Combination Treatment of High-dose Testosterone and CDK4/6 Inhibitors in CRPC.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
177. Hashemi A, Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Cristofaro V, Sullivan MP, Burkhard FC, Monastyrskaia K, Macoska JA, Adam RM (2019). “Temporal Analysis of Signaling Events Leading to Bladder Remodeling after Spinal Cord Injury.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
178. Turco AE, Oakes SR, Rodgers A, Underriner C, Cadena MT, Peterson RE, Hernandez L, Hacker T, Tykocki N, Vezina CM (2019). “Exogenous Testosterone and Estradiol Prolong Prostate Smooth Muscle Relaxation via Downregulation of MYPT2: A Novel Utility for Genetically Encoded Calcium Receptors.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
179. Ruetten HM, Wehber M, Cole C, Cadena MT, Wegner KA, Romero MF, Wood MW, Colopy SA, Bjorling DE, Vezina CM (2019). “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
180. Ruetten HM, Cole C, Wehber M, Sandhu S, Oakes SR, Waller III K, Vezina CM (2019). “A Retrospective Medical Review of Benign Prostatic Hyperplasia in a Well-defined Population of Client-owned Dogs: Clinical Presentation, Prevalence of Concurrent Bacterial Infection, and Response to Treatment.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
181. Cadena MT, Zhu J, Wang P, Underriner C, Hernandez L, Tykocki N, Shen T, Barasch J, Romero MF, Vezina CM (2019). “Prostate Neuroendocrine Cell Serotonin Aids to Prevent Microbial Infection.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
182. Zwaans BMM, Wegner KA, Bartalone SN, Vezina CM, Chancellor MB, Lamb LE (2019). “Radiation Cystitis Modeling: A Comparative Study of Radiation Induced Bladder Fibrosis in Different Mouse Strains.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
183. Wiessner G, Batourina E, Rosselot C, Vezina CM, Schneider K, Mendelsohn C (2019). “Roles of Retinoid Signaling in the Developing Urothelium.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
184. Crowell, PD, Fox JJ, Hashimoto T, Diaz JA, Henry GH, Lowe MG, Wu YE, Strand DW, Goldstein AS (2019). “Expansion of Luminal Progenitor Cells in the Aging Mouse and Human Prostate.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
185. Broman MM, Lanman NA, Vickman RE, Hayward SW, Henry GH, Strand DW, Ratliff TL (2019). “Immune Cell Interactions in Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
186. Wang Z, Xue B, Wu S, Tabatabaei S, WU C-L, Cheng Z, Xin L, Strand DW, Olumi AF, Wang Z (2019). “Obesity-associated Inflammation Induces Androgenic to Estrogenic Switch in the Prostate Gland.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
187. Lafin JT, Abe D, Ahmed M, Savelyeva A, Strand DW, Amatruda JF, Bagrodia A (2019). “Modeling Cisplatin Resistance in Testis Cancer with the Zebrafish.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
188. Joseph DB, Henry GH, Malewska A, Wegner KA, Roehrborn CG, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2019). “Identification of Cognate Proximal Cell Types of the Mouse and human Prostate and their Enrichment in Human Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
189. Binoy Joseph D, Henry GH, Malewska A, Hannan R, Raj GV, Strand DW (2019). “Urethral Epithelia Extend into the Proximal Prosate Stem Cell Niche and are Increased in Prostate Cancer.” Prostate Cancer Foundation Meeting, Carlsbad, CA, October 24, 2019.
190. Ricke WA, McLean DT (2018). “FGF5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer.” UW-Madison Prostate Research Group Seminar, Madison, WI, October 4, 2019.
191. Ortiz Hernandez CJ, Ricke EA, Ricke WA (2019). “Estrogens Induce Fibrosis and Myofibroblast Phenoconversion in Prostate Stromal Cells.” University of Wisconsin-Madison Molecular and Cellular Pharmacology Training Program 15^th Annual MCP Signal Transduction Research Training Symposium, Madison, WI, September 16, 2019.
192. Vellky JE, Ricke WA (2019). “DDX3-Mediated Translational Regulation of Androgen Receptor in Prostate Cancer Progression.” American Urological Association Annual Meeting, Chicago, IL, May 3-6, 2019.
193. Vellky JE, Ricke WA (2019). “DDX3-Mediated Translational Regulation of Androgen Receptor in Prostate Cancer Progression.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 11-12, 2019.
194. Liu TT, Ricke WA (2018). “The Impact of Aging on the Lower Urinary Tract of Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
195. Keil KP, Sethi S, Bjorling DE, Lein PJ (2018). “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, increased Nerve Density and Voiding Dysfunction in Young Adult Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
196. Gamat M, Malinowski RL, Steinke L, Roopra A, Marker PC (2018). “Connecting Development and Disease: Presenting a Potential Mouse Model for BPH.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
197. Cunningham K, McLean DT, Ricke WA (2018). “Isolating Prostate Stem-like Cells in a Progressive Cell Line Model.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
198. Bjorling DE, Wang Z, Gong Y, Hou J (2018). “MicroRNA-29a/b1 Inhibits Bladder Fibrosis and Supports Normal Bladder Function.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
199. Macoska JA, Wang Z, Virta J, Zacharias N, Bjorling DE (2018). “CXCL12 Mediates Increased Prostatic Fibrosis in Mice Fed a High Fat Diet.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
200. Liu TT, Ricke WA (2018). “The Impact of Age on the Lower Urinary Tract of Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
201. Ruetten HM, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Dose Size Matter? Reduced Prostate Size Alters Urinary Function in Male Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
202. Wegner KA, Guo J, McMahon JA, McMahon AP, Vezina CM (2018). “Characterization of Srd5a2^creErt2 Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
203. Thomas S, Hao L, Greer T, Vezina CM, Bajpai S, Ashok A, Bieberich C, Ricke WA, Li L (2018). “The Urine Proteomics of Genetically-induced Lower Urinary Tract Dysfunction (LUTD) Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
204. Thomas S, Liu TT, Ricke WA (2018). “Monitoring Serum Steroids in a Hormone-induced Model of Lower Urinary Tract Dysfunction.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
205. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, Hon GC, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). “Building a Comprehensive Cellular Anatomy of the Normal and Diseased Human Prostate.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
206. Ruetten HM, Wegner KA, Colopy S, Zhang HL, Sandhu S, Romero MF, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
207. Romero PZ, Holmes HL, Cadena MT, Vezina CM, Romero MF (2018). “NBCe1 in the Kidney and Lower Urogenital Tract.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
208. Neuman SD, Vellky JE, Ihry RJ, Bashirullah A, Ricke WA (2018). “Using Mouse and Drosophilia Models to Dissect the Role of DDX3-dependent Translational Control in BPH.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
209. McLean DT, Ricke WA (2018). “FGF5 Regulation of Androgen Receptor in Prostate Cells.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
210. O’Driscoll CA, Wegner KA, Ruetten HM, Abler LL, Oakes SR, Bjorling DE, Ricke WA, Mascoska J, Marker PC, Vezina CM (2018). “Exogenous Hormone Exposure: A Potential Platform for Testing Interventional Therapies for Lower Urinary Tract Dysfunction in Male Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
211. Ricke WA, McLean DT (2018). “Fibroblast Growth Factor-5 Increases Androgen Receptor Expression and Signaling in the Prostate.” UW-Madison Prostate Research Group Seminar, Madison, WI, December 7, 2018.
212. Ricke WA, Vellky JE (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 as a Mechanism for CRPC.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
213. Cadena MT, Turco AE, Romero PZ, Holmes HL, Romero MF, Tykocki N, Vezina CM (2018). “Mouse Prostatic Neuroendocrine Cells Mediate Smooth Muscle Contraction.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
214. Ruetten HM, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Alters Urinary Function in Male Mice.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
215. Wegner KA, Guo J, McMahon JA, McMahon AP, Vezina CM (2018). “Characterization of Srd5a2^creErt2 Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
216. Unterberger CJ, Wegner KA, Malinowski RL, Vezina CM, Swanson SM, Marker PC (2018). “Role of Growth Hormone in Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
217. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, Hon GC, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). “Single Cell RNA Sequencing of the Normal Human Prostate Reveals Identity of Novel Stromal and Epithelial Cell Types.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
218. Joseph DB, Chandrashekar AS, Abler LL, Chu L-F, Thomson JA, Vezina CM (2018). “Epithelial Dnmt1Regulates Prostate Bud Formation and Differentiation by Maintaining Survival of Early Prostate Progenitors”. Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
219. Sandhu S, Joseph DB, Strand DW, Vezina CM (2018). “Immunohistochemical Comparison of Novel Epithelial and Stromal Cell Types in the Human and Mouse Prostate”. Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
220. Ruetten HM, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Causes Urinary Dysfunction in Male Mice.” American College of Veterinary Pathology Annual Meeting, Washington, DC, November 2018.
221. Ricke WA, Vellky JE (2018). “DDX3 Expression and Localization in Prostate Cancer Progression.” UW-Madison Prostate Research Group Seminar, Madison, WI, October 5, 2018.
222. Zhang HL, Ruetten HM, Wegner KA, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Causes Urinary Dysfunction in Male Mice.” 3^rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
223. Mueller BR, Wegner KA, Vezina CM (2018). “Prostate Extracellular Matrix Morphology Associates with Lower Urinary Tract Dysfunction in Male Mice.” 3^rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
224. Sandhu S, Joseph DB, Strand DW, Vezina CM (2018). “Immunohistochemical Comparison of Novel Epithelial and Stromal Cell Types in the Human and Mouse Prostate.” 3^rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
225. Romero PZ, Holmes HL, Cadena MT, Vezina CM, Romero MF (2018). “Nbce1 in the Kidney and Lower Urogenital Tract.” 3^rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
226. Romero PZ, Holmes HL, Cadena MT, Vezina CM, Romero MF. “Nbce1 in the Kidney and Lower Urogenital Tract.” NIDDK KUH Summer Undergraduate Research Conference, Boston, MA, August 1-3, 2018.
227. Ricke WA, Li L, Thomas S (2018). “Collagenase Digestion Deepens Coverage of Extracellular Matrix in Urinary Proteomics.” Wisconsin Human Proteomics Symposium, Madison, WI, August 2018.
228. Ruetten HM, Wegner KA, Colopy S, Zhang HL, Sandhu S, Romero MF, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” 2018 Therio Conference, Milwaukee, WI, August 2018.
229. Sack B, Piper M, Cotellessa J, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan M, Macoska JA, Adam R (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased b3-Adrenergic Receptor Expression That Can Be Reversed By Inoside Treatment.” MP56-07. Urol.Vol.199, No. 4S, Supplement, May 20, 2018.
230. Ricke WA, Jeong CH, Liu TT (2018). “The Impact of Age on the Lower Urinary Tract of Mice.” Society for Basic Urologic Research (SBUR) Spring Symposium, San Francisco, CA, May 2018.
231. Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan MP, Macoska JA, Adam RM (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased beta 3-AR Expression That Can Be Reversed By Inoside Treatment.” American Urological Association (AUA) Annual Meeting, Boston, MA, May 12-16, 2018.
232. Zhang HL, Vezina CM (2018). “Castration Reduces Duration and Increases Frequency of Urination.” University of Wisconsin Undergraduate Research Symposium, Madison, WI, April 2018.
233. Ricke WA, Ricke EA, Walker I, Jeong CH, Thomas S, Liu TT (2018). “Altered steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”. University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
234. Li L, Ricke WA, Steinke L, Hyman S, Delaney K, Hao L, Thomas S (2018). “Proteomics by Mass Spectrometry for Molecular Insights into Lower Urinary Tract Dysfunction due to Endocrine Disruption in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
235. Macoska JA, Ricke WA, Uchtmann KS (2018). “Prostate Collagen Deposition is Associated with the Clinical Progression of LUTD and LUTS Among MTOPS Trial Participants.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
236. Ricke WA, Vellky JE (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 in Prostate Cancer Progression.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
237. Skelton PB, Ucthmann KS, Ricke WA (2018). “3D Visualization of Mouse Prostatic Urethra.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
238. Ricke WA, Vellky JE (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 in Prostate Cancer Progression.” American Association for Cancer Research (AACR), Chicago, IL, April 2018.
239. Ricke WA, Vellky JE, Cunningham K, McLean DT (2018). “Androgen Receptor Expression Through an FGF5 and YAP1 Driven Mechanism.” American Association for Cancer Research (AACR), Chicago, IL, April 2018.
240. Ruetten HM, Wegner KA, Zhang HL, Sandhu S, Romero MF, Wood MW, Marker PC, Strand DW, Colopy S, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” Abstract for poster and/or oral presentation, 6th Annual University of Wisconsin-Madison School of Veterinary Medicine-Phi Zeta Research Day, Madison, WI, April 2018.
241. Liu TT, Thomas S, Jeong CH, Walker I, Ricke EA, Ricke WA (2018). “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia.” The Endocrine Society (ENDO) 100^th Annual Meeting, Chicago, IL, March 17-20, 2018.
242. Coker A, Vellky JE, Wynder JL, Bradfield C, Ricke WA (2018). “Evaluating the Effects of Environmental Estrogen Induced Activation of Non-Genomic Signaling in Human Prostate Cells.” Society of Toxicology Annual Meeting, San Antonio, TX, March 11-15, 2018.
243. Jeong CH, Wynder JL, Thomas S, Lamarre NS, Wang Z, Bjorling DE, Ricke WA (2018). “Exposure to Bisphenols Causes Lower Urinary Tract Dysfunction in Mice Through an ER Alpha-Dependent Mechanism.” Society of Toxicology Annual Meeting, San Antonio, TX, March 11-15, 2018.
244. Li L, Ricke WA, Steinke L, Hyman S, Delaney K, Hao L, Thomas S (2018). “Proteomics by Mass Spectrometry for Molecular Insights into Lower Urinary Tract Dysfunction due to Endocrine Disruption in Mice”. 7^thAnnual International Meeting of Young Environmental Scientists of the Society of Environmental Toxicology and Chemistry, Madison, WI, March 2018.
245. Wegner KA, Turco AE, Wang P, Bjorling DE, Peterson RE, Vezina CM (2018). “In Utero and Lactational (IUL) TCDD Exposure Causes Lower Urinary Dysfunction in Adult Male C57BL/6J Mice.” Abstract for poster presentation, Society of Toxicology Annual Meeting, San Antonio, TX, March 2018.
246. Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan M, Macoska JA, Adam RM (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased β3-Adrenergic Receptor Expression that can be Reversed by Inosine Treatment”. Society for Urodynamics and Female Urology (SUFU) Annual Meeting, February 27 – March 3, 2018, Austin, TX.
247. Ruetten HM, Wegner KA, Joseph D, Colopy S, Sullivan R, Vezina CM (2017). “Collagen Architecture of Canine and Murine Prostate: Impact of Age and Androgen Deprivation.” Abstract for poster presentation. Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
248. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
249. Ricke WA, Ricke EA, Jeong CH, Liu TT (2017). “The Impact of Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia Progression.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
250. Ricke WA, Vellky JE (2017). “Hormonal Modulation of DDX3 and its Implications for Translational Regulation in Prostate Cancer.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
251. Wegner KA, Guo J, McMahon JA, Maeda N, Wang P, Bjorling DE, Marker PC, McMahon AP, Vezina CM (2017). “Pro-fibrotic Signaling in Prostate Stroma Increases Prostate Collagen Fiber Density and Disrupts Normal Urinary Function in Male Mice.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
252. Ruetten HM, Colopy S, Sullivan R, Wegner KA, Chandraskekar A, Vezina CM (2017). “Collagen Architecture of the Prostate in Neutered and Intact Canines.” Abstract for poster presentation, American College of Veterinary Pathologists (ACVP) & American Society for Veterinary Clinical Pathology (ASVCP) Concurrent Annual Meeting, Vacouver, British Columbia, Canada, November 2017.
253. Ricke WA, Vellky JE, McLean DT (2017). “Androgen Regulation of Fibroblast Growth Factor 5 In Prostate Cancer.” Gordon Research Conference, Newry, Maine, August 2017.
254. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” American Society for Mass Spectrometry, Indianapolis, IN, June 2017.
255. Patalano-Salsman S, Rodriguez-Nieves JA, Almanza D, Avery A, Judell-Halfpenney A, Riley T, Macoska JA (2017). “CXCL12-CXCR4 Axis Activation Promotes COP II Vesicle-Mediated Secretion of Collagen by Prostate Myofibroblasts.” MP17-09. J. Urol. Vol. 197, No. 4S, Supplement, Friday, May 12, 2017.
256. Gharaee-Kermani M, Macoska JA (2017). “TH2 Cytokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis.”  Urol. Vol. 197, No. 4S, Supplement, Friday, May 12, 2017.
257. Ricke WA, Macoska JA, James TT, Wynder JL, Walker I, Liu TT (2017). “The Identification of Estrogen Receptor Gene Networks in Benign Prostatic Hyperplasia.” American Urological Association (AUA), Boston, MA, May 2017.
258. Ricke WA, Macoska JA, James TT, Wynder JL, Walker I, Liu TT (2017). “The Identification of Estrogen Receptor Gene Networks in Benign Prostatic Hyperplasia.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
259. Macoska JA (2017). “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis.”   University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
260. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
261. Ricke WA, Timms BG, Vom Saal FS, Achenreiner A, John LM, Uchtmann KS (2017). “Fetal Bisphenol A Exposure Alters Urethra Morphology and Collagen Content of One Year-Old Rats: Findings from the NIEHS/FDA CLARITY-BPA Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
262. Vom Saal FS, Taylor J, Stahlhut R, Timms BG, Uchtmann KS, Ricke WA (2017). “Fetal Bisphenol A Exposure Alters Body Weight and Male Urogenital Tract Morphology At Birth: Findings From the NIEHS/FDA CLARITY Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
263. Bathke K, Trevena RL, Cadena MT, Wegner KA, Turco AE, Vezina CM (2017). “Classification of Gli1 Expressing Cell Lineages Within Mouse Prostate.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
264. Shea MP, Wegner KA, O’Leary KA, Schuler LA (2017). “Collagen Density and mTOR Inhibition Alter Cancer Stemness and Plasticity of ER+ Mammary Carcinomas.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
265. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2017). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
266. Ricke WA, Vellky JE, McLean DT (2017). “Androgen Regulation of Fibroblast Growth Factor 5 in Prostate Cancer.” Society for Basic Urologic Research (SBUR), Boston, MA, May 2017.
267. Wynder, JL (2017). “Bisphenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice”. University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, May 25, 2017.
268. Ricke WA, Macoska JA, James TJ, Wynder JL, Liu TT (2017). “The Role of Estrogen Receptor Activation in Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR), Boston, MA, May 2017.
269. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2017). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, University of Wisconsin Molecular & Environmental Toxicology Spring Symposium, Madison, WI, May 2017.
270. Ruetten HM, Vezina C (2017). “Prostatic Areas of Disease Show Changes in Collagen Fiber Thickness, Diameter, Density, and Orientation.” Abstract for poster presentation, 5th Annual University of Wisconsin-Madison School of Veterinary Medicine-Phi Zeta Research Day, Madison, WI, April 2017.
271. Patalano-Salsman S, Rodrigeuz-Nieves JA, Almanza D, Avery A, Riley T, Macoska JA (2017). “CXCL12-CXCR4 Axis Activation Promotes COP II Vesicle-Mediated Secretion of Collagen by Prostate Myofibroblasts.” Injury, Inflammation and Fibrosis Keystone Symposium, Snowbird, UT, March 26-30, 2017.
272. Patalano-Salsman S, Rodriguez-Nieves JA, Almanza D, Avery A, Judell-Halfpenney A, Riley T, Macoska JA (2016). “CXCL12-CXCR4 Axis Activation Promotes Cop Ii Vesicle-Mediated Secretion Of Collagen By Prostate Myofibroblasts.” Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
273. Ricke WA, McSweeney S, Vellky JE (2016). “Expression of Housekeeping Genes across Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
274. Oakes SR, Wegner KA, Eliceiri K, Vezina CM (2016). “High Thoroughput Computer-Based Analysis of Void Spot Assay Data.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
275. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2016). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
276. Trevena RL, Sullivan R, Wegner KA, Esquibel CR, Eliceiri K, Vezina CM (2016). “Deep Prostate Tissue Immunohistochemical Staining and Fluorescent Confocal Scanning for 3-Dimensional Microenvironment Analysis.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
277. Ricke WA, Vezina CM, Peterson RE, Moore RW, Ricke EA (2016). “In Utero and Lactational TCDD Exposure Increases Prostatic Estrogen Receptor Alpha and Secondary Complications Associated with Bladder Outlet Obstruction in Mice.” 36^thInternational Symposium on Halogenated Persistent Organic Pollutants, Florence, Italy, August-September 2016.
278. Nicholson TM, Wynder JL, Ricke WA (2016). “The Environmental Estrogen Bisphenol-A is Implicated in Hormonal Induction of Benign Prostatic Hyperplasia in Adult Male Mice.” Urology Research Day, University of Washington, Seattle, WA, June 2016.
279. Ricke WA, Jeffery J, McLean DT, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Midwestern Preclinical Imaging Consortium, Madison, WI, May 2016.
280. Ricke WA, Jeffery J, McLean DT, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Society for Basic Urological Research (SBUR), San Diego, CA, May 2016.
281. Vom Saal FS, Taylor J, Stahlhut R, Timms BG, Uchtmann KS, Ricke WA (2016). “Fetal Bisphenol A Exposure Alters Body Weight and Male Urogenital Tract Morphology At Birth: Findings from the NIEHS/FDA CLARITY-BPA Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
282. Trevena R, Sullivan R, Wegner KA, Vezina CM, Vokoun C, Eliceiri K, Joseph DB (2016). “Optimization of Whole-Tissue Immunohistochemical Staining and Fluorescence Confocal Scanning for 3-D Prostatic Microenvironmental Analysis.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
283. Jeong CH, Vezina CM, Ricke WA (2016). “Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
284. Lamarre NS, Wynder JL, Uchtmann KS, Liu TT, Wang Z, Vezina CM, Ricke WA, Bjorling DE (2016). “The Effects of Bisphenol A on Urinary Bladder Function.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
285. Thomas S, Hao L, Greer T, Vezina CM, Bajpal S, Ashok A, Bieberich CJ, Ricke WA, Li L (2016). “The Urine Proteomes of Genetically-Induced Lower Urinary Tract Dysfunction (LUTD) in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
286. Trevena R, Sullivan R, Wegner KA, Vezina CM, Esquibel CR, Eliceiri K, Joseph DB (2016). “Optimization of Whole-Tissue Immunohistochemical Staining and Fluorescent Confocal Scanning for 3-D Prostatic Microenvironmental Analyses.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
287. Oakes SR, Eliceiri K, Abler LL, Wegner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
288. Joseph DB, Keil KP, Abler LL, Vezina CM (2016). “A Map of DNA Methyltransferase Enzyme Expression in the Mouse Prostate During its Development and in Response to Prostate Injury.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
289. Cadena MT, Wegner KA, Bushman W, Ricke WA, Vezina CM (2016). “Elucidating Patterns of Smooth Muscle Contractility in Prostatic Urethral Tissue.: University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
290. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
291. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” University of Wisconsin-Madison Undergraduate Research Symposium, Madison, WI April 2016.
292. Joseph DB, Keil KP, Abler LL, Vezina CM (2016). “A Map of DNA Methyltransferase Enzyme Expression in the Mouse Prostate During its Development and in Response to Prostate Injury.” WARF Discovery Challenge Symposium, Madison, WI April 2016.
293. Wynder JL, Nicholson T, Lamarre N, Waldman A, vom Saal FS, Vezina CM, Bjorling DE, Ricke WA (2017). “The Environmental Estrogen Bishpenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice”, Society of Toxicology National Meeting, Baltimore, MD, March 13, 2016.
294. Macoska JA (2016). “Urinary Obstruction and Fibrosis”, Plenary Talk. Society for Urodynamics and Female Urology (SUFU) Annual Meeting, New Orleans, LA, February 23-27, 2016.
295. Ricke WA, Vellky JE (2015). “BOP1 Expression and Localization in Benign Prostatic Disease and Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
296. Lingjun L, Ricke WA, Bieberich C, Ashok A, Bajpai S, Vezina C, Greer T, Hao L, Thomas S (2015). “The Urine Proteomics of Genetically-Induced Lower Urinary Tract Dysfunction (LUTD) in Mice.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
297. Gharaee-Kermani M, Moore BB, Macoska JA (2015). “Resveratrol-Mediated Repression And Reversion Of Prostatic Myofibroblast Phenoconversion.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
298. Rodriguez-Nieves, Gharaee-Kermani M, Macoska JA (2015). “CXCL12/CXCR4-Axis Activation Mediates Prostate Myofibroblast Phenoconversion Through Non-Canonical EGFR/MEK/ERK Signaling.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
299. Wegner KA, Keil KP, Oakes SR, Edokpolor KS, Ricke WA, Vezina CM (2015).  “Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
300. Wegner KA, Vezina CM (2015). “Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
301. Jeong CH, Vezina CM, Ricke WA (2015). “Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
302. Bauman TM, Vezina CM, Halberg RB, Huang W, Peterson RE, Ricke WA (2015). “Expression and Co-localization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
303. Wynder JL, Nicholson T, Wood RW, Ricke WA (2015). “Testosterone and Bisphenol A Exposure Induces Increased Prostate and Bladder Mass of Male Mice.” University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, June 17, 2015.
304. Ricke WA, Vellky JE, McLean DT (2015). “Fibroblast growth factor 5 increases expression through prostate cancer progression.” Society for Basic Urologic Research (SBUR), New Orleans, LA, May 2015.
305. Bauman TM, Ricke EA, Huang W, Ricke WA (2015). “A Tissue Specific Role for Ligand Independent Arv7 Signaling in Benign Prostate Pathogenesis.” American Urological Association (AUA), New Orleans, LA, May 2015.
306. Nicholson TM, Wynder JL, Ricke WA (2015). “Bladder Fibrosis in Male Mice Treated with Testosterone and Estradiol is Not Prevented by the Selective Estrogen Receptor Modulator Raloxifene.” American Urological Association (AUA), New Orleans, LA, May 2015.
307. Hao L, Greer T, Zhong X, Page D, Lee S, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). “Combining DiLeu Isobaric Labeling and Label-free Approaches for Metabolite Quantification and Biomarker Discovery of Lower Urinary Tract Symptoms (LUTS).” 63^rdAnnual ASMS Conference on Mass Spectrometry and Allied Topics, St. Louis, MO, May 2015.
308. Hao L, Greer T, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). “Identification of Potential Metabolite Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Mouse and Human Urine.” University of Wisconsin-Madison/UMASS Boston Spring Symposium: Role of Fibrosis in Signaling and Lower Urinary Tract Disease, Madison, WI, April 2015.
309. Wynder JL, Nicholson T, Wood RW, Ricke WA (2015). “Testosterone and Bisphenol A Exposure Induces Increased Prostate and Bladder Mass of Male Mice”, University of Wisconsin-Madison/UMASS Boston Spring Symposium: Role of Fibrosis in Signaling and Lower Urinary Tract Disease, Madison, WI, April 2015.
310. Ricke WA, Lee C, Clapper T, Schneider A, Moore RW, Keil KP, Abler LL, Wynder JL, López Alvarado A, Beaubrun I, Vo J, Peterson RE, Vezina CM (2015). “Fetal TCDD Exposure Increases Adult Male Mouse susceptibility to Urinary Dysfunction.” The 54^thAnnual Meeting of the Society of Toxicology, San Diego, CA, March 2015.
311. Nicholson TM, Bauman T, Ricke WA (2014). “Bladder Fibrosis in Male Mice Treated with Testosterone and Estradiol is Not Prevented by the Selective Estrogen Receptor Modulator Raloxifene.” Society for Basic Urologyic Research (SBUR), Dallas, TX, November 2014.
312. Gamat M, Parkhurst L, Steinke L, Marker PC (2014). “Ornithine Decarboxylase Activity is Required for Prostatic Bud Initiation.” 6^thGreat Lakes Nuclear Receptor Conference (GLNRC), Madison, WI, October 17-18, 2014.

1. 2024 April 19th, Duke Multidisciplinary Benign Urology Research Symposium, Durham, NC. “Molecular mechanisms of aging that drive BPH/LUTS”. Dr. Teresa Liu.
2. 2024 February 8-10, Society of Benign Prostate Disease Annual Meeting, Dallas, TX. “Beyond alpha blockers and 5 ARIs for the treatment of LUTS/BPH”, Dr. William Ricke
3. 2024 February 8-10, Society of Benign Prostate Disease Annual Meeting, Dallas, TX. “How a Cellular Understanding of BPH Could Change Clinical Practice”, Dr. Douglas Strand
4. 2023 November 29th-December 1st, Society for Basic Urology Research (SBUR) Annual Meeting. “Environmental contaminants as risk factors for lower urinary tract symptoms”. San Antonio TX, Dr. Kim Keil-Steitz.
5. 2023 November 29th-December 1st, Collaborating for the Advancement in Research in Benign Urology (CAIRIBU) Annual Meeting. “The ABCs of PCBs: Can Environmental Factors Influence Voiding Function”. Kansas City, KS, Dr. Kim Keil-Steitz
6. 2023 December 7-10, Society of Pelvic Research Annual Meeting, Savannah, GA. “Age associated changes in prostatic mitochondrial function and development of LUTS and BPH””, Dr. William Ricke.
7. 2023 November 29th-December 1st Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Research Meeting, Kansas City, Missouri, “Targeting the aging prostate in the treatment of prostate associated LUTS”, Dr. William Ricke
8. 2023 November 12, Society for Basic Urology Research (SBUR) Annual Meeting. “Environmental contaminants as risk factors for lower urinary tract symptoms”. Dr. Kimberly Keil Stietz.
9. 2023 Nov. 9-1th, 2023, Society for Basic Urology Research (SBUR), San Antonio, TX, “Targeting Fibrosis in the Lower Urinary Tract for the Treatment of BPH/LUTS”, Dr. William Ricke
10. 2023 October 19th, Stanford University O’Brien Center Symposium, Stanford, California, “Identifying the next generation of therapies in the treatment of LUTS attributed to the prostate”, Dr. William Ricke
11. 2023 September 8th, Building on a Solid Foundation to Strategically Strengthen and Enhance PACHE, Bethesday, MD, Dr. Jill Macoska.
12. August 1st-3rd, 2023, KUH Undergraduate Research Symposium, Madison, WI, organized by Dr. Kris Penniston and Dr. Chad Vezina
13. 2023 May, KUH Forward Symposium, Chicago, IL. “A Cellular Atlas of the Human Lower Urinary Tract”, Dr. Douglas Strand.
14. 2023 April, Baylor College of Medicine CRT_CAQ Bench to Bedside Seminar, Houston, TX. “A Cellular Atlas of the Human Lower Urinary Tract”, Dr. Douglas Strand
15. 2023 April 28, UW-Madison Undergraduate Research Symposium, Madison, WI. “The Role of Osteopontin in Bladder Pathology Associated with Lower Urinary Tract Dysfunction”, Kegan Skalitzky
16. 2023 April 28, UW-Madison Undergraduate Research Symposium, Madison, WI. “Benign Prostatic Hyperplasia Through Spaciotemporal Proteomic Analysis Complimented by Immunohistochemistry”, Lydia Agnew
17. 2023 December 7-10, Society of Pelvic Research Annual Meeting, Savannah, GA, “Age associated changes in prostatic mitochondrial function and development of LUTS and BPH”, Dr. William Ricke.
18. 2023 November 28th-December 1st, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Research Meeting, Kansas City, Missouri, “Targeting the aging prostate in the treatment of prostate associated LUTS”, Dr. William Ricke
19. 2023 November 9-12, Society for Basic Urology Research (SBUR), San Antonio, TX, “Targeting Fibrosis in the Lower Urinary Tract for the Treatment of BPH/LUTS”, Dr. William Ricke
20. 2023 October 19, Stanford University O’Brien Center Symposium, Stanford, California, “Identifying the next generation of therapies in the treatment of LUTS attributed to the prostate”, Dr. William Ricke
21. 2023 October 6, Dr. Kelvin Moses (MD, PhD, Vanderbilt University) UW-Madison Prostate Research Group Seminar Series, “Controversies, Financial Toxicity and Disparities in Advanced Prostate Cancer”
22. 2023 May, KUH Forward Symposium, Chicago, IL. “A Cellular Atlas of the Human Lower Urinary Tract”, Dr. Douglas Strand.
23. 2023 April, Baylor College of Medicine CRT_CAQ Bench to Bedside Seminar, Houston, TX. “A Cellular Atlas of the Human Lower Urinary Tract”, Dr. Douglas Strand
24. 2023 March 28, Columbia University O’Brien Center Annual Meeting, New York, NY. “Identifying New Cellular and Molecular Targets for the Medical Treatment of BPH/LUTS”, Dr. William Ricke
25. 2023 March 28, Columbia University O’Brien Center Annual Meeting, New York, NY. “Bladder Function: Age Dependent Effects of Exercise on Voiding, Cell Senescence and Frailty Related Mechanisms”, Dr. Teresa Liu.
26. 2023 March 28, Columbia University O’Brien Center Annual Meeting, New York, NY. “A Starring Role for the Urethra in Response to Ascending E.coli Infection”, Dr. Chad Vezina.
27. 2023 March 28, Columbia University O’Brien Center Annual Meeting, New York, NY. “A Cellular Atlas of the Human Lower Urinary Tract”, Dr. Douglas Strand.
28. 2023 March 28, Columbia University O’Brien Center Annual Meeting, New York, NY. “Bladder Function: Impact of Developmental Exposure to Environmental Toxicant, PCBs, on the Lower Urinary Tract”, Dr. Kimberly Keil Stietz.
29. 2023 March 22, Society of Toxicology Annual Meeting, Nashville, TN. “Environmental Health Perspectives Early-Career Researcher Initiative (ECRI) Discussing Peer Review of Manuscripts”, Dr. Kimberly Keil Stietz.
30. 2023 March 6, US HUPO 2023: Enabling Technology for Biological Discovery, Chicago, IL. “High-throughput Quantification of Intact Sialylated Glycopeptides Enabled by 12-plex SUGAR Isobaric Tags”, Hannah Miles.
31. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Identifying HUMAN Cells to Target Therapeutically”, Dr. Douglas Strand.
32. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Identifying MOUSE Cells to Target Therapeutically”, Dr. Chad Vezina.
33. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Exercise and BPH/LUTS”, Dr. Teresa Liu.
34. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Biomarkers of Prostate Fibrosis”, Hannah Miles.
35. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Mitochondrial Bypassers for BPH Therapy”, Alexis Adrian.
36. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Resources Available Through the UW O’Brien Center U54”, Dr. Kimberly Keil Stietz.
37. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Non-Invasive MRI Assessment of the Lower Urinary Tract and Urodynamics”, Dr. Alejandro Roldán-Alzate.
38. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Prostatic Elastogram”, Dr. Shane Wells.
39. 2023 February 2-4, UW-Madison O’Brien Center Winter Symposium / 29^th Annual Paul C. Peters Urology Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?”, Irving, TX. “Insights into Future Clinical Trials in BPH/LUTS”, Dr. William Ricke.
40. 2023 January 12, CAIRIBU K12 Scholar Seminar, Virtual. “Age-dependent Effects of Voluntary Exercise on Urinary Voiding Function and Frailty-related Mechanisms in Mice”, Dr. Teresa Liu.
41. 2022 December 1, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2022 Annual Meeting, Bethesda, MD. “Role of Developmental Exposure to Environmental Neurotoxicant, PCBs, on the Lower Urinary Tract”, Dr. Kimberly Keil Stietz.
42. 2022 November 30, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2022 Annual Meeting, Bethesda, MD. “Tissue and Data Resources for Human Lower Urinary Tract Research”, Dr. Douglas Strand.
43. 2022 November 30, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2022 Annual Meeting, Bethesda, MD. “Tracing the Cell Lineage Responsible for Prostate Fibrosis”, Dr. Chad Vezina.
44. 2022 November 30, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2022 Annual Meeting, Bethesda, MD. “Fibroblast Plasticity in the Lower Urinary Tract”, Dr. Jill Macoska.
45. 2022 November 30, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2022 Annual Meeting, Bethesda, MD. Towards Image-based Biomarkers for the Prostate”, Dr. Shane Wells.
46. 2022 November 18, UW Carbone Cancer Center (UWCCC) Trainee Network Seminar Series, Madison, WI. “Pharmacological DDX3 Inhibition in a Model of Castration Resistant Prostate Cancer Induces a Senescent-like Phenotype”, Hannah Miles.
47. 2022 November, Texas Tech University Department of Biochemistry Lecture Series, Lubbock, TX. “Prostate Progenitors: Proximal Niche vs. Plasticity”, Dr. Douglas Strand.
48. 2022 November, ARTP Meeting Paris, Virtual. “Stem Cell Niche vs. Lineage Plasticity in Prostate”, Dr. Douglas Strand.
49. 2022 November, The University of Illinois Urbana Champaign Toxicology Graduate Program Seminar Series, Champaign, IL. “An Environmental Basis for Benign Prostatic Disease”, Dr. Chad Vezina.
50. 2022 October, Necker Institute, Paris, France. “Prostate Progenitors: Proximal Niche vs. Plasticity”, Dr. Douglas Strand.
51. 2022 October, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Advancing the Research Capacity of Trainees and Investigators at Early Career Stages (ARCTICS) Community Forum, Virtual. “How to Write and Effective CV and Biosketch”, Dr. Chad Vezina.
52. 2022 September 21, CAIRIBU ARCTICS (Advancing the Research Capacity of Trainees and Investigators at early Career Stages), Virtual. “How to Create an Overarching Research Agenda”, Dr. Teresa Liu.
53. 2022 August 19-20, Society for Benign Prostatic Disease (SoBPD), Dallas, TX. “Can a Cellular Understanding of BPH Change Clinical Practice?”, Dr. Douglas Strand.
54. 2022 August 19-20, Society for Benign Prostatic Disease (SoBPD), Dallas, TX. “Understanding Stromal-epithelial Interactions in the Prostate”, Dr. William Ricke.
55. 2022 August 19, CAIRIBU Summer Research Jamboree, Virtual. “Alteration in Estrogen Metabolism with Aging Alleviates the Development of Steroid Hormone Induced LUTD”, Lydia Agnew.
56. 2022 August 19, CAIRIBU Summer Research Jamboree, Virtual. “Examining the Role of NDUFS3 in Benign Prostatic Hyperplasia”, Lauren Hackner.
57. 2022 August 19, CAIRIBU Summer Research Jamboree, Virtual. “Identification of Cell Types that Contribute to Fibrotic Disease in the Prostate”, Sneha Chandrashekar.
58. 2022 August 19, CAIRIBU Summer Research Jamboree, Virtual. “Development of a Cellular Senescence Visualization Protocol with In Vivo Imaging and Luminescence for Benign Prostatic Hyperplasia in p16-3MR Mice”, Ryan Rezania.
59. 2022 August 19, CAIRIBU Summer Research Jamboree, Virtual. “Does IL-13 Promote Cell Motility in Primary Human Prostate Fibroblasts?”, Jilla Mahek.
60. 2022 August 19, HUBMAP Meeting, Virtual. “Hubmap Update: Lower Urinary Tract”, Dr. Douglas Strand.
61. 2022 July 31-August 9, Environment, Epigenetics, and Reproduction, Kenya, Africa. “Developmental Origins of Health and Disease (DOHaD): Fetal Exposure to EDCs Promotes Prostate Pathogenesis”, Dr. William Ricke.
62. 2022 July 31-August 9, Environment, Epigenetics, and Reproduction, Kenya, Africa. “Resources Available for the Urology/Toxicology Fields”, Emily Ricke.
63. 2022 July, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN. “The Lower Urinary Tract Needs Creative Problem Solvers”, Dr. Chad Vezina.
64. 2022 July, Parks Alive, Madison, WI. Outreach from ‘Urine Business’ group, Dr. Petra Popovics and Alexis Adrian.
65. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Hallmarks of the Aging Prostate”, Dr. William Ricke.
66. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Examining the Role of Defective Oxidative Phosphorylation in the Normal and Diseased Prostate”, Alexis Adrian.
67. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Prostate Immune Environment in a Steroid Hormone-induced Aging Model”, Dr. Petra Popovics.
68. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Alteration in Estrogen Metabolism with Aging Alleviates the Development of Steroid Hormone Induced LUTD”, Dr. Teresa Liu.
69. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “SERMS as a Treatment for Urinary Dysfunction in a Mouse Model of BPH/LUTS”, Maggie Stangis.
70. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Mass Spectrometry-based Approaches for Steroid Hormone Detection”, Hannah Miles.
71. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Non-invasive Assessment of the Lower Urinary Tract – MRI Urodynamics”, Dr. Alejandro Roldán-Alzate.
72. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Can Environmental Toxicants Predispose to More Severe Aging Phenotypes?”, Monica Ridlon.
73. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “The Rodent Urinary Function Testing Core (RUFT) Tools and Resources to Help Understand Voiding Physiology in Rodent Models”, Dr. Kimberly Keil Stietz.
74. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “A Cellular Etiology of Human BPH”, Dr. Douglas Strand.
75. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Aging Promotes Fibroblast Plasticity and ECM Accumulation”, Dr. Jill Macoska.
76. 2022 June 29-30, UW-Madison/UTSW/U.Mass-Boston O’Brien Center Annual Symposium: “Targeting Aging in the Lower Urinary Tract”, Madison, WI. “Cellular Basis of Prostatic Fibrosis”, Hannah Ruetten.
77. 2022 June 18, Juneteenth in the Park, Madison, WI. Outreach from ‘Urine Business’ group, Dr. Petra Popovics and Alexis Adrian.
78. 2022 May 17, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “Identifying Collagen Producing Cell Lineages in the Inflamed Mouse Prostate”, Jaskiran Sandhu.
79. 2022 April 28-29, UW-Madison Undergraduate Research Symposium, Madison ,WI. “The Role of Osteopontin in Steroid Hormone-induced Immune Cell Infiltration of the Prostate”, Kegan Skalitzky.
80. 2022 April 28-29, UW-Madison Undergraduate Research Symposium, Madison ,WI. “Steroid Hormone Imbalance Stimulates Osteopontin Expression and Inflammation in the Mouse Prostate”, Elise Schroeder.
81. 2022 April 19, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “Circular RNA Regulation of Collagen Expression and Fibrosis”, Marissa Sarna-McCarthy & Quentin D’Arcy.
82. 2022 April 18, UW-Madison Molecular and Cellular Pharmacology (MCP) Seminar, Madison, WI. “More Than a Risk Factor: Aging and the Prostate”, Alexis Adrian.
83. 2022 March, UTSW Biomechanical Interactions Group, “Modeling Stromal-epithelial Interactions in Human BPH”, Dallas, TX. Douglas Strand.
84. 2022 March 30-April 1, NIH/NIDDK BPH and Male LUTS Workshop: Intersection between Pathology and Disease, “Linking Prostate Development to BPH/LUTD”, Dr. Chad Vezina.
85. 2022 March 30-April 1, NIH/NIDDK BPH and Male LUTS Workshop: Intersection between Pathology and Disease, Virtual. “A Cellular Anatomy of Human BPH/LUTD”, Dr. Douglas Strand.
86. 2022 March 30-April 1, NIH/NIDDK BPH and Male LUTS Workshop: Intersection between Pathology and Disease, “The Role of Fibrosis in Prostate Disease”, Dr. William Ricke.
87. 2022 March 30-April 1, NIH/NIDDK BPH and Male LUTS Workshop: Intersection between Pathology and Disease, Virtual. “Aging-mediated Cellular Changes in BPH/LUTS”, Dr. Teresa Liu.
88. 2022 February 25, UW-Madison Pharmaceutical Sciences Drug Action Seminar, Madison, WI. “The Binding Mechanism and Cellular Regulations of RNA Helicase, DDX3, in Castration-resistant Prostate Cancer”, Han Zhang.
89. 2022 February 15, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “Age and the Prostate: More than a Risk Factor”, Alexis Adrian.
90. 2022 January 18, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “PCB Effects on Bladder Contractility: Identifying Potential Mechanisms”, Dr. Kimberly Keil Stietz.
91. 2022 January 5, The Sean Logan Distinguished Lecture Series on Neurodegeneration, Pittsburgh Institute for Neurodegenerative Diseases (PIND), Virtual. “Does Mitochondrial Dysfunction Contribute to Lower Urinary Tract Dysfunction in the Aging Male with Benign Prostatic Hyperplasia?”, Dr. Teresa Liu.
92. 2021 December 10, Urology Interagency Coordinating Committee Meeting, Virtual. “Advancing Translational BPH Research: What Are We Missing?”, Dr. William Ricke.
93. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “A Bench-to Bedside Pipeline for Benign Prostate Research”, Dr. William Ricke.
94. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Human Tissue and Data Resources for Benign Genitourinary Research”, Dr. Douglas Strand.
95. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Beyond Alpha Blockers and 5ARIs: Do Anti-fibrotics Have Potential?”, Dr. Chad Vezina.
96. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Health Disparities in Benign Urology: Gaps and Bridges”, Dr. Jill Macoska.
97. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Interleukin-4 Promotes Human Prostate Fibroblast Extracellular Matrix Protein Deposition”, Quentin D’Arcy.
98. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Interleukin-4 Represses Extrinsic Pathway-Mediated Apoptosis in Human Prostate Fibroblasts”, Marissa Sarna-McCarthy.
99. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Maximizing Opportunity: The Scientific Pitch”, Dr. Chad Vezina.
100. 2021 December 2-3, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Virtual. “Aging-mediated Cellular Changes Lead to BPH/LUTS”, Dr. Teresa Liu.
101. 2021 December 1, UW-Madison Aging Science Talks: Science for the Community, Madison, WI. “The Aging Powerhouse: Mitochondrial Dysfunction in Benign Prostatic Hyperplasia (BPH)”, Alexis Adrian.
102. 2021 November 15-16, NIAID Biological Functions of DEAD/H-box Helicase in Health and Diseases, Virtual. “Prostate Cancer and DDX3”, Dr. William Ricke.
103. 2021 November 5, Society for Basic Urologic Research Annual Meeting, Virtual. “Mitochondrial Dysfunction Contributes to Fibrosis in Aging Associated Benign Prostatic Hyperplasia (BPH)”, Alexis Adrian.
104. 2021 October 31-November 4, American Society for Mass Spectrometry (ASMS) Meeting, Philadelphia, PA. “The Impact of Pharmacological DDX3 Inhibition on a Model of Prostate Cancer Progression through Integrated Omics Analyses”, Hannah Miles.
105. 2021 October 20, Columbia O’Brien Center Symposium, Virtual. “Prostate Progenitors: A Case of Mistaken Identities”, Dr. Douglas Strand.
106. 2021 October 6, Advancing the Research Capacity of Trainees and Investigators at Early Career Stages (ARCTICS) forum, “Running Down the Dream”, Dr. Chad Vezina.
107. 2021 September 22, University of Minnesota Department of Pathology Grand Rounds, Virtual. “Prostate Progenitors: A Case of Mistaken Identities”, Dr. Douglas Strand.
108. 2021 September 10-13, 2021 Annual Meeting of the American Urological Association, Virtual. “Spatial Transcriptomics Approach to Pinpoint Cellular Heterogeneity in 5-alpha Reductase Treatment Resistance”, Dr. Diya Binoy Joseph.
109. 2021 September, University of Minnesota Grand Rounds. “Spatial Transcriptomics

Reveals a Prostate Luminal to Club-like Transition after 5-alpha Reductase Inhibitor Treatment that is Blocked in Glandular Nodules”, Dr. Douglas Strand.

90. 2021 August 23, GUDMAP Jamboree, Virtual. “A Comparative Cellular Anatomy of the Prostate”, Dr. Douglas Strand.
91. 2021 August 23, GUDMAP Jamboree, Virtual. “Defining Prostate Composition and Cell Lineages”, Dr. Chad Vezina.
92. 2021 August 4, NIH/NIDDK Advancing the Research Capacity of Trainees and Investigators at Early Career Stages (ARCTICS) forum, Virtual. “Running Down the Dream”, Dr. Chad Vezina.
93. 2021 July, GUDMAP Monthly Meeting, Virtual. “Combining Single Cell and Spatial Transcriptomics to Derive the Cellular Pathogenesis of Bladder Cancer”, Dr. Douglas Strand.
94. 2021 July 8, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN. “A Surprisingly Early Start for An Aging-related Urologic Disease”, Dr. Chad Vezina.
95. 2021 April 29-30, Duke Multidisciplinary Benign Urology Research Symposium, Virtual. “Spatial Transcriptomics Approach to Pinpoint Cellular Heterogeneity in 5-alpha Reductase Treatment Resistance”, Dr. Diya Binoy Joseph.
96. 2021 April 29-30, Duke Multidisciplinary Benign Urology Research Symposium, Virtual. “Identification of Collagen Producing Cell Lineages in the Inflamed Prostate”, Jaskiran Sandhu.
97. 2021 April 29-30, Duke Multidisciplinary Benign Urology Research Symposium, Virtual. “The Role of CTGF in the Development of Lower Urinary Tract Dysfunction (LUTD)”, Brandon Scharpf.
98. 2021 April 29-30, Duke Multidisciplinary Benign Urology Research Symposium, Virtual. “Loss of Osteopontin Leads to the Resolution of E.coli-induced Prostatic Inflammation and Fibrosis”, Dr. Petra Popovics.
99. 2021 April 20, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “Phytotherapy for BPH Treatment – Hope or Hoax?”, Dr. Jill Macoska.
100. 2021 April 9, University of Wisconsin Undergraduate Research Symposium, Madison, WI. “Evaluating an Alternative Analysis Pipeline of Collagen Detection to Examine the Role of Osteopontin and Its Role in Inflammation-induced Prostatic Fibrosis”, Kegan Skalitzky.
101. 2021 April 8, University of Wisconsin Undergraduate Research Symposium, Madison, WI. “Investigating the Role of Inflammatory Molecule Osteopontin in Prostatic Fibrogenesis and Lower Urinary Tract Dysfunction”, Asha Jain.
102. 2021 June 28-29, New Investigator Forum, NIA Division of Aging Biology, Virtual. “Impact of Age on Altered Steroidogenesis and Estrogen Receptor Activation on BPH Progression”, Dr. Teresa Liu.
103. 2021 January 28, The 3^rd Annual CRepHS Symposium, Washington University, St. Louis, MO, January 28, 2021. “A Surprisingly Early Start for An Aging-related Disease”, Dr. Chad Vezina.
104. 2021 January, The 3^rd Annual CRepHS Symposium, Washington University, St. Louis, MO. “A Cellular Anatomy of the Lower Urinary Tract”, Dr. Douglas Strand.
105. 2020 December 3-4, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual. “Effects of Aging in the Prostate”, Dr. Teresa Liu.
106. 2020 December 3-4, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual. “Segregating Urinary Phenome Responses to Microbes and Other Factors – New Opportunities”, Dr. Chad Vezina.
107. 2020 December 3-4, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual. “Novel Magentic Resonance Imaging Methods”, Dr. Diego Hernando.
108. 2020 November 12, Society for Basic Urologic Research Annual Meeting: Cellular Interactions and Identities in Urologic Biology, Virtual. “Mouse Models of Prostatic Collagen Accumulation”, Dr. Chad Vezina.
109. 2020 November 12, Society for Basic Urologic Research Annual Meeting: Cellular Interactions and Identities in Urologic Biology, Virtual. “Aging-mediated Cellular Changes Lead to Prostatic Fibrosis: A Lower Urinary Tract Dysfunction”, Dr. Teresa Liu.
110. 2020 November 12, Society for Basic Urologic Research Annual Meeting: Cellular Interactions and Identities in Urologic Biology, Virtual. “Interleukin-4 Represses Extrinsic Pathway-Mediated Apoptosis in Human Prostate Fibroblasts”, Marissa Sarna-McCarthy.
111. 2020 November 12, Society for Basic Urologic Research Annual Meeting: Cellular Interactions and Identities in Urologic Biology, Virtual. “Interleukin-4 Promotes Human Prostate Fibroblast Extracellular Matrix Protein Deposition”, Quentin D’Arcy.
112. 2020 November 11, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “Age and BPH: What is Aging?”, Dr. Teresa Liu.
113. 2020 November 6, University of Wisconsin Prostate Research Group Meeting, Virtual. “Non-Invasive Comprehensive Assessment of BPH/LUTS”, Dr. Alejandro Roldán-Alzate.
114. 2020 November 6, University of Wisconsin Prostate Research Group Meeting, Virtual. “Novel Magnetic Resonance Imaging Methods”, Dr. Diego Hernando.
115. 2020 October 29, UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice”, Virtual. “Uroflometry”, Dr. Dale Bjorling.
116. 2020 October 29, UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice”, Virtual. “Q&A”, Dr. William Ricke.
117. 2020 October 29, UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice”, Virtual. “Q&A”, Drs. Kim Keil-Steitz & Chad Vezina.
118. 2020 October 14, NIDDK Female Urethra Webinar Series: Session 3, “The Role of Hormones: Lessons Learned from the Animal Kingdom”, Hannah Ruetten.
119. 2020 October 2, University of Wisconsin Prostate Research Group Meeting, Virtual. “Fibroblast Growth Factor-5 (FGF-5) Promotes AR Nuclear Localization and Ligand-Independent Activation via the YAP/TAZ Pathway”, Dalton McLean.
120. 2020 July, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN. “In Search of Superheroes to Address Lower Urinary Tract Dysfunction”, Dr. Chad Vezina.
121. 2020 July 2, PCF Journal Club, Virtual. “Urethral Luminal Epithelia are Castration-insensitive Cells of the Proximal Prostate”, Dr. Douglas Strand.
122. 2020 May 26, GUDMAP Monthly Meeting, Virtual. “Building a Cellular Anatomy of the Human and Mouse Prostate”, Dr. Douglas Strand.
123. 2020 April 24, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual. “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells” (1-minute flash talk), Christian Ortiz Hernandez.
124. 2020 April 24, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual. “Prostatic Osteopontin Expression is Associated with Symptomatic Benign Prostatic Hyperplasia” (2-minute flash talk), Dr. Petra Popovics.
125. 2020 April 24, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual. “Stromal Estrogen Receptor-alpha is Involved in the Development of Lower Urinary Tract Dysfunction” (1-minute flash talk), Dr. Debra Garvey.
126. 2020 April 24, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual. “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia” (2-minute flash talk), Dr. Teresa Liu.
127. 2020 April 24, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual. “An Immunohistochemical Prostate Cell Identification Key Indicates that Aging Shifts Procollagen 1A1 Production from Myofybroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction” (1-minute flash talk), Hannah Ruetten.
128. 2020 April 21, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. Dr. Paul Marker & Chris Unterberger.
129. 2020 March 2, Northshore P20 Meeting, Chicago, IL. “Building a Cellular Anatomy of Human Prostate Disease”, Dr. Douglas Strand.
130. 2020 February 28, Nephrology Grand Rounds, UTSW, Dallas, TX. “Building a Cellular Anatomy of Human Prostate Disease: Insight for Kidney Stone Disease”, Dr. Douglas Strand.
131. 2020 February, University of Wisconsin School of Veterinary Medicine, Comparative Biomedical Science Seminar Series, Madison, WI. “Challenging Dogma: A Story of Prostates and Urinary Function”, Hannah Ruetten.
132. 2020 January 14, UW O’Brien Center Innovative Idea Incubator Internal Seminar, Madison, WI. “The Collagen Producing Cell – Fibroblast, Myofibroblast, or Other?”, Hannah Ruetten & Christian Ortiz Hernandez.
133. 2019 December 19, Hamon Center WIPs, UTSW, Dallas, TX. “Androgen-independent Luminal Progenitors are Derived from the Prostatic Urethra”, Dr. Douglas Strand.
134. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Overview of Cell Types in the Prostate”, Dr. Chad Vezina.
135. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction” (Oral Presentation, Poster Award Winner), Hannah Ruetten.
136. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Estrogen Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia”, Dr. Teresa Liu.
137. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Aging Exacerbates Lower Urinary Tract Dysfunction and Causes Epigenetic Modifications Altering the Sex Steroid Hormone Environment in Mice”, Teresa Liu.
138. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Increased Expression of Osteopontin in the Prostate is Associated with the Clinical Progression of BPH”, Petra Popovics.
139. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells”, Christian Ortiz Hernandez.
140. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Single Cell RNA Sequencing for Cell Discovery”, Douglas Strand.
141. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Identification of Cognate Proximal Cell Types of the Mouse and Human Prostate and their Enrichment in Human Benign Prostatic Hyperplasia”, Douglas Strand.
142. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Prostate Fibrosis is Coupled to a Mesenchymal IL-4/IL-3 Autocrine Loop”, Mathilde Bonnemaison.
143. 2019 December 4-6, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO. “Segmentation and 3D Anatomical Renderings from Pelvic MRI Provide a Novel Method to Quantify Clinically Relevant Features of the Bladder and Prostate”, Alejandro Roldán-Alzate.
144. 2019 November, University of Wisconsin School of Veterinary Medicine, First Year Veterinary Histology Course, Madison, WI. “Male Reproductive Histology-Research Correlate: Following the Green Dye”, Hannah Ruetten.
145. 2019 November, Rock Valley Veterinary Medical Association November Meeting, Janesville, WI. Hannah Ruetten.
146. 2019 November 7-10, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA. “Osteopontin Exacerbates the Inflammatory Environment in the Prostate”, Dr. Petra Popovics.
147. 2019 November 8, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA. “A Retrospective Medical Record Review of Benin Prostatic Hyperplasia in a Well-Defined Population of Client-Owned Dogs: Clinical Presentation, Prevalence of Concurrent Bacterial Infection, and Response to Treatment”, Hannah Ruetten.
148. 2019 November 8, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA. “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction”, Hannah Ruetten.
149. 2019 November 8, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA. “Leadership in Benign Urology”, Dr. William Ricke.
150. 2019 November 8, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA. “Inflammation and Lower Urinary Tract Function: A Volatile Relationship”, Dr. Jill Macoska.
151. 2019 October 24, PCF Meeting, Carlsbad, CA. “Proximal Epithelia are Increased in Prostate Cancer, but are they Progenitors?”, Dr. Douglas Strand.
152. 2019 October 4, University of Wisconsin Prostate Research Group Meeting, Madison, WI. “FGF5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer”, Dalton McLean.
153. 2019 October 4, University of Wisconsin Prostate Research Group Meeting, Madison, WI. “Under Pressure: Deciphering the Role of Prostate Smooth Muscle in Urinary Dysfunction”, Anne Turco.
154. 2019 October, Columbia O’Brien Urology Center Symposium, New York, NY. “University of Wisconsin George M. O’Brien Center (U54): Cellular and Molecular Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction”, Dr. William Ricke
155. 2019 September, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Prostate Inflammation Increases Collagen and Voiding Dysfunction” (Seminar Presentation), Hannah Ruetten.
156. 2019 July, National Veterinary Scholars Symposium, Worcester, MA. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Physiology: Gross and Histologic Assessment” (Poster Presentation), Hannah Ruetten.
157. 2019 June, STP 38^th Annual Symposium, Raleigh, NC. “Impact of Sex, Androgens, and Prostate Size on C57Bl6/J Mouse Urinary Physiology: Functional Assessment of a New Platform for Toxicological Testing” (Poster Presentation), Hannah Ruetten (Conference Travel Award Winner).
158. 2019 June, STP 38^th Annual Symposium, Raleigh, NC. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Mouse Urinary Physiology: Gross and Histologic Assessment of a New Platform for Toxicological Testing”, Hannah Ruetten (Conference Travel Award Winner).
159. 2019 June, STP 38^th Annual Symposium, Raleigh, NC. “Impact of Sex, Androgens, and Prostate Size on C57Bl6/J Mouse Urinary Physiology: Functional Assessment of a New Platform for Toxicological Testing” (Poster Presentation), Kyle Wegner (Conference Travel Award Winner).
160. 2019 June, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN. “Benign Prostate Disease: What It Is and Why You Should Care”, Dr. Chad Vezina.
161. 2019 June 11, University of Pittsburgh O’Brien Benign Urology Center Symposium, Pittsburgh, PA. “To Protect and Serve: A New Paradigm for an Old Prostate Cell”, Dr. Chad Vezina
162. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL. “Social (and Antisocial) Cell Signaling Networks in the Urinary Tract”, Dr. Chad Vezina.
163. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL. “DDX3-Mediated Translational Regulation of Androgen Receptor in Prostate Cancer Progression”, Jordan Vellky.
164. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL. “Establishing a Negative Feedback loop between FGF5 and AR in prostate cancer”, Dalton McLean and Katelin Cunningham.
165. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL. “Lower Urinary Tract Fibrosis”, Dr. Jill Macoska.
166. 2019 May 3, University of Wisconsin Prostate Research Group Meeting, Madison, WI. “Impact of Sex, Androgens, and Prostate Size on Mouse Urinary Function”, Hannah Ruetten.
167. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Housekeeping Genes and Rigor & Reproducibility”, Jordan Vellky.
168. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Ring Around the Urethra: Do SRD5A2+ Fibroblasts Cause LUTS?”, Dr. Douglas Strand.
169. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “To Be or Not to Be: How Does a Prostate Cell Decide to Cause Fibrosis?”, Dr. Chad Vezina.
170. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “The Big Squeeze: The Role of Prostate Smooth Muscle Contraction in Urinary Obstruction”, Anne Turco.
171. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “From Mice to Men: Activation of the CXCL12/CXCL4 Axis in Prostatic Fibrosis”, Dr. Jill Macoska.
172. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Emerging MRI Techniques: New Tools for Research and the Clinic”, Dr. Diego Hernando.
173. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Age-Related Changes in the Urinary System – MRI Assessment”, Dr. Alejandro Roldán-Alzate.
174. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Estrogen Receptor Expression and Steroid Hormone Metabolism in Benign Prostatic Hyperlasia”, Dr. Teresa Liu.
175. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Are All Men Destined to get BPH?”, Dr. William Ricke.
176. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “MRI-based Method for Analyzing Lower Urinary Tract Dysfunction in Adult Male Mice”, Dalton McLean.
177. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Exploring Collagen Changes in C57BL/6J Mice with Bacterial-induced Prostate Inflammation”, Brett Mueller.
178. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Osteopontin: A Key Link Between Inflammation and Prostatic Fibrosis”, Dr. Petra Popovics.
179. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density and Voiding Dysfunction in Young Adult Mice”, Dr. Kim Keil.
180. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Translational Control in Steroid Hormone Signaling: Insights from Drosophilia”, Dr. Sarah Neuman.
181. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Rodent Urodynamics: What’s the Point?”, Dr. Dale Bjorling.
182. 2019 April 11-12, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Function” (Poster), Hannah Ruetten.
183. 2019 April 10, 7^th Annual University of Wisconsin SVM-Phi Zeta Research Day, Madison, WI. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Function” (Oral Presentation), Hannah Ruetten.
184. 2019 April 4, University of Wisconsin Carbone Cancer Center Retreat, Madison, WI. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Function”, Hannah Ruetten.
185. 2019 March, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Mouse Urinary Function” (Seminar Presentation), Hannah Ruetten.
186. 2019 January, University of Florida Department of Physiological Sciences, Gainsville, FL. “The Mouse as a Preclinical Model for Urology: Mechanisms of Prostate and Lower Urinary Tract Symptoms (LUTS)”, Dr. Chad Vezina.
187. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Exogenous Hormone Exposure: A Potential Platform for Testing Interventional Therapies for Lower Urinary Tract Dysfunction in Male Mice”, Chelsea A. O’Driscoll.
188. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “FGF5 Regulation of Androgen Receptor in Prostate Cells”, Dalton McLean.
189. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Building a Comprehensive Cellular Anatomy of the Normal and Diseased Human Prostate”, Dr. Douglas Strand.
190. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Impact of Age and Castration on Canine Prostate Collagen Organization”, Hannah Ruetten.
191. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Does Size Matter? Reduced Prostate Size Alters Urinary Function in Male Mice.”, Helen Zhang.
192. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Isolating Prostate Stem-like Cells in a Progressive Cell Line Model”, Katelin Cunningham.
193. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density, and Voiding Dysfunction in Young Adult Mice.”, Dr. Kimberly Keil.
194. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Characterization of Srd5a2^creErt2 Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors”, Kyle Wegner.
195. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Connecting Development and Disease: Presenting A Potential Mouse Model for BPH”, Melissa Gamat.
196. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “New Techniques to Measure Coordinated Ca²⁺ Signals, Micromotions, and Transient Pressure Events in the Mouse Urinary Bladder”, Dr. Nathan Tykocki (University of Vermont).
197. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “The Urine Proteomics of Genetically-induced Lower Urinary Tract Dysfunction (LUTD) Mice”, Sam Thomas.
198. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Monitoring Serium Steroids in a Hormone-Induced Model of Lower Urinary Tract Dysfunction”, Sam Thomas.
199. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Using Mouse and Drosophila Models to Dissect the Role of DDX3-dependent Translational Control in BPH”, Dr. Sarah Neuman.
200. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “The Impact of Age on the Lower Urinary Tract of Mice”, Dr. Teresa Liu.
201. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “Mind Over Matter – Healthy Bowels, Healthy Bladder: A Randomized Controlled Trial”, Dr. Heidi Brown.
202. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “CXCL12 Mediates Increased Prostatic Fibrosis in Mice Fed a High Fat Diet”, Dr. Jill Macoska.
203. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, MD. “MicroRNA-29a/b1 Inhibits Bladder Fibrosis and Supports Normal Bladder Function”, Dr. Dale Bjorling.
204. 2018 November, Society for Basic Urologic Research (SBUR) Fall Symposium Trainee Workshop, Palm Springs, CA. “Formulating a career development plan to maximize training productivity”, Dr. Chad Vezina.
205. 2018 November, Society for Basic Urologic Research (SBUR) Fall Symposium Trainee Workshop, Palm Springs, CA. “Role of O’Brien Centers in Benign Urology Research”, Dr. William Ricke.
206. 2018 August, Jackson Laboratories Workshop on Techniques in Modeling Human Cancer in Mice, Bar Harbor, ME. “Prostate Cancer: Clinical Problems, Research Resources and Opportunities”, Dr. Chad Vezina
207. 2018 July, UMASS-Boston, Boston, MA. “Connecting Cellular Behaviors to Prostatic Disease”, Dr. Chad Vezina.
208. 2018 July, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN. “Benign Prostate Disease: What It Is and Why You Should Care”, Dr. Chad Vezina.
209. 2018 June, External Expert Panel (EEP) Meeting, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
210. 2018 June, External Expert Panel (EEP) Retreat, Bethesda, MD. “State of the Center”, Dr. William Ricke.
211. 2018 June, Urology Research Day, University of Washington, Seattle, WA. June 16, 2018, “Defining Endpoints of Recovery of Urinary Health after Prostatectomy”, Dr. Tristan Nicholson.
212. 2018 May, University of Wisconsin Undergraduate Research Symposium, Madison, WI. “Understanding the Role of Prostate Fibrosis in Mouse Models of Hormone-Induced Urinary Dysfunction”, Brett Mueller.
213. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “Identification of Cell Types and Pathways in Normal and Diseased States”, Dr. William Ricke.
214. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “Urinary Flow Dynamics in BPH – Effects of Bladder Neck Angle.”, Dr. Alejandro Roldán-Alzate.
215. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “A Genetic Toolbox to Spy on Mouse Prostate Stromal Cells in Situ”, Dr. Chad Vezina.
216. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “Modeling and Treating Fibrosis in the Urinary Tract”, Dr. Paul Marker.
217. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”, Dr. Teresa Liu.
218. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “Impact of Age and Castration on Prostate Collagen Organization”, Hannah Ruetten.
219. 2018 April 20-21, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI. “What can the UW-Madison/U.Mass-Boston O’Brien Center Do For You”, Dr. Dale Bjorling.
220. 2018 March 13, Society of Toxicology National Meeting, San Antonio, TX. “Exposure to Bisphenols Causes Lower Urinary Tract Dysfunction in Male Mice through an ER Alpha-Dependent Mechanism”, Dr. Jalissa Wynder (Nguyen) & Dr. Clara Jeong.
221. 2018 February, University of Puget Sound, Tacoma, WA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
222. 2018 January, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Novel Endpoints and Mouse Strains in Prostate Research”, Kyle Wegner.
223. 2018 January, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series, Madison, WI. “Urinary Complications of Benign Prostatic Disease: Impact of Fetal and Neonatal Environment”, Kyle Wegner.
224. 2017 November, Veterinary Histology, School of Veterinary Medicine, University of Wisconsin-Madison, Madison WI. “Prostate Histology Research Correlate”, Hannah Ruetten.
225. 2017 November, Society of Toxicology Midwest Regional Chapter Annual Meeting, Chicago, IL. “Urinary Complications of Benign Prostatic Disease: Impact of Fetal and Neonatal Environment”, Kyle Wegner.
226. 2017 November, University of Wisconsin-Madison Molecular and Environmental Toxicology Center, Madison, WI, November 2, 2017. “Investigating the Role of Environmental Estrogens in Lower Urinary Tract Dysfunction”, Dr. Jalissa Wynder (Nguyen).
227. 2017 October, Southern University’s 6^th Annual Clarke Symposium, Baton Rouge, LA, October 5, 2017. “My Journey Towards a Career in Toxicology”, Dr. Jalissa Wynder (Nguyen).
228. 2017 October, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Collagen Architecture of the Prostate: Impact of Age and Androgen Status”, Hannah Ruetten.
229. 2017 October, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “A Nightmare in the Prostate”, Kyle Wegner.
230. 2017 September, Santa Clara University, Santa Clara, CA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
231. 2017 August, O’Brien Center Retreat, Mount Morris, WI. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
232. 2017 July, University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Summer Program for Undergraduates in Urologic Research, Madison, WI. “Toxicology: Overview and Career Options/Imaging Demonstration”, Kyle Wegner.
233. 2017 June, External Expert Panel (EEP) Meeting, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
234. 2017 June, External Expert Panel (EEP) Retreat, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
235. 2017 June, Northwest Regional Meeting – American Chemical Society Biochemistry Session, Corvallis, OR. “Microscale Culture Systems to Probe Small Molecule Signaling”, Dr. Ashleigh Theberge.
236. 2017 June, Northwest Regional Meeting – American Chemical Society Analytical Chemistry Session, Corvallis, OR. “Open Microfluidics for Chemical Analysis of Organotypic Cell Cultures”, Dr. Ashleigh Theberge.
237. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Opportunities and Challenges for Modeling BPH and LUTS in Rodents”, Dr. Paul Marker.
238. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Linking Lower Urinary Tract Function and Structure”, Dr. Dale Bjorling.
239. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Mass Spectrometry-based Urinary Proteomics”, Sam Thomas.
240. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Urinary Flow Dynamics – An MR Based Computational Modeling Approach”, Dr. Alejandro Roldán-Alzate.
241. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis”, Dr. Jill Macoska.
242. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Identification of Estrogen Regulated Gene Networks in BPH”, Dr. Teresa Liu.
243. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “What is BPH and What Roles Might Estrogen Be Playing?”, Dr. William Ricke.
244. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Androgen Regulation of FGF5 and its Role in the Prostate”, Dalton McLean.
245. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Pinpointing Cellular Origins and Physiological Consequences of Prostate Fibrosis”, Dr. Chad Vezina.
246. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Harnessing Lineage Tracing to Study Hormonal Responses in the Prostate”, Diya Binoy Joseph.
247. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Measurement of Multi-steroid Hormones in Mouse Serum using LC-MS/MS”, Clara Jeong.
248. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Quantitative MRI Techniques for the Assessment of BPH: Background and Proposed Research”, Dr. Diego Hernando.
249. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Deciphering the Influence of Diabesity and Intermittent Hypoxia on the Male Environment in Urinary Tract Dysfunction”, Dr. Lisa Abler.
250. 2017 May, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “One Health Approach to Studying Benign Prostatic Hyperplasia”, Hannah Ruetten.
251. 2017 May, University of Wisconsin-Madison Summer Program for Undergraduate Urology Research (SPUUR), Madison, WI, May 25, 2017. “How to Get the Most Out of a Summer Internship”, Dr. Jalissa Wynder (Nguyen).
252. 2017 May, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series, Madison, WI. “Unraveling the Prostate Collagen Network”, Kyle Wegner.
253. 2017 May, University of Washington, Bioengineering, Seattle, WA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
254. 2017 May, Children’s Hospital, Harvard University, Boston, MA. “Fibrosis as a Mediator of Lower Urinary Tract Dysfunction”, Dr. William Ricke.
255. 2017 April, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Objective Collagen Detection in Thin Sections”, Kyle Wegner.
256. 2017 March, University of Wisconsin Laboratory for Optical and Computational Instrumentation Seminar Series, Madison, WI. “Mesoscale Imaging of Stromal Elements and Interactions in Histologic Preparations”, Kyle Wegner.
257. 2017 March, University of California, Berkeley, Bioengineering, Berkeley, CA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
258. 2017 March, University of Massachusetts-Boston, Boston, MA. “Understanding the Molecular Mechanism of Estrogens in Pathogenesis”, Dr. William Ricke.
259. 2017 February, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Prostatic Collagen Architecture in Neutered and Intact Canines”, Hannah Ruetten.
260. 2017 January, Resident Seminar, Department of Urology, University of Washington, Seattle, WA, January 25, 2017. “Estrogen Receptor-alpha is a Key Mediator and Therapeutic Target in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
261. 2017 January, University of Toronto, Mechanical and Industrial Engineering, Toronto, Canada. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
262. 2016 December, EMBS Micro and Nanotechnology in Medicine (IEEE Conference), Waikoloa, HI. “Examining Cellular Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
263. 2016 December, Urology Program Directors’ Meeting, NIDDK, Pacific Grove, CA. “Estrogen Action in the Development of Fibrosis”, Dr. William Ricke.
264. 2016 November, Society for Basic Urologic Research Annual Meeting, Scottsdale, AR. “Examining Cell Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
265. 2016 October, University of Wisconsin Carbone Cancer Center Translational Imaging Group, Madison, WI. “Mesoscale Imaging of Stromal Elements and Interactions in Histologic Preparations”, Kyle Wegner.
266. 2016 September, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Genetic Background Influences Susceptibility of Male Mice to Hormone-Induced Urinary Dysfunction”, Kyle Wegner.
267. 2016 September, University of Wisconsin-Department of Urology Grand Rounds, Madison, WI. September 2016, “Modeling Prostate Disease in Mice and Cell Culture”, Dr. William Ricke.
268. 2016 August, O’Brien Center Retreat, Mount Morris, WI. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
269. 2016 August, University of Wisconsin Comparative Biomedical Sciences Departmental Meeting, Minoqua, WI. “The Role of Prostate Fibrosis in Male Urinary Dysfunction”, Kyle Wegner.
270. 2016 July, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “New Findings in Prostate Fibrosis”, Kyle Wegner.
271. 2016 July, Pacific Northwest National Laboratory, Richland, WA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
272. 2016 June, University of Wisconsin-Madison Endocrinology and Reproductive Physiology Annual Symposium, Madison, WI. “Unraveling the Connection Between Prostate and Urinary Dysfunction”, Dr. Chad Vezina.
273. 2016 June, External Expert Panel (EEP) Meeting, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
274. 2016 June, External Expert Panel (EEP) Retreat, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
275. 2016 May, American Urologic Association, Plenary Session, San Diego, CA. May 8, 2016, “Patient Stratification in the Treatment of BPH”, Dr. William Ricke.
276. 2016 April, Duke University, Multidisciplinary Benign Urology Research Day, KURe and PMRC, Durham, NC, April 29, 2016. “Hormonal Regulation and Fibrosis in the Lower Urinary Tract”, Dr. William Ricke.
277. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “Estrogen Induction of LUTD in Mice”, Dr. William Ricke.
278. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “Impact of AHR Signaling on Benign Urinary Function”, Dr. Chad Vezina.
279. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “IUL TCDD Exacerbates LUTD in Mice”, Dr. Chad Vezina.
280. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract”, Kyle Wegner.
281. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “The Role of Bisphenol A in LUTD”, Jalissa Wynder.
282. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “BPA Exposure and Associated Gene Expression Changes in Prostate Cancer”, Jordan Vellky.
283. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “Background and Collaborations”, Dr. Dale Bjorling.
284. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “Investigating the Role of DNA Methylation in Prostate Development and Disease”, Diya Binoy Joseph.
285. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI, April 4-5, 2016. “SERMs and BPH”, Dr. Teresa Liu.
286. 2016 March (Stephen ‘Royal’ Oakes), University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Seminar Series, Madison WI. “Computer-Based High-Throughput Urinary Function Analysis”, Stephen ‘Royal’ Oakes.
287. 2016 March, University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Seminar Series, Madison WI. “Large Sample Tissu eArrays and Picrosirius Red: Useful Tools for Prostate Histological Analysis”, Kyle Wegner.
288. 2016 March, Pittcon, Symposium: Quantifying the Tumor Microenvironment, Atlanta, GA. “Examining Cellular Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
289. 2016 February, The Society for Urodynamics and Female Urology (SUFU) Annual Meeting, New Orleans, LA, February 23-27, 2016. “Urinary Obstruction and Fibrosis”, Dr. Jill Macoska.
290. 2016 February, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series, Madison, WI. “Developmental Origins of Adult Disease: Effects of Fetal Dioxin Exposure on Adult Prostate Disease Progression”, Kyle Wegner.
291. 2016 January, Fred Hutchinson Cancer Research Center, Program in Prostate Cancer Research (PPCR), Seattle, WA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
292. 2015 December, University of Massachusetts Boston, Boston, MA. December 7, 2015, “Identifying Molecular Mechanisms of Prostate Cancer Using Transposon-Mediated Mutagenesis and Mouse Models”, Dr. Paul Marker.
293. 2015 December, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “The Role of Beta Catenin in Benign Prostatic Disease”, Kyle Wegner.
294. 2015 December, University of Wisconsin Prostate Researchers Group, Madison, WI. “The Role of Beta Catenin in Benign Prostatic Disease”, Kyle Wegner.
295. 2015 November, National Institute of Environmental Health Sciences, Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA), Durham, NC. “Estrogenic Effects of BPA on the Lower Urinary Tract of Postnatal Day 1 Rats”, Dr. William Ricke.
296. 2015 November, Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “Inflammation of the Lower Urinary Tract”, Dr. Dale Bjorling.
297. 2015 November, Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “The Influence of Intermittent Hypoxia and Diabetes on Lower Urinary Tract Function”, Dr. Chad Vezina.
298. 2015 November, Columbia University: Symposium on The Genetic Origins and Complications of Urinary Tract Abnormalities, New York, NY. “A Role for DNA Methylation in Prostate Development and Urinary Function”, Dr. Chad Vezina.
299. 2015 October, University of Illinois Chicago Medical School (Rockford satellite), Rockford, IL, October 7, 2015. “Identifying molecular mechanisms of prostate cancer and BPH using mouse models”, Dr. Paul Marker.
300. 2015 September, Urology Program Directors Meeting, Wisconsin K12cure Program, Madison, WI. “University of Wisconsin K12cure Training Program”, Dr. Dale Bjorling.
301. 2015 September, NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Estrogen Action in Urinary Dysfunction”, Dr. William Ricke.
302. 2015 September, NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Roles of Beta-Catenin in Urinary Dysfunction”, Dr. Chad Vezina.
303. 2015 September, NIDDK Urology Developmental Centers Meeting, Madison, WI. “Probing Paracrine Signaling in Benign Prostatic Hyperplasia with New Microfluidic Methods”, Dr. Ashleigh Theberge.
304. 2015 August, O’Brien Center Retreat, Mount Morris, WI. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
305. 2015 June, NIH/NIDDK Urology Centers Steering Committee Meeting, Bethesda, MD. “Overview of O’Brien Center”, Dr. William Ricke.
306. 2015 June, NIH/NIDDK Urology Centers Steering Committee Meeting, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
307. 2015 June, External Expert Panel (EEP) Retreat, Bethesda, MD. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke
308. 2015 June, Gordon Research Conference on the Physics and Chemistry of Microfluidics, West Dover, VT. “Metabolomics at the Microscale”, Dr. Ashleigh Theberge.
309. 2015 May, American Urological Association Basic Science Symposium, New Orleans, LA, May 15 2015. “Estrogen Regulation in the Prostate”, Dr. William Ricke.
310. 2015 May, American Urological Association, New Orleans, LA, May 15 2015. “Estrogen Regulation in BPH and the Lower Urinary Tract”, Dr. William Ricke.
311. 2015 May, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “The Role of Prostate Fibrosis in Lower Urinary Dysfunction”, Kyle Wegner.
312. 2015 April, University of Wisconsin/UMASS Boston George M. O’Brien Urology Research Symposium, Madison,WI, April 8-9, 2015. “Fibrosis of the Lower Urinary Tract: An Alternative to Prostate Hyperplasia in LUTD”, Dr. William Ricke.
313. 2015 April, University of Wisconsin/UMASS Boston George M. O’Brien Urology Research Symposium, Madison,WI, April 8-9, 2015. “CXCL12-Mediated Non-canonical Signaling Promotes Myofibroblast Phenoconversion in the Prostate”, Dr. Jill Macoska.
314. 2015 February, Clark-Atlanta University, Atlanta, GA, February 6, 2015. “Hormone Action and Paracrine Interactions in Prostate Carcinogenesis”, Dr. William Ricke.
315. 2015 February, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “A New Direction: Prostate Fibrosis”, Kyle Wegner.
316. 2015 February, University of Chicago, Chicago IL. “Mapping the Developing Mouse Prostate to Reveal New Ductal Growth Mechanisms: A Focus on DNA Methylation”, Dr. Chad Vezina.
317. 2015 February, Pathology Student Seminar, University of Rochester, Rochestern, NY, February 3, 2015. “Estrogen Receptor-alpha is a Key Mediator and Therapeutic Target in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
318. 2015 February, University of North Carolina, Chapel Hill, Department of Biomedical Engineering, Chapel Hill, NC. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
319. 2015 February, University of California, Davis, Department of Chemistry, Davis, CA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
320. 2015 January, University of Wisconsin-Madison Prostate Cancer Research Group Meeting, Madison, WI, January 9, 2015. “Estrogen Receptors in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
321. 2015 January, University of Utah, Department of Biochemistry, Salt Lake City, UT. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
322. 2015 January, Indiana University, Department of Chemistry, Bloomington, IN. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
323. 2015 January, University of Washington, Department of Chemistry, Seattle, WA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
324. 2014 December, University of Wisconsin-Madison Vertebrate Development Biology Group Presentation, Madison, WI, December 16, 2014. “Environmental Estrogens and BPH”, Dr. Jalissa Wynder (Nguyen).
325. 2014 December, NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Urinary Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Men”, Dr. Paul Marker.
326. 2014 December, NIDDK Urology Developmental Centers Meeting, Asilomar, CA. “Examining Microenvironmental Regulation of Angiogenesis in Benign Prostatic Hyperplasia with Microscale Culture”, Dr. Ashleigh Theberge.
327. 2014 December, NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Developmental Mapping of the Prostate”, Dr. Chad Vezina.
328. 2014 December, University of Wisconsin-Madison, Department of Biomedical Engineering, Madison, WI. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
329. 2014 November, Society for Basic Urologic Research (SBUR) Fall Meeting, Dallas, TX, November 13-16, 2014. “Estrogen Regulation of Fibrosis in Lower Urinary Tract Dysfunction”, Dr. William Ricke.
330. 2014 November, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI. “Prostate Research in the Vezina Lab: Past, Present, and Future”, Dr. Chad Vezina.
331. 2014 November, Society for Basic Urologic Research Fall Symposium, Dallas, TX. “Microscale Metabolomics Platform for Studying Cell Signaling in Benign Prostatic Hyperplasia”, Dr. Ashleigh Theberge.
332. 2014 October, University of Wisconsin Department of Urology Uehling Lectures, Madison, WI, October 24, 2014. “Hormones and BPH: Glandular Growth and/or Fibrosis”, Dr. William Ricke.
333. 2014 October, Association of Underrepresented Minority Fellows Symposium (AUMF), Cleveland, OH, October 18, 2014. “Testosterone and Bisphenol A Exposure Induces Increased Prostate Mass of Male Mice”, Dr. Jalissa Wynder (Nguyen).
334. 2014 October, University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, October 16, 2014. “Bisphenol A Exposure and Prostate Disease”, Dr. William Ricke, Dr. Tristan Nicholson, & Dr. Jalissa Wynder (Nguyen).
335. 2014 May, Vanderbilt Center for Benign Urologic Diseases, Nashville, TN. “Emerging Players in Urinary Dysfunction: Epigenetics and Sleep Apnea”, Dr. Chad Vezina.

1. February 3-4, 2023, 2023 UW-Madison George M. O’Brien Urology Research Center Winter Symposium “How Close Are We to New Targets for Clinical Trials in BPH/LUTS?“ in Irving, TX. 
2. August 19-22, 2022 Society of Benign Prostate Disease (SoBPD) 2022, Birmingham, AL (canceled)
3. December 9, 2021, Scott Bauer, MD (K12 Scholar, University of California San Francisco-Kaiser Permanente Urological Epidemiology (KUroEpi) Institutional Research Career Development Program (K12)), UW O’Brien Center-sponsored CAIRIBU K12 Invited Speaker Seminar Series “Geoscience, Epidemiology, and Benign Urology”
4. November 11, 2021, Matthew Grimes, MD (K12 Scholar, University of Wisconsin-Madison Multidisciplinary Urologic Research Career Development Program (K12)), UW O’Brien Center-sponsored CAIRIBU K12 Invited Speaker Seminar Series “Mechanisms of Urethral Fibrosis in Lichen Sclerosus”
5. October 14, 2021, Maryellen Kelly, DNP, CPNP, MHSc (K12 Scholar, Duke University Multidisciplinary Urologic Research Career Development Program (K12)), UW O’Brien Center-sponsored CAIRIBU K12 Invited Speaker Seminar Series “Pediatric Lower Urinary Tract Dysfunction”
6. September 15, 2021, Thu H. Le, MD, FAHA (John J. Kuiper Distinguished Professor of Medicine, Chief, Division of Nephrology, University of Rochester School of Medicine), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual) “GSTM1 in Kidney Disease: From the Bench to the Clinic”
7. September 9, 2021, Guilia Lane, MD (K12 Scholar, University of Michigan), UW O’Brien Center-sponsored CAIRIBU K12 Invited Speaker Seminar Series “Patient Decision Making in Urology”
8. August 12, 2021, Eva Raphael, MD, PhD (K12 Scholar, University of California San Francisco-Kaiser Permanente Urological Epidemiology (KUroEpi)), UW O’Brien Center-sponsored CAIRIBU K12 Invited Speaker Seminar Series “Prevalence, Risk Factors, and Spatial Distribution of Bacteriuria Caused by Antimicrobial-resistant E.coli”
9. July 8, 2021, Casey Steadman, PhD (K12 Scholar, Duke University KURe Program), UW O’Brien Center-sponsored CAIRIBU K12 Invited Speaker Seminar Series “Kilohertz Frequency Spinal Cord Stimulation for the Restoration of Bladder Function after Spinal Cord Injury”
10. April 20, 2021, Jill A. Macoska, PhD (UW O’Brien Center Project 3 PI, Distinguished University Professor of Science and Mathematics, Professor of Biological Sciences, University of Massachusetts Boston), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual) – “Phytotherapy for BPH Treatment – Hope or Hoax?”
11. March 16, 2021, Lauren Baker, MS, DVM (UW-Madison), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual) – “Genetic Drivers of Calcium Levels in Blood and Urine Affect Risk of Calcium Oxalate Urinary Stones in a Dog Model”
12. February 16, 2021, Anne Turco (UW-Madison, Vezina Lab) & Nathan R. Tykocki, PhD (Assistant Professor, Department of Pharmacology and Toxicology, Michigan State University), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
13. January 19, 2021, Barry G. Timms, PhD (Professor Emeritus, UCS Sandford School of Medicine), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
14. November 11, 2020, Teresa Liu, PhD (K01 Scholar, UW-Madison Department of Urology), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual) – “Age and BPH: What is Aging?”
15. October 29, 2020, Dale Bjorling, DVM (UW-Madison, School of Veterinary Medicine), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Uroflowmetry”
16. October 29, 2020, William Ricke, PhD (UW-Madison, Department of Urology), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
17. October 29, 2020, Warren Hill, PhD (Harvard University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Void Spot Assay”
18. October 29, 2020, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
19. October 29, 2020, Kim Keil Steitz, PhD (UW-Madison, School of Veterinary Medicine), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
20. October 29, 2020, Matt Fraser, PhD (Duke University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Cystometry”
21. October 29, 2020, Maryrose Sullivan, PhD (Harvard University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
22. October 29, 2020, Mike Ruggieri, SR (Temple University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “In Vitro Testing”
23. October 29, 2020, Rosalyn Adam, PhD (Harvard University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
24. CROSS–DISCIPLINE INTERACTION: October 14, 2020, LaTasha Crawford, VMD, PhD, DACVP (UW-Madison, School of Veterinary Medicine), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
25. CROSS–DISCIPLINE INTERACTION: September 9, 2020, Alejandro Roldán-Alzate, PhD (UW-Madison, Departments of Mechanical Engineering and Radiology), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
26. May 12, 2020, Matthew Grimes, MD (UW-Madison, Department of Urology), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
27. CROSS–DISCIPLINE INTERACTION: April 21, 2020, Paul Marker, PhD & Chris Unterberger (UW-Madison, School of Pharmacy), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
28. March 24, 2020, Dan Gralnek, MD & Chris Manakas, MD (UW-Madison, Department of Urology), UW O’Brien Center Innovative Idea Incubator (I³) Seminar (virtual)
29. CROSS–DISCIPLINE INTERACTION: February 18, 2020, Zunyi Wang, PhD (UW-Madison, School of Veterinary Medicine), UW O’Brien Center Innovative Idea Incubator (I³) Seminar -“Collagen Synthesis by Urothelial Cells”
30. CROSS–DISCIPLINE INTERACTION: January 14, 2019, Hannah Ruetten (UW-Madison, Department of Pathobiological Sciences) & Christian Ortiz-Hernandez (UW-Madison, Department of Urology), UW O’Brien Center Innovative Idea Incubator (I³) Seminar
31. CROSS–DISCIPLINE INTERACTION: December 17, 2019, Kimberly Keil Stietz, PhD (UW-Madison, School of Veterinary Medicine), UW O’Brien Center Innovative Idea Incubator (I³) Seminar
32. CROSS–DISCIPLINE INTERACTION: November 19, 2019, William Ricke, PhD (UW-Madison, Department of Urology) & Diego Hernando, PhD (UW-Madison, Department of Radiology and Medical Physics), UW O’Brien Center Innovative Idea Incubator (I³) Seminar
33. November 13, 2019, Nathan Tykocki, PhD (Michigan State University), UW O’Brien Center Invited Speaker Seminar – “When Spice Isn’t Nice: TRPV1 Channels in Bladder Physiology and Dysfunction”
34. November 1, 2019, Magdalena Grabowska, PhD (Case Western Reserve University), UW-Madison Prostate Research Group (PRG) Meeting – “Elucidating NFIB Contributions to Prostatic Diseases”
35. October 15, 2019, Douglas Strand, PhD (UT-Southwestern), UW O’Brien Center Innovative Idea Incubator (I³) Seminar
36. October 9, 2019, Lori Birder, PhD (University of Pittsburgh School of Medicine), UW O’Brien Center Invited Speaker Seminar – “Aging Associated Changes in Oxidative Stress and Metabolic Processes in the Bladder Wall”
37. September 17, 2019, William Ricke, PhD (UW-Madison, Department of Urology) & Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW O’Brien Center Innovative Idea Incubator (I³) Seminar
38. June 26, 2019, Michael Freeman, PhD (Cedars-Sinai Medical Center), UW O’Brien Center Invited Speaker Seminar – “Androgen Receptor-Indifferent Prostate Cancer”
39. May 22, 2019, Aria Olumi, MD (Beth Israel Deaconess Medical Center and Harvard Medical School), UW O’Brien Center Invited Speaker Seminar – “Epigenetic Changes in 5-Alpha Reductase 2 – Opportunities for Personalized Care for Management of Prostatic Disease”
40. CROSS-DISCIPLINE INTERACTION: May 15, 2019, Kristen Malecki, PhD, MPH (UW-Madison, Population Health Sciences), UW O’Brien Center Internal Speaker Seminar – “Translating Research for Human Health and the Environment – An Epidemiologist’s Perspective”
41. May 1, 2019, Adam Klausner, MD (Virginia Commonwealth University), UW O’Brien Center Invited Speaker Seminar – “Urodynamics 2.0 – Novel Technologies for the Evaluation of Voiding Dysfunction”
42. CROSS-DISCIPLINE INTERACTION: April 17, 2019, Melissa Skala, PhD (UW-Madison, Biomolecular Engineering), UW O’Brien Center Internal Speaker Seminar – “Metabolic Imaging of Cellular Heterogeneity in Cancer”
43. CROSS–DISCIPLINE INTERACTION: April 12, 2019, Matt Conklin, PhD (UW-Madison, Department of Cell and Regenerative Biology), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Methods for Decoding the Collagen ECM in Prostate Cancer and BPH: Out of Many Fibers, A Biomarker?”
44. April 12, 2019, Petra Popovics, PhD (Case Western Reserve University), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Osteopontin: A Key Link Between Inflammation and Prostatic Fibrosis”
45. INTERACTION WITH COLUMBIA O’BRIEN CENTER: April 12, 2019, Nicholas Steers, PhD (Columbia University), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Elucidating the Origin and Function of Bladder Resident Macrophages”
46. INTERACTION WITH GRADUATE TRAINEE: April 12, 2019, Jordan Vellky (PhD Candidate, UW-Madison Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Housekeeping Genes and Rigor & Reproducibility”
47. April 12, 2019, Scott Gabrielsen, MD (Baylor College of Medicine), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Finding the Needle in the Haystack: Harnessing Big Data to Identify Novel Causes of Male Infertility”
48. April 12, 2019, Kim Keil, PhD (UW-Madison, School of Veterinary Medicine, Department of Surgical Sciences), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density and Voiding Dysfunction in Young Adult Mice”
49. April 12, 2019, Adriane Sinclair, PhD (UCSF), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Hypospadias in Humans and Mice”
50. CROSS–DISCIPLINE INTERACTION: April 12, 2019, Sarah Neuman, PhD (UW-Madison, School of Pharmacy), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Translational Control in Steroid Hormone Signaling: Insights from Drosophilia”
51. April 12, 2019, Dale Bjorling, DVM (UW-Madison, School of Veterinary Medicine), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Rodent Urodynamics: What’s the Point?”
52. CROSS NIH INSTITUTE INTERACTION: April 11, 2019, Kristina Penniston, PhD (NIH/NIDDK), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Synergistic Interdisciplinary Research Interactions in Benign Urology: How Can We Be More Like Bacteria?”
53. April 11, 2019, Douglas Strand, PhD (UT-Southwestern), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Ring Around the Urethra: Do SRD5A2+ Fibroblasts Cause LUTS?”
54. April 11, 2019, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “To Be or Not to Be: How Does a Prostate Cell Decide to Cause Fibrosis?”
55. INTERACTION WITH GRADUATE TRAINEE: April 11, 2019, Anne Turco (PhD Candidate, UW-Madison METC Program), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – ”The Big Squeeze: The Role of Prostate Smooth Muscle Contraction in Urinary Obstruction”
56. April 11, 2019, Jill Macoska, PhD (University of Massachusetts-Boston), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “From Mice to Men: Activation of the CSCL12/CXCL4 Axis in Prostatic Fibrosis”
57. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: April 11, 2019, Pradeep Tyagi, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Insights from the Link Between Adipokine Levels in Urine and the Obesity of BPH Patients”
58. April 11, 2019, Scott Bauer, MD (UCSF), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Using Large Observational Studies to Study Mechanisms of BPH/LUTS”
59. April 11, 2019, Balakrishna Lokeshwar, PhD (Augusta University), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “The Interleukin-8 Axis in the Development of BPH”
60. CROSS-DISCIPLINE INTERACTION: April 11, 2019, Diego Hernando, PhD (UW-Madison, Department of Radiology and Medical Physics), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Emerging MRI Techniques: New Tools for Research and the Clinic”
61. INTERACTION WITH UW-MADISON K12: April 11, 2019, Teresa Liu, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Estrogen Receptor Expression and Steroid Hormone Metabolism in Benign Prostatic Hyperplasia”
62. April 11, 2019, Will Ricke, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Are All Men Destined to Get BPH?”
63. INTERACTION WITH GRADUATE TRAINEE: April 11, 2019, Dalton McLean (PhD Candidate, UW-Madison Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “MRI-Based Method for Analyzing Lower Urinary Tract Dysfunction in Adult Male Mice”
64. INTERACTION WITH TRAINEE: April 11, 2019, Brett Mueller (UW-Madison), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Exploring Collagen Changes in C57BL/6J Mice with Bacterial-induced Prostate Inflammation”
65. April 11, 2019, Jeremy Duffield, MD, PhD, FRCP (Vertex Pharmaceuticals), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Cellular and Molecular Mechanisms Underlying Solid Organ Fibrosis: What to Target and Why?”
66. April 1, 2019, Aaron Mickle, PhD (Washington University School of Medicine), UW O’Brien Center Invited Speaker Seminar – “Optogenetic Neuromodulation of Bladder Pain and Function”
67. March 28, 2019, Beatrice Knudsen, MD, PhD (Cedars-Sinai Medical Center), UW O’Brien Center Invited Speaker Seminar – “Computational Pathology and the Tumor Microenvironment”
68. March 20, 2019, Timothy Ratliff, PhD (Purdue University Center for Cancer Research), UW O’Brien Center Invited Speaker Seminar – “Contributions of Inflammation to Benign Prostate Hyperplasia”
69. CROSS-DISCIPLINE INTERACTION: January 16, 2019, Lauren Michael, MS (UW-Madison Center for High Throughput Computing), UW O’Brien Center Internal Speaker Seminar – “Accelerate Your Research with Scalable Computing: Resources on Campus and Beyond”
70. CROSS-DISCIPLINE INTERACTION: December 19, 2018, Heidi Dvinge, PhD (UW-Madison, Biomolecular Chemistry), UW O’Brien Center Internal Speaker Seminar – “Prevalence and Function of Nuclear Receptor Isoforms in Cancer”
71. December 12, 2018, Petra Popovics, PhD (Case Western Reserve University), UW O’Brien Center Invited Speaker Seminar – “Molecular Links Between Chronic Inflammation and Benign Prostatic Hyperplasia”
72. December 10, 2018, Hari Koul, PhD (LSUHSC), UW O’Brien Center Invited Speaker Seminar – “Role of PDEF in Prostate Luminal Epithelium”
73. November 14, 2018, Sara Roccabianca, PhD (Michigan State University), UW O’Brien Center Invited Speaker Seminar – “Extracellular Matrix Remodeling in the Urinary Bladder Wall in Two Animal Models of Type 2 Diabetes”
74. October 11, 2018, Marc Cox, MSPH, PhD (University of Texas at El Paso), UW O’Brien Center Invited Speaker Seminar – “Molecular Chaperones and Cochaperones in Hormone-Dependent Physiology and Disease”
75. October 10, 2018, Gerard Apodaca, PhD (University of Pittsburgh), UW O’Brien Center Invited Speaker Seminar – “Umbrella Cells: Life in a Liquid Environment”
76. CROSS-DISCIPLINE INTERACTION: October 3, 2018, Tony Goldberg, DVM, PhD (UW Madison, Department of Pathobiological Sciences), UW O’Brien Center Internal Speaker Seminar – “Metabiome of Male Lower Urinary Tract Syndrome: An Epidemiological and Ecological Study”
77. September 12, 2108, Carolyn Best, PhD (American Urological Association), UW O’Brien Center Invited Speaker Seminar – “The AUA and Urology Care Foundation: Providing Opportunities to Advance Urology Research”
78. August 29, 2018, Andrey Shaw, PhD (Genentech Inc.), UW O’Brien Center Invited Speaker Seminar – “A Single Cell Sequencing View of the Glomerulus in Health and Disease”
79. April 21, 2018, Heidi Wendell Brown, MD (UW-Madison, Department of OB/GYN), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Marketing Continence Promotion in the Community: The “Sell-ular” Level
80. April 21, 2018, Tatyana Sysoeva, PhD (Duke University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Regulation of Conjugative Transfer of B-lactam Resistance from Uropathogenic Strains of Escerichia Coli”
81. April 21, 2018, Maryellen Kelly, CPNP, CNP (Duke University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Diabetes and the Pediatric Lower Urinary Tract”
82. April 21, 2018, Michael Wood, DVM, PhD (UW-Madison, Department of Pathobiological Sciences), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Urothelial Response to Targeted Soluble and Membrane Bound IL-6 Signaling”
83. April 21, 2018, Miguel Verbitsky, PhD (Columbia University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Large-scale CNV Analysis Provides Insight Into the Genomic Architecture of Congenital Anomalies of the Kidney and Urinary Tract”
84. INTERACTION WITH MAYO O’BRIEN CENTER: April 21, 2018, Marcelino Rivera, MD (Mayo Clinic), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Improving Stone Disease Treatment by Accurate Phenotyping and Risk Stratification”
85. April 21, 2018, Dale Bjorling, DVM (UW-Madison, School of Veterinary Medicine), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “What Can the UW-Madison/U Mass-Boston O’Brien Center Do For You?”
86. April 20, 2018, Brian Van Le, MD (UT Southwestern), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology -, “Current Paradigms for Understanding and Managing Benign Prostatic Hyperplasia”
87. April 20, 2018, Douglas Strand, PhD (UT Southwestern), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “A Cellular Atlas of the Human Prostate”
88. April 20, 2018, Will Ricke, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Identification of Cell Types and Pathways in Normal and Disease States”
89. April 20, 2018, Jill Macoska, PhD (University of Massachusetts-Boston), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “CXCL12/CXCR4-Mediated Procollagen Secretion is Coupled to Cullin-RING Ubiquitin Ligase Activation”
90. CROSS-DISCIPLINE INTERACTION: April 20, 2018, Jacques Galipeau, MD (UW-Madison, Hematology/Oncology), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Translational Use of MSCs in Urology”
91. CROSS-DISCIPLINE INTERACTION: April 20, 2018, Alejandro Roldán-Alzate, PhD (UW-Madison, Departments of Mechanical and Biomedical Engineering), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Urinary Flow Dynamics in BPH – Effects of Bladder Neck Angle”
92. April 20, 2018, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “A Genetic Toolbox to Spy on Mouse Prostate Stromal Cells in Situ”
93. April 20, 2018, Li Xin, PhD (Baylor University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Inflammation and Prostate Epithelial Lineage Hierarchy”
94. INTERACTION WITH GRADUATE TRAINEE: April 20, 2018, Mark Cadena (PhD Candidate, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Neuroendocrine Cells: Mediators of Prostate Smooth Muscle Contractility”
95. CROSS–DISCIPLINE INTERACTION: April 20, 2018, Sheena Kerr (UW-Madison, Department of Biomedical Engineering), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Development of a Microscale Organotypic Model of Prostate Cancer”
96. April 20, 2018, Paul Marker, PhD (UW-Madison, School of Pharmacy), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Modeling and Treating Fibrosis in the Urinary Tract”
97. INTERACTION WITH UW-MADISON K12: April 20, 2018, Teresa Liu, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”
98. INTERACTION WITH GRADUATE TRAINEE: April 20, 2018, Sam Thomas (PhD Candidate, UW-Madison METC Program), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Proteomics by Mass Spectrometry for Molecular Insights into Hormone-Induced Lower Urinary Tract Dysfunction in Mice”
99. INTERACTION WITH GRADUATE TRAINEE: April 20, 2018, Hannah Ruetten (PhD Candidate, UW-Madison Comparative Biomedical Sciences Program), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Impact of Age and Castration on Prostate Collagen Organization”
100. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: April 20, 2018, Zhou Wang, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Inflammation, Androgen Signaling, and Luminal Epithelial Barrier Dysfunction in BPH”
101. March 7, 2018, Jianghui Hou, PhD (Washington University), O’Brien Center Invited Speaker Seminar – “MicroRNA, Kidney, and Bladder Diseases”
102. October 11, 2017, Charles Bieberich, PhD (University of Maryland), O’Brien Center Invited Speaker Seminar – “Pelvic Pain, Proliferation, and PIN: Consequences of Chronic Prostatic Inflammation in a Mouse Model”
103. INTERACTION WITH UW-MADISON K12: May 24, 2017, Heidi Wendell Brown, MD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “How SHAIP is Shaping Up”
104. INTERACTION WITH COLUBMIA O’BRIEN CENTER: May 24, 2017, Jonathan Barasch, MD, PhD (Columbia University), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “An Iron Defense Against UTI”
105. May 24, 2017, Lindsay Hampson, MD (UCSF), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Improving Transitional Urology Care”
106. May 24, 2017, Adriane Sinclair, PhD (UCSF), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Analysis of Gene Expression in Human Penile Development”
107. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: May 24, 2017, Laura Pascal, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “E-cadherin Downregulation and Increased Luminal Epithelial Permeability in BPH”
108. May 24, 2017, Adam Szafran, MD, PhD (Baylor College of Medicine), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Using Cellular Imaging to Investigate the Role of Nuclear Receptor Expression and Mitochondria in Hypospadias”
109. May 24, 2017, Mike Wood, DVM, PhD, DACVIM (UW-Madison, Department of Medical Sciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Classic IL-6 Signaling Mitigates Urothelial Infection”
110. CROSS–DISCIPLINE INTERACTION: May 24, 2017, Diego Hernando, PhD (UW-Madison, Department of Radiology and Medical Physics), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Quantitative MRI Techniques for the Assessment of BPH: Background and Proposed Research”
111. May 24, 2017, Lisa Abler, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Deciphering the Influence of Diabesity and Intermittent Hypoxia on the Male Environment in Urinary Tract Dysfunction”
112. May 23, 2017, Dolores Lamb, PhD, HCLD (Baylor College of Medicine), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Exploring Novel Alterations in Steroid Hormone Receptor Signaling that Underlie Human Congenital Genitourinary Anomalies”
113. CROSS-DISCIPLINE INTERACTION: May 23, 2017, Joan Jorgensen, DVM, PhD (UW-Madison, Department of Pharmacology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Development of Individual Male Urogenital Tract Components Require Distinct Threshold Concentrations of Fetal Testosterone”
114. May 23, 2017, Larry Baskin, MD (UCSF), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Hormonal Control of Genital Development”
115. May 23, 2017, Fred vom Saal, PhD (University of Missouri), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Estradiol and Estrogenic Chemicals Modulate Androgen Action During Prostate Development”
116. May 23, 2017, Paul Cooke, PhD (University of Florida), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Role of Membrane Estrogen Receptor 1 in the Development and Function of the Male Reproductive Tract”
117. May 23, 2017, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Pinpointing Cellular Origins and Physiological Consequences of Prostate Fibrosis”
118. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017, David Lung (PhD Candidate, UW-Madison McArdle Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Investigating the Mechanism of Estrogen Receptor α Regulation by Paracrine Interactions”
119. May 23, 2017, Brett Johnson, MD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “One in Six Hypogonadal Men Treated with Clomiphene Citrate Need Combination Therapy with an Aromatase Inhibitor”
120. INTERACTION WITH UNIVERSITY OF PITTSBURGH O’BRIEN CENTER: May 23, 2017, Don DeFranco, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Opposing Roles for Cox-2 in Regulating Estrogen Receptor Beta Function in the Prostate”
121. CROSS–DISCIPLINE INTERACTION: May 23, 2017, Linda Schuler, VMD, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Hormone-ECM Collusion in Breast Cancer”
122. May 23, 2017, Lisa Arendt, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Obesity and Erα: Selecting for Hormonal Responsiveness?”
123. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017, Diya Binoy Joseph (PhD Candidate, UW-Madison Cellular and Molecular Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Harnessing Lineage Tracing to Study Hormonal Responses in the Prostate”
124. CROSS-DISCIPLINE INTERACTION: May 23, 2017, Elaine Alarid, PhD (UW-Madison, Department of Oncology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Postranslational Dynamics of ER and Its Paradoxical Roles in Cancer”
125. CROSS–DISCIPLINE INTERACTION: May 23, 2017, Pamela Kreeger, PhD (UW-Madison, Department of Biomedical Engineering), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Computational Modeling of Cell Signaling Networks”
126. May 23, 2017, Clara Jeong, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Measurement of Multi-steroid Hormones in Mouse Serum using LC-MS/MS”
127. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017, Kyle Helzer (PhD Candidate, UW-Madison McArdle Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Investigating the Effects of Phosphorylation on the DNA Binding Properties of Erα”
128. May 22, 2017, Kyle Richards, MD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “BPH: Androgens, Estrogens, and Fibrosis”
129. May 22, 2017, Paul Marker, PhD (UW-Madison, School of Pharmacy), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Opportunities and Challenges for Modeling BPH and LUTS in Rodents”
130. INTERACTION WITH GRADUATE TRAINEE: May 22, 2017, Sam Thomas (PhD Candidate, UW-Madison METC Program, UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Mass Spectrometry-based Urinary Proteomics”
131. INTERACTION WITH UW-MADISON K12: May 22, 2017, Alejandro Roldán-Alzate, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Urinary Flow Dynamics – An MR Based Computational Modeling Approach”
132. May 22, 2017, Claus Roehrborn, MD (UT Southwestern), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Steroid Hormones and Clinical LUTS/BPH: Correlations, Causations and Therapeutic Targets”
133. May 22, 2017, Jill Macoska, PhD (University of Massachusetts-Boston), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis”
134. CROSS-DISCIPLINE INTERACTION: May 22, 2017, Wei Xu, PhD (UW-Madison, Department of Oncology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Next Generation ER and AR Blockers for Cancer Treatment”
135. INTERACTION WITH UW-MADISON K12: May 22, 2017, Teresa Liu, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Identification of Estrogen Regulated Gene Networks in BPH”
136. CROSS-DISCIPLINE INTERACTION: May 22, 2017: Paul Lambert, PhD (UW-Madison, Department of Oncology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Hormone Action in the Cervix”
137. May 22, 2017, Will Ricke, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “What is BPH and What Roles Might Estrogen Be Playing?”
138. INTERACTION WITH GRADUATE TRAINEE: May 22, 2017, Molly Morgan (PhD Candidate, UW-Madison METC Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Reconstructing the Tissue Microenvironment to Understand the Role of Estrogens in Prostate Disease Progression”
139. May 22, 2017, Stephen Hammes, MD, PhD (University of Rochester), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Steroids and Inflammation: How Studying Androgen Signaling Leads to the Neutrophil”
140. May 22, 2017, Jun Luo, PhD (Johns Hopkins Medical Center), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Androgen Receptor Splice Variants: From Biology to Utility”
141. INTERACTION WITH GRADUATE TRAINEE: May 22, 2017, Dalton McLean (PhD Candidate, UW-Madison Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Androgen Regulation of FGF5 and its Role in the Prostate”
142. May 22, 2017, Jim Dalton, PhD (University of Michigan), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Selective Androgen Receptor Modulators (SARMs) as Prostate-sparing Anabolic Therapy”
143. March 8, 2017, Praveen Thumbikat, DVM, PhD (Northwestern University), UW O’Brien Center Invited Speaker Seminar – “Mast Cells are Potential Mediators of Lower Urinary Tract Dysfunction”
144. December 14, 2016, Scott Dehm, PhD (University of Minnesota Masonic Cancer Center), UW O’Brien Center Invited Speaker Seminar – “Truncated AR Variants and Resistance to AR-targeted Therapies”
145. November 9, 2016, Donald Vander Griend, PhD (University of Chicago), UW O’Brien Center Invited Speaker Seminar – “Prostate Disease and Prostate Development: The Role of Sox2 and Atomic Bombs”
146. INTERACTION WITH UW-MADISON K12: December 10, 2016, Teresa Liu, PhD (K12 scholar, UW-Madison), “The role of estrogen receptor activation on BPH progression”
147. October 12, 2016, Maria Hadjifrangiskou, PhD (Vanderbilt University), “Oxygen Mediates Biofilm Formation in Uropathogenic E.Coli In Vitro and In Vivo”
148. September 14, 2016, Omar Franco, MD, PhD (NorthShore University), “Understanding the ‘Cancer Village’ – A Practical Approach to Study Cellular Heterogeneity in Cancer”
149. May 12, 2016, Jay Reeder, PhD (University of Rochester), “The Role of SCN9A in Pain Perception and Interstitial Cystitis”
150. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT): May 11, 2016, Mark T. Nelson, PhD (University Distinguished Professor and Chair, Department of Pharmacology, University of Vermont), “Non-Voiding Contractions Encode Essential Information on Urinary Bladder Fullness”
151. INTERACTION WITH UW-MADISON K12: April 14, 2016, Michael Wood (K12 Scholar, UW-Madison), “Barrier Function in Bladder Disease”
152. INTERACTION WITH UW-MADISON K12: April 5, 2016, Teresa Liu, PhD (K12 Scholar, UW-Madison), “Selective Estrogen Receptor Modulators and BPH”
153. INTERACTION WITH GRADUATE TRAINEE: April 5, 2016, Megan Livingston (UW-Madison), “Utilizing Micro-scale Tools to Identify Key Factors in the Microenvironment”
154. CROSS–DISCIPLINE INTERACTION: April 5, 2016, Wei Xu, PhD (UW-Madison, Department of Oncology), “Direct Estrogen Receptor Dimerization Using Chemical Probes”
155. INTERACTION WITH GRADUATE TRAINEE: April 5, 2016, Diya Binoy Joseph (UW-Madison), “Investigating the Role of DNA Methylation in Prostate Development and Disease”
156. CROSS–DISCIPLINE INTERACTION: April 5, 2016, John Denu (UW-Madison, Department of Biomolecular Chemistry), “Histone-typing as an Epigenetic Tool in Diagnosis and Treatment”
157. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT): April 5, 2016, Shuk-Mei Ho (University of Cincinnati), “BPA Effects on Methylation in Reproductive Tissues”
158. CROSS–DISCIPLINE INTERACTION: April 5, 2016, Linda Schuler (UW-Madison), “Desmoplasia: Hijacking Hormones in Breast Cancer”
159. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Kyle Wegner (UW-Madison), Department of Comparative Biosciences, “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract”
160. April 4, 2016, Allison Brodbeck (UW-Madison) “Ultrasound Imaging of the Mouse Renal System”
161. April 4, 2016, Lingjun Li (UW-Madison), “Developing Mass Spectrometry-based Omics Strategies for Candidate Biomarker Discovery in LUTS”
162. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Justine Coburn (UW-Madison), “ER and AhR Crosstalk in Breast Cancer”
163. CROSS–DISCIPLINE INTERACTION: April 4, 2016, Weiping Tang (UW-Madison), “The Next Generation of SAhRM as Potential Therapeutics”
164. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Jordan Vellky (UW-Madison), “BPA Exposure and Associated Gene Expression Changes in Prostate Cancer“
165. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Jalissa Wynder (UW-Madison), “The Role of Bisphenol A in LUTD”
166. April 4, 2016, Barry Timms (University of South Dakota), “The Role of Bisphenol-A in LUTDevelopment and LUTD”
167. CROSS NIH INSTITUTE INTERACTION: April 4, 2016, Rick Woychik (Deputy Director, NIEHS),“Toxicological Insights for Future Research.
168. April 4, 2016, Reginald Bruskewitz (UW-Madison), “Overview of BPH/LUTS: A Role for Compliance and Fibrosis”
169. INTERACTION WITH TRAINEES: March 10, 2016, (mini-talks from Lisa Abler (scientist), Kyle Wegner(graduate student), Mark Cadena (Graduate Student) and Royal Oakes (Undergraduate)), “Urologic Research Tools in Development”
170. INTERACTION WITH FORMER P20 CENTER: March 8, 2016, Anna Malykhina, PhD (Associate Professor of Urology University of Colorado School of Medicine), “The Role of Neural Circuits in Regulation of Lower Urinary Tract Function”
171. February 10, 2016, Lingjun Li, PhD (Professor of Pharmaceutical Sciences and Chemistry, UW-Madison), “Developing Mass Spectometry-based Omics Strategies for Candidate Biomarker Discovery in Lower Urinary Tract Symptoms (LUTS) and Beyond”
172. INTERACTION WITH FORMER WASHINGTON UNIVERSITY P20 CENTER: January 13, 2016, Jeffrey H. Miner, PhD, FASN (Professor of Medicine and of Cell Biology and Physiology, Washington University School of Medicine), “Roles of Basement Membranes in the Urogenital System”
173. January 14, 2016, Neil Lamarre (Post-doctoral Fellow, Dale Bjorling Lab, UW-Madison), “Relevance of Lower Urinary Tract Function Testing in Mice to Humans”
174. January 11, 2016: Jianfeng Xu, MD, DrPH (NorthShore University), “Pyramid Model for Precision Medicine of Cancer: Genomic-based Individualized Cancer Care from Prevention and Screening to Diagnosis and Treatment”
175. INTERACTION WITH MAYO O’BRIEN CENTER:December 9, 2015, Michael F. Romero, PhD (Professor of Physiology & Biomedical Engineering and Nephrology & Hypertension, Mayo Clinic College of Medicine), “The Electrogenic Na+ Bicarbonate Cotransporter (NBCe1) – metabolic acidosis and glaucoma”
176. October 14, 2015, Douglas Strand, PhD (UT Southwestern Medical Center), “Dissecting the Pathogenesis of Clinical BPH”
177. May 6, 2015, Teresa Liu, PhD (University of Pittsburgh), “5α-reductase inhibition drives production of Erβ ligands via a COX-2 dependent mechanism in BPH”
178. INTERACTION WITH COLUMBIA O’BRIEN CENTER: April 10, 2015, Cathy Mendelsohn (Professor of Urology, Pathology & Cell Biology,(Institute of Human Nutrition) and Genetics & Development, U54 O’Brien Urology Research Center Director, Columbia University), “Progenitors important for formation and regeneration of the urothelium, and their contribution to bladder cancer”
179. April 9, 2015, Kevin Elicieri (UW-Madison), “Multiscale Imaging Approaches for Investigating ECMChanges in Disease”
180. April 9, 2015, Wei Huang (UW-Madison), “Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules”
181. April 9, 2015, Ben Humphreys (Harvard), “Resident Perivascular Cells and Organ Fibrosis”
182. CROSS–DISCIPLINE INTERACTION: April 8, 2015, Paul Campagnola (UW-Madison, Department of Engineering), “High Resolution Imaging and Modeling Approaches to Study ECM Changes in Cancer, Fibrosis, and Connective Tissue Disorders”
183. CROSS–DISCIPLINE INTERACTION: April 8, 2015, Linda Schuler (UW-Madison, Department of Comparative Biosciences), “Matric Stiffness: Recruitment of Hormones to the Dark Side of Breast Cancer”
184. CROSS–DISCIPLINE INTERACTION: April 8, 2015, Patricia Keely, PhD (UW-Madison, Cell and Regenerative Biology), “Molecular changes of fibrosis during mammary gland pathogenesis”
185. CROSS NIH INSTITUTE INTERACTION: April 8, 2015, Tom Wynn (NIAID), “Targeting immunological mechanisms of fibrosis”
186. April 8, 2015, Jill Macoska, PhD (UMASSBoston), “CXCL12-mediated non-canonical signaling promotes myofibroblast phenoconversion in the prostate”
187. March 9, 2015, Gail Risbridger, PhD (Professor, Director of Centre for Urologic Research and Monash University), “Patient Derived Xenografts: Preclinical Insights that Influence Clinical Practice”
188. February 18, 2015, Rosalyn Adam, PhD (Harvard University), “Signaling networks in the bladder: implications for benign urologic disease”
189. January 21, 2015, Simon W. Hayward, PhD (Vanderbilt University), “Inflammation and androgen receptor variant expression in benign prostatic hyperplasia”

Scientific Organizations – positions held

• WORKSHOPS
• 2018-present (Vezina), Faculty Instructor, Workshop on Techniques in Modeling Human Cancer in Mice, The Jackson Laboratory, Bar Harbor MA

• COMMITTEES
• 2020-present (Vezina), Chair, UW-Madison Graduate Program in Clinical Investigation Admissions Committee
• 2020 (Strand), Annual Meeting Planning Committee, CAIRIBU
• 2020 (Vezina), Annual Meeting Planning Commitee, Society of Basic Urologic Research (SBUR)
• 2020 (Vezina), Don and Eula Coffey Award Committee Member, Society of Basic Urologic Research (SBUR)
• 2019-present (Ricke), Dean’s Strategic Planning Committee, UW-Madison School of Medicine and Public Health
• 2019-present (Vezina), Steering Committee Member, UW-Madison Endocrinology and Reproductive Physiology T32 Training Grant
• 2019 (Macoska), Program Steering Committee Member, The Mays Cancer Center at UT Health San Antonio and The University of Texas at San Antonio: A Partnership to Reduce Cancer Health Disparities
• 2018 (Vezina), Trainee Affairs Committee Member, Society of Basic Urologic Research (SBUR)
• 2018 (Vezina), Finance Committee Member, Society of Basic Urologic Research (SBUR)
• 2017-present (Ricke), Member, American Urological Association (AUA) Research, Education, Conferences, Communications (RECC) Committee
• 2016 (Vezina), Program Committee, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health”, Lithicum, MD
• 2016 (Vezina), Session Chair, Epigenetic Considerations for Bladder Dysfunction & Pain Syndromes, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health”, Lithicum, MD
• 2016 (Macoska), Chair, Organizing Committee, 2016 Basic Science Symposium, American Urological Association Annual Meeting, San Diego, CA
• 2015 (Vezina), Planning committee, Society for Basic Urologic Research (SBUR) Fall Meeting
• 2015 (Vezina), Session Chair, Discussion Forum: Emerging Model Systems for Research. SBUR Fall Symposium, F. Lauderdale, FL
• 2015 (Vezina), Session Chair, Cell-Specific Responses to Comorbidities in BPH. SBUR Fall Symposium, Ft. Lauderdale, FL
• 2014-present (Ricke), U54 Symposium Organizing Committee, Chair
• 2014-present (Ricke), Steering Committee, University of Wisconsin Molecular Environmental Toxicology Center
• 2014-present (Ricke), Steering Committee, NIDDK Urology U54
• 2014-present (Ricke), Steering Committee, University of Wisconsin George M. O’Brien Center
• 2014-present (Ricke), Senior Executive Committee, University of Wisconsin George M. O’Brien Center
• 2014 (Ricke), Representative, American Urological Association Office of Research
• 2014 (Ricke), Consultant, NIDDK Centers, Norm Braveman Inc. – Future of Benign Urology
• 2012-present (Ricke), Awards Committee, Society of Basic Urologic Research
• 2011-present (Ricke), Abstraction Selection Committee, Society of Basic Urologic Research
• 2011 (Ricke), Organizing Committee, Society of Basic Urologic Research
• 2010-2013 (Ricke), Finance Committee, Society of Basic Urologic Research
• 2008-2010 (Ricke), Executive Committee Board Member, Society of Basic Urologic Research

• BOARDS
• 2020-present (Strand), Director at Large, Society for Basic Urologic Research
• 2020-present (Ricke), Cancers, Editorial Board Member
• 2020-present (Vezina), Midwest Regional Chapter of the Society of Toxicology, Past President
• 2019-2020 (Vezina), Midwest Regional Chapter of the Society of Toxicology, President
• 2019-present (Vezina), Director, UW-Madison Molecular and Environmental Toxicology Program
• 2019-present (Vezina), Associate Director, UW-Madison George M. O’Brien Benign Urology Research Center
• 2018 (Vezina), President Elect, Midwest regional chapter, Society of Toxicology
• 2017-present (Vezina), Associate Director, UW-Madison Toxicology T32 Training Grant
• 2016-present (Vezina), Director, UW-Madison Summer Program in Undergraduate Urology Research (SPUUR)
• 2015 (Macoska), Past-President, the Society for Basic Urologic Research
• 2014 (Macoska), President, the Society for Basic Urologic Research
• 2014-present (Vezina), American Journal of Physiology – Renal, Editorial Board
• 2013-present (Vezina), American Journal of Clinical and Experimental Urology, Editorial Board
• 2012-present (Macoska), The Prostate, Editorial Board
• 2012-present (Macoska), The Bladder, Editorial Board
• 2008-2010 (Ricke), Board Member, Society for Basic Urologic Research

• MODERATOR
• 2017 (Vezina), Invited Subject Matter Expert, responsible for creating an online training module for NIH K-series career development awards for the American Urological Association (AUA)
• 2015 (Vezina), NIDDK Meeting, Baltimore, MD
• 2015 (Ricke), NIDDK Centers Meeting, Baltimore, MD
• 2015 (Ricke), AUA Meeting, New Orleans, LA
• 2014 (Ricke), P20 Centers Directors Meeting Update, Pacific Grove, CA
• 2014 (Ricke), Great Lakes Nuclear Receptor Meeting, Madison, WI

• ADVISORY ROLES
• 2020-present (Vezina), External Advisor, NorthShore University / Indiana University P20 Center for Benign Urologic Research
• 2020-2021 (Macoska), Member, Academic Reorganization Taskforce (ART)
• 2020-2021 (Macoska), Member, UMass System-Wide Brain Trust in Applied Science Committee, Data-Driven and Technology-Informed Precision Health Sub-Committee
• 2020-2021 (Macoska), Academic Reorganization Task Force, University of Massachusetts Boston
• 2020-2021 (Macoska), Data-Driven and Technology-Informed Precision Health Group, University of Massachusetts, Office of the President
• 2019 (Macoska), Ad-Hoc Member, NIDDK Advisory Council
• 2018-present (Vezina), External Advisor, Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Fellowship Program

• 2022 (Strand), VA Grant Review Panel
• 2022 (Strand), AUA Research Scholars Grant Review Panel
• 2021 (Strand), AUA Research Scholars Grant Review Panel
• 2021 (Bjorling), Member, Review Panel, SCIRP DYS-1, 2021 Spinal Cord Injury Research Program, Congressionally Directed Medical Research Programs (CDMRP)
• 2021 (Macoska), Member, Review Panel, NIH/NCI CPACE P20 Review Panel 05 ZCA1 SRB-2 (M2)
• 2021 (Macoska), Member, Review Panel, ZDK1 GRB-T (M3) U54 Urology Research Center Applications
• 2020 (Strand), Ad Hoc Reviewer, Belgian Foundation against Cancer
• 2020 (Ricke), Ad Hoc Reviewer, NIH/NIDDK Special Emphasis Panels in Nephrology Small Business/Digestive Diseases
• 2019 (Ricke), Chair, NIH/NIDDK DKUS SEP (Kidney, Urological and Hematological, review of R01 grants)
• 2019-present (Vezina), Chair, NIH/NIDDK DDK-D Subcommittee (Kidney, Urological and Hematological, review of career development awards)
• 2019 (Bjorling), NIH ZDK1 GRB-M (M1), Multidisciplinary Approach to Pelvic Pain, March 27, 2019
• 2018-present (Bjorling), NIH ZDK1 GRB-G J1, NIDDK-KUH Fellowship Review Committee (meets 3x/year)
• 2018 (Macoska), Member, Review Panel, ZDK1-GRB-3 George M. O’Brien Urology Cooperative Research Centers Program (U54)
• 2018 (Macoska), Member, Review Panel, ZDK-GRB-S (M3), NIDDK Central Repository X01
• 2018 (Macoska), Member, Review Panel, ZCA1 SRB-2, NCI CPACHE U54 and P20
• 2018 (Macoska), Member, Review Panel, ZDK1 GRB-03 (01) U54 Urology Research Center Applications
• 2018 (Bjorling), NIH ZDK1 GRB-6 (O2), P01 Application Urinary Tract Dysfunction
• 2018 (Bjorling), NIH ZDK1 GRB-M (O1), P01 Application Bladder Physiology
• 2018 (Bjorling), NIH Special Emphasis Panel ZRG1 IMST-D (80)
• 2018 (Bjorling), USDA NCAC-02 program review
• 2017 (Bjorling), NIH Special Emphasis Panel ZDK1 GRB-M (O2)
• 2017 (Bjorling), NIH Panel ZRG1 IMST-U (80)
• 2017 (Bjorling), Department of Defense, Urological Disorders, PRMPR program
• 2016 (Macoska), Member, NIH/NIDDK Review Panel, 2016/10 ZRG1 DKUS-G (90) S Urologic and Urogynecologic Applications
• 2016 (Macoska), Member, NIH/NIDDK Review Panel, 2016/10 ZDK1-GRB-3 (O2) 1 George M. O’Brien Urology Cooperative Research Centers Program (U54)
• 2016 (Macoska), Member, NIH/NIDDK Review Panel, George M. O’Brien Urology Cooperative Research Centers Program (U54) NIH/NIDDK Review Panel, ZDK-GRB-S (M3)
• 2016 (Vezina), NIH/NIDDK Special Emphasis Review Panel ZRG1 DKUS-G (90) S
• 2016-2019 (Vezina), Standing Member, NIH/NIDDK DDK-D Panel
• 2016 (Bjorling), NIH ZDK1 GRB-2 (M3) GUDMAP RFA
• 2015-2018 (Ricke), University of Wisconsin-Madison ICTR/CTSA Pilot Awards Review
• 2015 (Vezina), NIH/NIDDK Special Emphasis Review Panel ZDK1 GRB-S (O4)
• 2015 (Macoska), Member, Review Panel, NIH/NIDDK ZDK1 GRB-3 (01), U54 Urology Research Center Applications
• 2015, 2016 (Vezina), NIH/NIDDK DDK-D Subcommittee (Kidney, Urological and Hematological, review of career development awards)
• 2015-2017 (Vezina), Department of Veterans Affairs Review Panel 10P9B/SURG
• 2015 (Bjorling), NIH Special Emphasis Panel ZRG1 DKUS-N (90)
• 2014 (Macoska), Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (O5), Novel Methods for Measurement of Organ Fibrosis (U01)
• 2014 (Macoska), Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (M1), NIDDK Central Repositories Non-Renewable Sample Access
• 2014 (Bjorling), NIH/NIDDK Urological and Urogynecological Sciences and Small Business Special Emphasis Panel, NIH/NIDDK ZRG1 DKUS-G (90)
• 2014-present (Ricke), University of Wisconsin George M. O’Brien Center Pilot Project Program, Chair
• 2014-2017 (Ricke), University of Wisconsin-Madison Molecular and Environmental Toxicology Center Grad Student Training Grant Selection
• 2014-2017 (Ricke), University of Wisconsin-Madison Molecular and Environmental Toxicology Postdoctorate Training Grant Selection
• 2016 (Ricke), ZCA1 RPRB-N (J1), P01 NCI Program Project Review III
• 2016 (Ricke), ZCA1 RPRB-7(01) SPORE Review II
• 2017 (Ricke), ZCA1 RPRB-7(M1) NCI SPORE II Review
• 2017 (Ricke), ZDK1 GRB-3(02) Developmental Centers in Benign Urology (P20)
• 2018 (Ricke), NIH/NIDDK Special Emphasis Review Panel ZRG1-DKUS-B(90) R01

Funded:

1. Notice of Special Interest (NOSI): Administrative Supplements to Enhance Institutional Data Science Capacity (MPIs: Jill A. Macoska, Adan Colon-Carmona,  Kourosh Zarringhalam, Brook Moyers), 9/1/2023-8/31/2025. “iTCGA: Integrated Training in Computational Genomics and Data Sciences.”
2. Project Development Grant, The University of Massachusetts Boston (Macoska, Jill A. PI) 7/1/2023-12/31/2024. Circular RNAs as Causative Agents of Prostatic Fibrosis.
3. R25 1R25GM144251-01 (Jorgensen, Joan (PI); Ricke, William A. (Mentor); Agnew, Lydia (Awardee)), 8/1/2023-7/31/2024, National Institute of General Medical Sciences/NIH, UW-Madison Postbaccalaureate Research Educational Program (PREP).
4. UW-Madison Office of the Vice Chancellor for Research and Graduate Education Fall Competition (Hernando, Diego (PI)), 7/1/2023-6/30/2024, Diffusion MRI for Assessment of Tissue Structure and Microperfusion.
5. F31-Diversity DK136355 (Adrian, Alexis (PI); Ricke, William A. (Co-Mentor)), 4/1/2023-4/1/2026, NIH/NIDDK, Examining the Role of Defective Oxidative Phosphorylation in the Normal and Diseased Prostate.
6. F31 DK135376-01 (Miles, Hannah (PI); Ricke, William A. (Mentor)), 9/12/2023-9/12/2025, NIH/NIDDK, The Role of Estrogen Receptor Alpha in Prostatic Fibrosis Contributing to Benign Prostatic Hyperplasia.
7. R01DK135535 (Strand, Douglas (PI); Vezina, Chad (Co-I)), 6/1/2023-5/31/2028, NIH-NIDDK, Interstitial Fibroblasts Drive Prostate Branching Morphogenesis.
8. R25DK130838 (Vezina, Chad M. (MPI); Penniston, Kristina (MPI)), 9/21/2022–10/30/2027, NIH/NIDDK, Summer Program in Undergraduate Urology Research (SPUUR).
9. RC2 DK12994 / PAR-19-202 (Strand, Douglas W. (MPI); Vezina, Chad M. (MPI)), 9/1/2022-10/30/2027, NIH/NIDDK, Bedside to Bench Resources for Lower Urinary Tract Research.
10. MSN261994-Stanford Opportunity Fund (Keil Stietz, Kimberly P. (PI)), 8/1/2022-7/31/2023, Impact of Developmental PCBs on Neural Activity in the Pontine Micturition Center.
11. R01 DK117354 (Reeder, Scott (Co-I); Hernando, Diego (Co-I)), 4/1/2022-3/31/2026, NIBIB, Fully Automated High-Throughput Quantitative MRI of the Liver.
12. 1R03ES033304-01A1 (Keil Stietz, Kimberly (PI)), 3/17/2022-2/29/2024, National Institute of Environmental Health Sciences, Contribution of Obesity-environment Interaction in Bladder Dysfunction.
13. UAB Nathan Schock Pilot/Feasibility Grant Award (Liu, Teresa (PI); Ricke, William A. (Mentor)), 1/3/2022-1/3/2023, UAB Nathan Shock Center, Mitochondrial Dysfunction Leads to Dysregulation of the Krebs Cycle in BPH/LUTS.
14. Wisconsin Urologic Research Institute (WURI) grant (Popovics, Petra (PI); Ricke, William A. (Mentor); Vezina, Chad M. (Co-Mentor)), 1/2/2022-1/1/2024, Wisconsin Urologic Research Institute, Development of Urinary Markers for Prostatic Fibrosis.

11. T32GM141013-01 (Audhya, Anjon (PI); Ricke, William A. (Mentor); Adrian, Alexis E. (Awardee)), 1/1/2022-12/31/2022, National Institute of General Medical Sciences, Graduate Training in Molecular and Cellular Pharmacology.
12. 1 R01DK131175-01 (Ricke, William A. (PI)), 9/24/2021-8/31/2025, NIH/NIDDK, Elucidating Hallmarks of Aging in the Development of Lower Urinary Tract Dysfunction (LUTD).
13. U24DK127726-Opportunity Pool (Liu, Teresa (PI); Ricke, William A. (Mentor)), 9/1/2021-8/31/2025, NIH, Prenatal Estrogenic Exposure Contributes to Racial Disparity in the Development of BPH/LUTS.
14. Subcontract to Columbia University U54 (Mendelson, Cathy; Barasch, Jonathan; Gharavi, Ali (MPIs); Vezina, Chad M. (Co-I)), 7/1/2021-6/30/2026, NIH/NIDDK, Neuroendocrine Cells Protect Against UTI.
15. U54CA156734 (Macoska, Jill A. (PI); Colon-Carmona (Contact PI)), 9/1/2021-8/31/2026, NIH/NCI, 1/2 The University of Massachusetts Boston – Dana Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research.
16. U54DK104310-Opportunity pool (Liu, Teresa (PI); Ricke, William A. (Mentor)), 9/1/2021-8/31/2023, NIDDK, Cellular Senescence Leads to Accelerated Epigenetic Aging and Frailty in BPH/LUTS.
17. 1R01EB030497-01 (Hernando, Diego (PI)), 8/15/2021-8/14/2024, NIBIB, Diffusion MRI of the Abdomen.
18. U54DK104310-Convergence award (Ricke, William A. (PI)), 6/1/2021-5/31/2023, NIDDK, Assessing Mitochondrial Dysfunction in the Development of Prostate Fibrosis and LUTD.

19. 1T32HD101384-01A1 (Bird, Ian M. (PI); Ricke, William A. (Trainer)), 4/1/2021-3/31/2022, Eunice Kennedy Shriver National Institute of Child Health & Human Development, Integrated Program in Endocrinology Translational Postdoctoral Training Program.
20. R01DK127081-01 (Ricke, William A. (PI)), 4/1/2021-3/31/2022, NIDDK, Estrogen Pathways in the Development of Prostatic Fibrosis and Lower Urinary Tract Dysfunction.
21. 1K01DK127150-01 (Popovics, Petra (PI); Ricke, William A. (Mentor); Vezina, Chad M. (Co-Mentor)), 1/15/2021-6/14/2025, NIH/NIDDK, Osteopontin: A Novel Mediator of Prostatic Inflammation and Fibrosis.
22. U54DK104310-Convergence Award (Strand, Douglas (PI)), 2021-2022, NIDDK, Spatial Transcriptomics in the Lower Urinary Tract (Subcontract from Wisconsin O’Brien Center).
23. Chan Zuckerberg Initiative Subcontract from UCSF (Huang, Franklin (PI); Strand, Douglas W. (Co-I)), 2021-2024, A Prostate Cell Atlas across Ancestries.
24. 3R01ES001332-43S1 (Peterson, Richard E (MPI); Vezina, Chad M (MPI); Ricke, William A. (Co-I)), 2021, NIEHS, Cellular and Molecular Mediators of Fibrosis in the Development of Urinary Tract Dysfunction (Research Supplement to Promote Diversity in Health-Related Research, Dr. Debra Garvey)
25. 5P50 CA101942-16 (McDermott (PI); Macoska, Jill A. (Project PI)), 9/1/2020-8/31/2021, NIH/NCI, DF/HCC Kidney Cancer SPORE DCA Awardee: APOL1 Risk Alleles Synergize Myofibroblast Accumulation and RCC Tumor Growth and Progression.
26. 3U54DK104310-07S1 (Ricke, William A. (PI); Ortiz Hernandez, Christian)); 8/1/2020-7/31/2021, NIH, Cellular and Molecular Mediators of Fibrosis in the Development of Urinary Tract Dysfunction (Research Supplement to Promote Diversity in Health-Related Research, Christian Ortiz Hernandez)

• R01 DK107436 05 (Xin (PI); Strand, Douglas W. (Co-I)), 7/1/2020-6/30/2025, NIH/NIDDK, Molecular Mechanisms of Initiation of Benign Prostatic Hyperplasia.

28. K12 (Grimes, Matthew (PI); Vezina, Chad M. (Co-Mentor)), 7/1/2020-6/30/2025, NIH/NIDDK, Loss of CD44 Expression Drives Altered Collagen Structure in Lichen Sclerosus.
29. American Urological Association Research Scholar Award #659333 ((Binoy Joseph, Diya (PI), Strand, Douglas W. (Mentor)), 7/2020-6/2022, The Role of Novel Urethral Cell Types in Benign Prostatic Hyperplasia.
30. Massachusetts Life Sciences (Macoska, Jill A. (PI)), 7/1/2020-6/31/2020, Next Gen Sequencing at the Next Level: The University of Massachusetts Boston CPCT Genomics Core. Center for Personalized Cancer Therapy (Capital Grant)
31. 1 K01 AG059899-01A1 (Liu, Teresa (PI) & Ricke, William A. (Mentor)), 5/15/2020-4/30/2025, NIA, Impact of Age on Altered Steroidogenesis and Estrogen Receptor Activation in Benign Prostatic Hyperplasia Progression.
32. R01 DK124067 01A1/8720-UTSW (Jerde (PI); Strand, Douglas W. (Co-I)), 5/15/2020-2/29/2024, NIH/NIDDK, Interleukin-1 and Steroid Signaling Drive Toxoplasma-induce Prostatic Hyperplasia.
33. F31 ES030968 (Turco, Anne (PI) & Vezina, Chad M. (Mentor)), 4/21/2020-4/20/2022, NIH/NIDDK, Origins of Prostate-related Urinary Dysfunction in Adult Males: TCDD Exposure Increases Prostatic Noradrenergic Innervation and Smooth Muscle Contraction.
34. 1 F32 DK123880-01A1 (Bonnemaison, Mathilde (PI) & Macoska, Jill A. (Sponsor)), 4/01/2020-3/31/2023, NIDDK, Promotion of Prostatic Fibrosis and Lower Urinary Tract Dysfunction Through a Mesenchymal IL-4/IL-13 Autocrine Loop.
35. Boehringer Ingelheim (Bjorling, Dale E. (PI)), 4/1/2020-3/31/2021, Short-term Research Training of Veterinary Students in Wisconsin.
36. Massachusetts Life Sciences Center (Macoska, Jill A. (PI)), 4/1/2020-3/31/2020, Center for Personalized Cancer Therapy (Capital Grant).

• R01 CA245294 01 (Mani (PI); Strand, Douglas W. (Co-I)), 1/1/2020-12/31/2024, NIH/NCI, 3D Genome Architecture and the Origins of Genomic Rearrangements in Prostate Cancer.

38. 5 R01 DK115477 03 (Strand, Douglas W. (PI)), 2020, NIDDK, Notch-mediated 5ARI Resistance in Human BPH.
39. R00ES029537 (Keil Stietz, Kimberly P. (PI)), 11/1/2019-10/31/2023, NIH, PCB Induced Neurogenic Inflammation Mediates Bladder Dysfunction.
40. 2R44-EB025729 (Brittain, Jean H. (PI); Hernando, D. (Co-I)), 10/1/2019-6/31/2021, NIBIB, Quantitative Magnetic Resonance Imaging Phantoms.
41. 2U54DK104310-06 (Ricke, William A.), 9/25/2019-7/31/2024, NIH, Cellular and Molecular Mediators of Fibrosis in the Development of Urinary Tract Dysfunction.
42. F30DK122686-01 (Ruetten, Hannah (PI); Vezina, Chad M. (Mentor)), 9/5/2019-10/4/2021, NIH/NIDDK, Prostate Inflammation Increases Collagen and Voiding Dysfunction.
43. 5P50 CA101942-15 (McDermott (PI); Macoska, Jill A. (Project PI)), 9/1/2019-8/31/2020, NIH/NCI, DF/HCC Kidney Cancer SPORE DCA Awardee: Urinary Biomarkers Predictive of RCC Diagnosis and Prognosis.
44. DK100022-06 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Ricke, William A. (Mentor); Vezina, Chad M. (Co-Mentor); Popovics, Petra (Awardee); 7/1/2019-1/14/2021, NIH, The Role of Osteopontin in Lower Urinary Tract Dysfunction.
45. R01 DK118145 (Bjorling, Dale E. (Co-I); Jianghui, Hou (Co-I); Vezina, Chad M. (Co-I)), 4/30/2019-4/30/2023, NIH/NIDDK, Regulation of Bladder Structure and Function by Micro-RNA29.
46. 2U54DK104310-06 (Vezina, Chad M. (MPI); Strand, Douglas W. (MPI)), 12/1/2019-11/30/2024, NIH/NIDDK, CTGF Drives Voiding Dysfunction Through Expression of Collagen in Periurethral SRD5A2+ Fibroblasts.
47. R21CA238105 (Marker, Paul C. (PI)), 2019-2021, NCI, Growth Hormone Actions in Prostate Carcinogenesis.
48. 1 R13 DK121565-01 (Olumi, Aria (PI); Ricke, William A. (Co-I)), 2019, NIDDK, 2019 AUA-SBUR Basic Sciences Symposium, Social (and Antisocial) Cell Signaling Networks in the Urinary Tract.
49. R01 HD094759-01 (Hernandez, Laura (PI); Vezina, Chad M. (Co-I)), 7/20/2018–4/30/2023, NIH/NICHD, Influence of SSRI Use During Pregnancy and Lactation on Maternal Bone Health.
50. T32 ES007015 (Bradfield, Christopher (PI); Vezina, Chad M. (Co-PI, Deputy Director)), 7/01/2018-6/30/2023, NIH/NIEHS, Molecular & Environmental Toxicology Pre- and Postdoctoral Training Grant.
51. 1R21 Al1382501/in4686396UTMC (Arrizabalaga (PI); Strand, Douglas W. (Co-I)), 5/18/2018-4/30/2020, Prostate Pathogenesis during Toxoplasma gondii
52. U54 CA156734 PILOT (Macoska, Jill A. (PI)), 5/1/2018-8/31/2019, NIH/NCI, Validation of Urinary RNA Biomarkers Predictive for RCC Diagnosis.
53. R01 DK117354 (Hernando, D. (PI)), 4/1/2018-3/31/2022, NIDDK, MRI-based Quantitative Susceptibility Mapping of Hepatic Iron Overload.
54. TL-1 (Ruetten, Hannah (PI); Vezina, Chad M. (Mentor)), 2018-2020, UW-Madison Clinical and Translational Research Center (IICTR), TL-1 Fellowship, Prostate Inflammation Drives Fibrosis and LUTD.

• W81XWH-16-1-0246 (Neuman, Sarah (PI); Ricke, William A. (Mentor)), 2018-2019, DoD/Army, Effects of Phthalates on Androgen Receptor Regulation Associated with Castration-Resistant Prostate Cancer Development.

56. 3 U54 DK104310 05S1 (Ricke, William A. (PI)), 2018, NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction – Training and Website Development.

• 5 U54 DK104310-04 REVISED (Ricke, William A. (PI)), 2018, NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction – Interaction Core Development.

58. R01 DK115477-01 (Strand, Douglas W. (PI)), 2018, NIH/NIDDK, Notch-mediated 5ARI Resistance in Human BPH.
59. R01ES001332 (Peterson, Richard (MPI); Vezina, Chad M. (MPI); Ricke, William A. (Co-I)), 8/01/2017-7/31/2023, NIH/NIEHS, Reproductive and Developmental Toxicity of Dioxin.
60. 5K12DK100022 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Ricke, William A. (Mentor); Roldán-Alzate, Alejandro (Awardee), 2017-2022, NIDDK, Non-invasive Assessment of Urinary Flow and Prostatic Urethral Stiffness in Benign Prostate Hyperplasia Using MRI.
61. F31ES028594-01A1 (Wegner, Kyle (PI); Vezina, Chad M. (Co-I)), 7/1/2017-6/30/2020, NIH/NIEHS, TCDD Reprograms Prostate Stroma and Causes Fibrosis to Induce Urinary Dysfunction.
62. DK100022-06 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Ricke, William A. (Mentor); Hernando, Diego (Awardee); 4/1/2017-3/31/2018, NIH, Development and Validation of Advanced MRI Techniques for Assessment of Benign Prostatic Hyperplasia.
63. U01DK110807-02S1 Supplement (Vezina, Chad M. (PI); Cadena, Mark (Mentee)), 6/01/2017–5/31/2018, NIH/NIDDK, Role of Prostate Neuroendocrine Cells in Homeostatic Regulation of Prostate Stroma; NAF=0.
64. R01CA204320 (Shull, Jim (PI); Vezina, Chad M. (Co-I)), 1/1/2017-12/31/2018, NIH/NCI, Characterization of Emca4, the Rat Ortholog of the 8q24 Breast Cancer Risk Locus.
65. 5R21CA195313—02 (Marker, Paul C. (PI)), 2017, NCI, MAGI2 in Aggressive Prostate Cancer.
66. 3 U54DK104310-04S1 (Ricke, William A. (PI)), 2017, NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
67. U01DK110807 (Vezina, Chad M. (PI)), 9/15/2016-5/31/2021, NIH/NIDDK, Molecular and Fate Maps of Prostatic Stroma.
68. U54 CA156734 (Macoska, Jill A. (PI); Colon-Carmona (Contact PI)), 9/01/2016-8/31/2021, NIH/NCI, (1/2) The University of Massachusetts, Boston – Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research.
69. 2R01 DK077195-06 (Adam (PI); Macoska, Jill. A (Co-I)), 8/07/2016-6/30/2021, NIH/NIDDK, Mechanotransduction In Bladder Smooth Muscle.
70. 2T35OD011078-06 (Bjorling, Dale E. (PI)), 4/1/2016-3/31/2021, DHS/PHS/NIH, Short-term Research Training of Veterinary Students in Wisconsin.
71. RP170152 (Bagrodia (PI); Strand, Douglas W. (Co-I)), 12/1/2016-11/30/2020, CPRIT, Targeting the H NF4A and WNT/Beta-Catenin Pathways in Childhood Malignant Yolk Sac Tumors.

• T32 (McLean, Dalton (PI); Ricke, William A. (Mentor)), 2016-2019, University of Wisconsin-Madison Cancer Biology.
• T32 (Vellky, Jordan (PI); Ricke, William A. (Mentor)), 2016-2019, University of Wisconsin-Madison Cancer Biology.

74. T32 (Nguyen, Jalissa (PI); Ricke, William A. (Mentor)), 2016-2018, University of Wisconsin-Madison Molecular and Environmental Toxicology Center.

• T32 (James, Taryn (PI); Ricke, William A. (Mentor)), 2016-2018, University of Wisconsin-Madison Molecular and Environmental Toxicology Center.

76. 5K12DK100022 (Wood, Michael (PI); Ricke, William A. (Mentor), 2016-2018, NIDDK, IL-6 Signaling Mediates Urothelial Production of Glycosaminoglycans.
77. W81XWH-16-1-0246 (Jeong, Clara (PI); Ricke, William A. (Mentor)), 2016-2018, DoD/Army, Effects of Phthalates on Androgen Receptor Regulation Associated with Castration-Resistant Prostate Cancer Development.
78. 3 U54 DK104310 03S1 (Ricke, William A. (PI)), 2016, NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
79. 1R21CA195313-01A1 (Marker, Paul C. (PI)), 2016, NCI, MAGI2 in Aggressive Prostate Cancer.
80. 2P30CA014520-44 PILOT (Ricke, William A. (PI); Bashirullah, A. (Co-I); Vezina, Chad M. (Co-I)), 2016-2017, NCI, Identification of DDX3-RNA Binding Protein mRNAs in Prostate Cancer: Potential Roles in Castration Resistant Prostate Cancer.

• DK100022-06 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Ricke, William A. (Mentor); Liu, Teresa (Awardee)), 9/1/2015-5/14/2020, NIH, The Role of Estrogen Receptor Activation on Benign Prostatic Hyperplasia Progression.

82. 2R01 DK077195-06 (Adam (PI); Macoska, Jill A. (Co-I)), 8/07/2015-4/30/2019, NIH/NIDDK, Mechanotransduction In Bladder Smooth Muscle.
83. T32 grant # (Thomas, Sam (PI); Ricke, William A. (Mentor)), 2015-2017, UW-Madison Molecular Environmental Toxicology Center.
84. 3 U54 DK104310 02S1 (Ricke, William A. (PI)), 2015, NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
85. 5R01DK091193-10 (Marker, Paul C. (PI)), 2015, NIDDK, Steroid Hormones and SFRP1 in the Age-related Incidence of BPH and BOO.
86. 1U54DK104310-06 (Ricke, William A. (PI); Bjorling, Dale E. (Biomed. Core Lead, Co-I), 9/24/2014-7/31/2024, NIH/NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
87. DK100022-06 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Brown, Heidi Wendell (Awardee)), 9/1/2014-9/30/2019, NIH, Transforming Community-Based Urinary Continence Promotion: The Bowel Movement.
88. DK100022-06 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Ricke, William A. (Mentor); Theberge, Ashleigh (Awardee); 3/1/2014-12/31/2015, NIH, The Role of Stromal Paracrine Signals in Angiotenesis in Benign Prostatic Hyperplasia.
89. R01 DK099328 (Vezina, Chad M. (PI); Bjorling, Dale E. (Co-I)), 2014-2019,NIDDK, Role of DNA Methylation in Prostate Glandular Development and Urinary Function.
90. 5 U54 DK104310-02 (Ricke, William A. (PI)), 9/24/14-7/31/19, NIDDK, Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
91. 1K12DK100022-01 (Bjorling, Dale E. (PI), 8/1/2013-9/13/2023, DHHS/PHS/NIH, Wisconsin Multidisciplinary K12 Urologic Research Career Development Program.
92. U01 ES020952 (vom Saal, Frederick (PI); Ricke, William A. (Co-I)), 2012-2017, NIEHS, Research Consortium for 2-Year Bisphenol A Toxicity Study “Lifetime Exposure to Bisphenol-A (BPA) and Urethral Malformations, Obstructive Voiding Disorder and Prostate Neoplasia: Cellular and Epigenetic Effects”.
93. R01 DK093690 (Ricke, William A. (PI), 9/15/2011-7/31/2016, Estrogen Regulation in BPH and the Lower Urinary Tract.
94. 2U54CA156734-11 (Macoska, Jill A. (PI)), 9/28/2010-8/31/2026, NCI, Genomics Core.

Pending

1. R01CA286441-01A1 (Ricke, William (PI); Li, Lingun (Co-I); MacGillivray, Leonard (Co-I)), 07/01/2024-06/30/2029, NIH/NCI, Molecular mechanisms and therapeutic targeting of DDX3X in castration resistance.
2. R01DK138004-01A1 (Liu, Teresa (MPI), Ricke, William (MPI), 07/01/2024-06/30/2029, NIH/NIDDK. Aerobic exercise reduces aging-mediated frailty and urinary dysfunction.
3. UC2/TL1 000000-00 (Lieske, John (MPI); Vezina, Chad M. (MPI)), 7/1/2023-6/30/2028, NIH/NIDDK, Next Generation KUH Researchers (GENERATOR).
4. K12 DK100022 (Vezina, Chad M (PI); Brown, Heidi (PI)), 7/1/2023-6/30/2028, NIH/NIDDK, Wisconsin Multidisciplinary K12 Urologic Research Career Development Program.
5. AR220138P1 (Keil Stietz, Kimberly P. (Co-PI)), 4/2023-3/2026, Effects of Dietary Bioactive Components on Disease Comorbidities in Autism Model Mice.
6. R01DK136114 (Crawford, Latasha (PI); Keil Stietz, Kimberly P. (Collaborator), 4/2023-3/2028, Somato-visceral Crosstalk in Sensory Ganglia as a Driver of Referred Pain in Urologic Chronic Pain Syndrome.
7. R01ES035020 (Keil Stietz, Kimberly P. (PI)), 4/2023-3/2028, Impact of Developmental Polychlorinated Biphenyls on Bladder Contractility.
8. F31-Diversity DK136355 (Adrian, Alexis (PI); Ricke, William A. (Co-Mentor)), NIH/NIDDK, Examining the Role of Defective Oxidative Phosphorylation in the Normal and Diseased Prostate. Submitted, pending evaluation.
9. F31 DK135376-01 (Miles, Hannah (PI); Ricke, William A. (Mentor)), NIH/NIDDK, The Role of Estrogen Receptor Alpha in Prostatic Fibrosis Contributing to Benign Prostatic Hyperplasia. Impact score 20, pending funding review
10. R01ES001332, (Vezina, Chad and Peterson Richard (PI), 08/01/2022-07/31/2027, NIH-NIEHS, Reproductive and Developmental Toxicity of Dioxin.
11. (Southard-Smith, Michelle (PI); Bjorling, Dale E. (Co-I)), Defining Neural Crest Developmental Mechanisms that Regulate Lower Urinary Tract Innervation.
12. NCI P50 Prostate SPORE (Jarrard, David (PI); McNeel, Douglas (Co-I), Ricke, William A. (Co-Director), 1/15/2022-1/14/2027, NCI, $10,895,470 TC/5yr for full SPORE, $482,270 TC/5yr for Developmental Research Program (DRP), Developmental Research Program.

• 12/2023, Monica Ridlon (Keil Stietz Lab, PhD Student), 1st place, Collaborating for the Advancement of Interdisciplinary Benign Urology Research (CAIRIBU) Annual Meeting, Urinary Dysfunction section.
• 12/2023, Ajinkya Limkar (Ricke Lab, PhD Candidate), Tied for Best Abstract at the Collaborating for the Advancement of Interdisciplinary Benign Urology Research (CAIRIBU) Annual Meeting, Urinary Dysfunction section.
• 11/2023, Ajinkya Limkar (Ricke Lab, PhD Candidate), Travel Award to attend the 2023 Society for Benign Urologic Research Annual Meeting (SBUR)
• 11/2023, Han Zhang (Ricke Lab, PhD Candidate), Travel Award from UW WISH to attend the 2023 Society for Benign Urologic Research Annual Meeting (SBUR)
• 10/2023, Alexis Adrian (Ricke Lab, PhD Candidate), Travel Award to attend the 2023 Annual Meeting for CAIRIBU (Collaborating for the Advancement of Interdisciplinary Research in Benign Urology)
• 10/2023, Stephanie Li (Ricke Lab, Undergraduate Researcher), Travel Award to attend the 2023 Annual Meeting for CAIRIBU (Collaborating for the Advancement of Interdisciplinary Research in Benign Urology)
• 6/2023, Ruiqi Geng (Hernando Lab, PhD Candidate), Finalist for International Society for Magnetic Resonance in Medicine (ISMRM) Young Investigator Award
• 6/2023, Paula Manan-Meijas (Ricke Lab, PhD Candidate) Information Network (dkNET) Summer Participant Award
• 6/2023, Ajinkya Limkar (Ricke Lab, PhD Candidate) Information Network (dkNET) Summer Participant Award
• 6/2023, Ruiqi Geng (Hernando Lab, PhD Candidate), Finalist for the International Society for Magnetic Resonance in Medicine (ISMRM) Young Investigator Award
• 3/2023, Diego Hernando, PhD, UW-Madison Vilas Faculty Early-Career Investigator Award
• 12/2022, Alejandro Roldán-Alzate (K12 Scholar), Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) 2022 Best Poster Award
• 9/2022, Han Zhang (Ricke Lab, PhD Candidate), UW School of Pharmaceutical Sciences Graduate Travel Award
• 9/2022, Han Zhang (Ricke Lab, PhD Candidate), Society for Basic Urologic Research (SBUR) Trainee Travel Award
• 9/2022, Teresa Liu (Ricke Lab, Scientist I/K01 Scholar), Society for Basic Urologic Research (SBUR) Trainee Travel Award
• 9/2022, Hannah Miles (Ricke/Li Labs, PhD Student), Society for Basic Urologic Research (SBUR) Trainee Travel Award
• 9/2022, Hannah Miles (Ricke/Li Labs, PhD Student), UW School of Pharmaceutical Sciences Graduate Travel Award)
• 8/2022, Maggie Stangis (Ricke Lab, PhD Student), UW Carbone Cancer Center (UWCCC) Heidi Dvinge & Patti Keely Travel Award
• 7/2022, Monica Ridlon (Keil Stietz Lab, PhD Student), 1^st place, Graduate Women in Science (GWIS) Benign Urology-sponsored Abstract and Poster Award
• 7/2022, Alexis Adrian (Ricke Lab, PhD Student), runner up, Graduate Women in Science (GWIS) Benign Urology-sponsored Abstract and Poster Award
• 6/2022, Kimberly Keil Stietz (O’Brien Center Biomed Core Co-Director), 2022 Society of Toxicology Midwest Regional Chapter Early Career Toxicologist Award
• 6/2022, Hannah Miles (Ricke/Li Labs, PhD Candidate), UW Pharmaceutical Sciences Student Travel Award
• 6/2022, Han Zhang (Ricke Lab, PhD Candidate), UW Pharmaceutical Sciences Student Travel Award
• 6/2022, Maggie Stangis (Ricke Lab, PhD Candidate), 2022 dkNET Summer of Data Student Internship Scholarship
• 6/2022, Hannah Miles (Ricke/Li Labs, PhD Candidate), American Society for Mass Spectrometry (ASMS) Graduate Student Travel Award
• 4/2022, Kegan Skalitzky (Ricke Lab, Undergraduate), 2022 Hilldale Fellowship
• 4/2022, Jaskiran Sandhu (Vezina Lab, Undergraduate), 2022 Hilldale Fellowship
• 12/2021, Diya Binoy Joseph (Strand Lab, Post-doctoral Research Fellow), 2021 CAIRIBU Best Poster Award (Voiding Category)
• 12/2021, Alexis Adrian (Ricke Lab, PhD Candidate), 2021 CAIRIBU Best Poster Award (Animal Models Category)
• 11/2021, Alexis Adrian (Ricke Lab, PhD Candidate), 2021 SBUR Trainee Travel Award
• 11/2021, Chris Unterberger (Marker/Swanson Lab, PhD Candidate), UW-Madison School of Pharmacy Travel Award to attend 2021 SBUR Annual Meeting
• 9/2021, Diya Binoy Joseph (Strand Lab, Post-doctoral Research Fellow), Early-Career Investigator Travel Awards for AUA2021
• 9/2021, Hannah Miles (Ricke/Li Labs, PhD Candidate), UW Carbone Cancer Center Heidi Dvinge and Patti Keely Trainee Honor Society Travel-Enrichment Award
• 5/2021, Diego Hernando (O’Brien Center Project 1 Co-I), Magna Cum Laude Award, Abstract 3304, International Society for Magnetic Resonance in Medicine (ISMRM) Magna Cum, Virtual Meeting, May 15-20, 2021

• 5/2021, Asha Jain (Ricke Lab, Undergraduate Student), Finalist-Alternate for the Fulbright U.S. Student Program for an English Teaching Assistantship in India
• 4/2021, Petra Popovics (Ricke Lab, Assistant Scientist), Best Basic Science Abstract for 6^th Annual DUKE Multidisciplinary Benign Urology Research Symposium
• 3/2021, Jill Macoska (O’Brien Center Project 3 PI), Commonwealth of Massachusetts 2020 Citation for Outstanding Performance
• 3/2021, Hannah Ruetten (Vezina Lab, F30 Fellow), UW Comparative Biomedical Sciences (CBMS) Graduate Program Richard F. Marsh Outstanding Graduate Student Award
• 1/2021, Petra Popovics (Ricke Lab, Assistant Scientist), NIH Mentored Research Scientist Development Award (K01) to study “Osteopontin: a novel mediator of prostatic inflammation and fibrosis”
• 12/2020, Teresa Liu (Ricke Lab, Assistant Scientist/K01 Scholar), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Best Poster Award (tied for 1^st place)
• 12/2020, Livianna Myklebust (Ricke Lab, Research Assistant), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Best Poster Award (tied for 1^st place)
• 12/2020, Hannah Ruetten (Vezina Lab, Graduate Student), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Best Poster Award (3^rd place)
• 12/2020, Debra Garvey (Ricke Lab, Postdoctoral Researcher), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Honorable Mention Abstract Award
• 12/2020, Alexis Adrian (Ricke Lab, Graduate student), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) ‘Close Second’ Poster Award
• 12/2020, Diya Binoy Joseph (Strand Lab, Post-doctoral Research Fellow), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) ‘Close Second’ Poster Award
• 12/2020, Riley Medenwald (Ricke Lab, Undergraduate student), 2020 Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) ‘Close Second’ Poster Award
• 11/2020, Diya Binoy Joseph (Strand Lab, Post-doctoral Research Fellow), 2020 Society of Basic Urologic Research virtual meeting travel award
• 11/2020, Anne Turco (Vezina Lab, Graduate student), 2020 Society of Basic Urologic Research virtual meeting travel award
• 5/2020, Teresa Liu (Ricke Lab, Assistant Scientist), NIH Mentored Research Scientist Development Award (K01) to study the “impact of age on altered steroidogenesis and estrogen receptor activation in benign prostatic hyperplasia progression”
• 5/2020, Anne Turco (Vezina Lab, Graduate student), NIH F31 grant for her project entitled “Developmental Origins of Prostate-related Urinary Dysfunction in Adult Males: TCDD Exposure Increases Prostatic Noradrenergic Innervation and Smooth Muscle Contraction”
• 5/2020, Asha Jain (Ricke lab, Undergraduate student), UW-Madison 2020-2021 Sophomore Research Scholarship
• 5/2020, Thrishna Chathurvedula (Vezina lab, Undergraduate), 2020-2021 Hilldale Undergraduate/Faculty Research Fellowship
• 4/2020, Anne Turco (Vezina lab, Graduate student), 2020 Dr. Eric A. Andreasen Graduate Student Award for Excellence in Research and Scholarship
• 2/2020, Diya Binoy Joseph (Strand Lab, UT-Southwestern, Post-doctoral Researcher), 2020 Urology Care Foundation Research Scholar Award (Indian American Urological Association Sakti Das, MD Award)
• 1/2020, Kyle Wegner (Vezina Lab, Graduate student), Wisconsin Initiative for Science Literacy Award for Communicating Graduate Chemistry Research to the Public
• 12/2019, Anne Turco (Vezina Lab, Graduate student), Celebrating Women in Toxicology Award from the Women in Toxicology (WIT) Special Interest Group
• 12/2019, Hannah Ruetten (Vezina Lab, Graduate student), Best Poster Award at the Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Meeting, Kansas City, MO
• 12/2019, Livianna Myklebust (Ricke Lab, former SPUUR Intern), Best Poster Award at the Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Meeting, Kansas City, MO
• 12/2019, Mathilde Bonnemaison (Macoska Lab, Post-Doctoral Fellow), Best Poster Award at the Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Meeting, Kansas City, MO
• 11/2019, Nicholas Girardi, UW-Madison College of Letters and Science Trewartha Senior Thesis Research Grant recipient
• 10/2019, Chad Vezina, 2019 University of Wisconsin-Madison Vilas Mid-Career Award
• 10/2019, Anne Turco, Research Assistant/PhD Student (Vezina Lab), 2019 Zaman-Saroya Award (University of Wisconsin-Madison School of Pharmacy)
• 09/2019, Hannah Ruetten, Research Assistant/DVM-PhD Student (Vezina Lab), Four Year National Institutes of Health Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship (F30)
• 09/2019, Petra Popovics, K12 Scholar/Assistant Scientist (Ricke Lab), SBUR Travel Award and podium presentation selection
• 09/2019, Teresa Liu, K12 Scholar/Assistant Scientist (Ricke Lab), SBUR Travel Award
• 09/2019, Diya Binoy Joseph, Post-doctoral Researcher (Strand Lab, UT-Southwestern), SBUR Travel Award and podium presentation selection
• 09/2019, Wanting Han, Graduate Student (Macoska Lab, University of Massachusetts-Boston), SBUR Travel Award and podium presentation selection
• 09/2019, Mathilde Bonnemaison, Postdoctoral Researcher (Macoska Lab, University of Massachusetts-Boston), SBUR Travel Award
• 06/2019, Livianna Myklebust, Research Assistant(Ricke Lab), Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Research Training and Development Award
• 06/2019, Kyle Wegner, PhD Candidate (Vezina Lab), Travel Award Grant, Society of Toxicologic Pathology
• 06/2019, Anne Turco, PhD Candidate (Vezina Lab), Travel Award Grant, Society of Toxicologic Pathology
• 05/2019, William Ricke, 2019 Society of Toxicology Kenneth P. DuBois Award
• 04/2019, Kyle Wegner, PhD Candidate (Vezina Lab), Student Travel Award, UW-Madison
• 04/2019, Phinea Romero, Former SPUUR Undergraduate Intern (Vezina Lab), Robert Gunn Student Award, Experimental Biology Meeting, American Physiological Society
• 04/2019, Diya Binoy Joseph (Vezina Lab), UW-Madison Cellular and Molecular Biology Graduate Program 2018 Exceptional Thesis Award
• 03/2019, Phinea Romero, SPUUR Intern, Robert Gunn Student Award, American Physiological Society
• 2019-present, Chad Vezina, Director, Molecular and Environmental Toxicology Center, University of Wisconsin-Madison
• 2019, Kim Keil, PhD, 2019 Women in Toxicology Postdoctoral Achievement Award
• 12/2018, Anne Turco, Research Associate (Vezina Lab), Society of Toxicology Supplemental Training for Education Program (STEP) Award
• 12/2018, Chelsea O’Driscoll, Research Associate (Vezina Lab), Best Poster Award, Collaborating for the Advancement of Interdisciplinary  Research in Benign Urology (CAIRIBU) Meeting, Ellicott City, MD
• 12/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Best Poster Award, Collaborating for the Advancement of Interdisciplinary  Research in Benign Urology (CAIRIBU) Meeting, Ellicott City, MD
• 11/2018, Dalton McLean, Graduate Student, Travel Award, SBUR, Palm Springs, CA: “Fibroblast Growth Factor-5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer”
• 10/2018, Anne Turco, Research Assistant (Vezina Lab), Eula and Donald S. Coffey Research Innovation Award, Society for Basic Urologic Research
• 10/2018, Mark Cadena, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
• 10/2018, Anne Turco, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
• 10/2018, Kyle Wegner, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
• 10/2018, Hannah Ruetten, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
• 10/2018, Diya Binoy Joseph, Research Assistant (Vezina Lab), Cellular and Molecular Biology Travel Award
• 04/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Comparative Biomedical Sciences Spring Travel Award
• 04/2018, Kyle Wegner, Research Assistant (Vezina Lab), Midwest Regional Chapter of the Society of Toxicology Young Investigator Award
• 04/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Institute of Clinical and Translational Research TL-1 clinical training grant
• 03/2018, Kyle Wegner, Research Assistant (Vezina Lab), Eric Andreasen Memorial Award for Research Excellence
• 03/2018, Kyle Wegner, Research Assistant (Vezina Lab), National Institutes of Health F31 Research Fellowship Award
• 03/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Comparative Biomedical Science Graduate Program Travel Award
• 03/2018, Teresa Liu, K12 scholar (Ricke Lab), moderated poster session: “Altered steroidogenesis on estrogen receptor activation in benign prostatic hyperplasia”, ENDO, Chicago, IL
• 2018, Ashleigh Theberge, former K12 Scholar (Ricke Lab), one of ten 2018 Beckman Young Investigator (BYI) Award recipients
• 2018, Ashleigh Theberge, former K12 Scholar (Ricke Lab), NIH Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35)
• 2018, Jalissa Wynder (Nguyen), Post-doc (Ricke Lab), Burdock Group student travel award
• 2018, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Toxicologists of African Origin (TAO) travel award
• 2018, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Graduate Student Excellence Award from the Regulatory and Safety Evaluation Specialty Section (RSESS) of the Society of Toxicology
• 11/2017, Kyle Wegner, Research Assistant (Vezina Lab), Society of Toxicology Supplemental Training for Education Program (STEP) Award
• 09/2017, Diya Binoy Joseph, Research Assistant (Vezina Lab), Gregory F. Daniels Best Poster award, UW-Madison Stem Cell & Regenerative Medicine Center Fall Conference
• 08/2017, Jordan Vellky, Graduate Student (Ricke Lab), Gordon Research Conference: Hormone-Dependent Cancers, Newry, ME: “Hormonal Modulation of DDX3 and its Implications for Translational Regulation in Prostate Cancer”
• 08/2017, Jordan Vellky, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
• 08/2017, Dalton McLean, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
• 08/2017, Kyle Wegner, Research Assistant (Vezina Lab), Zaman-Saroya Award winner for excellence in research and scholarship (University of Wisconsin-Madison)
• 08/2017, Anne Turco, Research Assistant (Vezina Lab), National Institutes of Health T32 training grant in Molecular and Environmental Toxicology
• 08/2017, Diya Binoy Joseph, Scholar, Workshop on Epigenetics at the Van Andel Research Institute
• 08/2017, Kyle Wegner, Research Assistant (Vezina Lab), cover art in J Histochem Cytochem
• 07/2018, Mark Cadena, Research Assistant (Vezina Lab), two year research grant from the National Institutes of Health to support his studies of prostate neuroendocrine cells.
• 04/2017, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
• 02/2017, Anoop Chandrashekar, Undergraduate Researcher (Vezina Lab), National Merit Scholar Finalist
• 2017, Ashleigh Theberge, former K12 Scholar (Ricke Lab), one of three worldwide recipients of the Kavli Microbiome Ideas Challenge Award (ASM, ACS & APS)
• 2017, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Invited Speaker at Southern University’s Wilbur B. Clarke Chemistry Symposium
• 2017, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), ILSI North America Summer Fellow
• 2017-present, William Ricke, CoLeader, Tumor Microenvironment, Senior Leadership-UW Carbone Cancer Center
• 2017-present, William Ricke, Member, Research, Education, Conferences , Communications (RECC) Committee, American Urological Association
• 09/2019, Hannah Ruetten, Research Assistant (Vezina Lab), four year National Institutes of Health Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship (F30)
• 11/2016, Dalton McLean, Graduate Student (Ricke Lab), Travel Award, SBUR, Scottsdale, AZ: “In vivo Modeling of Metastasis Using a Prostate Cancer Progression Model”
• 09/2016, Mark Cadena, Research Assistant (Vezina Lab), Society for Basic Urologic Research Fall Meeting Travel Award.
• 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), Society for Basic Urologic Research Fall Meeting Travel Award.
• 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), Cellular and Molecular Biology Travel award
• 09/2016, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), UW-Madison College of Engineering Frederick J. Mancheski Scholarship
• 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), American Urological Association Summer Research Conference Travel Award
• 08/2016, Jordan Vellky, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
• 08/2016, Dalton McLean, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
• 05/2016, William Ricke, Plenary talk, American Urological Association, San Diego, CA
• 05/2016, Chad Vezina, Zoetis Award for Veterinary Research Excellence 04/2016, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), Sophomore Undergraduate Research Fellowship
• 2016-present, William Ricke, Affiliate Associate Professor, Division of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy
• 2016-present, Ashleigh Theberge, former K12 Scholar (Ricke Lab), Assistant Professor of Chemistry and Adjunct Assistant Professor of Urology, University of Washington
• 2016-present, Chad Vezina, Director, Summer Program in Undergraduate Urologic Research (SPUUR), University of Wisconsin-Madison
• 11/2015, Jordan Vellky, Graduate Student (Ricke Lab), Travel Award, SBUR, Ft. Lauderdale, FL: “BOP1 Expression and Localization in Benign Prostatic Disease and Prostate Cancer Progression”
• 06/2015, Helene Altmann, Undergraduate Researcher (Vezina Lab), Promega International Scientific Internship Scholarship
• 06/2015, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Barry Goldwater Federal Scholarship
• 06/2015, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Rhoades Scholarship Finalist
• 06/2015, Helene Altmann, Undergraduate Researcher (Vezina Lab), Covance Laboratories Pharmacology and Toxicology Excellence Award
• 02/2015, William Ricke, Associate Professor, Clark-Atlanta University Lecture, Atlanta, GA, Graduate student and postdoc association, “Hormone action and paracrine interactions in prostatic carcinogenesis”
• 2015, Tristan Nicholson, former Graduate Student (Ricke Lab), MD with Distinction in Research, PhD Pathology, University of Rochester School of Medicine and Dentisry
• 2015, Tristan Nicholson, Graduate Student (Ricke Lab), Robert E. Kates Award for excellence in clinical medicine and research, University of Rochester School of Medicine and Dentistry
• 2015, Tristan Nicholson, Graduate Student (Ricke Lab), Glasgow-Rubin Citation for graduating 1^stin Class of 2015, University of Rochester School of Medicine and Dentistry
• 2015, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Edward Bouchet Graduate Honor Society Inductee
• 2015-present, William Ricke, UW Medical Foundation Professor of Urologic Research, Endowed Professorship
• 2015-present, Teresa Liu, K12 Scholar (Ricke Lab), Investigator, NIH K Career Development Award Scholar, Department of Urology, University of Wisconsin-Madison
• 2015-present, Chad Vezina, Associate Professor, Dept. Comparative Biosciences, University of Wisconsin-Madison
• 2015-present, Chad Vezina, Adjunct Associate Professor, Dept. Urology, University of Wisconsin-Madison School of Medicine and Public Health
• 2015-present, Chad Vezina, Affiliate Associate Professor, Division
• 11/2014, Kimberly Keil, Research Assistant (Vezina Lab), Society of Basic Urology Research Travel Award
• 04/2014, Helene Altmann, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
• 04/2014, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
• 04/2014, Kimberly Keil, Research Assistant (Vezina Lab), NSF Graduate Research Fellowship
• 04/2014, Kimberly Keil, Research Assistant (Vezina Lab), Richard F. Marsh Outstanding Graduate Student Award
• 2014-present, William Ricke, University of Wisconsin, George M. O’Brien Center Director
• 2014-2016, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), NIEHS (T32) Pre-doctoral Traineeship in Environmental Toxicology
• 2014-2015, Dr. Ashleigh Theberge, K12 Scholar (Ricke Lab), Investigator, NIH K Career Development Award Scholar, Departments of Biomedical Engineering and Urology, University of Wisconsin-Madison
• 2014, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Travel award for Underrepresented Minority Fellows Symposium (AUMF)
• 1988-present, Dale Bjorling, Associate Professor, University of Wisconsin, Department of Surgical Sciences
• 1988-2011, Dale Bjorling, Department Chair, University of Wisconsin, Department of Surgical Sciences
• 1994-present, Dale Bjorling, Professor, University of Wisconsin, Department of Surgical Sciences
• 2008-present, Dale Bjorling, Professor, University of Wisconsin, Department of Urology
• 2011-present, Dale Bjorling, Associate Dean for Research, University of Wisconsin, School of Veterinary Medicine